Metabolomics Workbench : NIH Data Repository

Samples for study ST001237

Species: Homo sapiens (Factor headings shown in green)

mb_sample_id	Subject name	Sample name	Time point	OS_Censor (1 means the time is a censoring time and 0 means a failure time in OS)	CRF_MSKCC_Risk_Group	Treatment	Prior antiangiogenic regimens (≥2)	Sample_Data:OS (Overall Survival, months)	Trial	Region	Derived_Age_at_Consent	Sex	Race	raw file name
SA089172	CA209025-1-1048	CA209025-1-1048_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	38.275	Phase III_RCC_CA209025	US/CANADA	56	M	WHITE	0227_Marios_PD1_Inhib2_HP-AF439758-9.raw
SA089186	CA209025-1-110	CA209025-1-110_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	34.793	Phase III_RCC_CA209025	US/CANADA	58	M	WHITE	0726_Marios_PD1_Inhib2_HP-AD424475-8.raw
SA089174	CA209025-114-56	CA209025-114-56_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	52.403	Phase III_RCC_CA209025	WESTERN EUROPE	62	F	WHITE	0603_Marios_PD1_Inhib2_HP-E9123054-7.raw
SA089179	CA209025-11-481	CA209025-11-481_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	29.339	Phase III_RCC_CA209025	US/CANADA	55	M	WHITE	0637_Marios_PD1_Inhib2_HP-AD604107-7.raw
SA089182	CA209025-12-216	CA209025-12-216_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	35.647	Phase III_RCC_CA209025	WESTERN EUROPE	64	F	WHITE	1161_Marios_PD1_Inhib2_HP-E9108720-7.raw
SA089185	CA209025-12-275	CA209025-12-275_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	48.296	Phase III_RCC_CA209025	WESTERN EUROPE	56	M	WHITE	0228_Marios_PD1_Inhib2_HP-EA000634-7.raw
SA089187	CA209025-135-434	CA209025-135-434_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	46.949	Phase III_RCC_CA209025	REST OF WORLD	51	F	WHITE	0782_Marios_PD1_Inhib2_HP-L1366488-10.raw
SA089201	CA209025-139-224	CA209025-139-224_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	48.230	Phase III_RCC_CA209025	US/CANADA	55	M	WHITE	0335_Marios_PD1_Inhib2_HP-AE052725-7.raw
SA089203	CA209025-139-227	CA209025-139-227_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	46.883	Phase III_RCC_CA209025	US/CANADA	56	M	WHITE	1188_Marios_PD1_Inhib2_HP-AE052720-7.raw
SA089188	CA209025-139-827	CA209025-139-827_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	43.138	Phase III_RCC_CA209025	US/CANADA	69	F	WHITE	0554_Marios_PD1_Inhib2_HP-AE913730-7.raw
SA089173	CA209025-141-667	CA209025-141-667_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	28.583	Phase III_RCC_CA209025	US/CANADA	70	M	WHITE	0362_Marios_PD1_Inhib2_HP-AE462180-7.raw
SA089170	CA209025-141-730	CA209025-141-730_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	34.793	Phase III_RCC_CA209025	US/CANADA	53	M	WHITE	0712_Marios_PD1_Inhib2_HP-AD780394-7.raw
SA089202	CA209025-14-943	CA209025-14-943_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	41.429	Phase III_RCC_CA209025	US/CANADA	75	F	WHITE	0929_Marios_PD1_Inhib2_HP-AE902415-7.raw
SA089171	CA209025-154-1019	CA209025-154-1019_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	39.754	Phase III_RCC_CA209025	REST OF WORLD	70	M	OTHER	0707_Marios_PD1_Inhib2_HP-S4107199-9.raw
SA089190	CA209025-154-125	CA209025-154-125_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	34.168	Phase III_RCC_CA209025	REST OF WORLD	62	M	OTHER	0835_Marios_PD1_Inhib2_HP-S3470295-7.raw
SA089207	CA209025-158-182	CA209025-158-182_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	49.774	Phase III_RCC_CA209025	REST OF WORLD	59	M	OTHER	0224_Marios_PD1_Inhib2_HP-S3473954-7.raw
SA089206	CA209025-159-812	CA209025-159-812_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	43.400	Phase III_RCC_CA209025	REST OF WORLD	68	M	OTHER	1205_Marios_PD1_Inhib2_HP-S4005764-7.raw
SA089184	CA209025-159-994	CA209025-159-994_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	24.476	Phase III_RCC_CA209025	REST OF WORLD	60	F	OTHER	0319_Marios_PD1_Inhib2_HP-S4199733-8.raw
SA089169	CA209025-160-157	CA209025-160-157_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	50.201	Phase III_RCC_CA209025	REST OF WORLD	71	M	OTHER	0390_Marios_PD1_Inhib2_HP-S3474788-7.raw
SA089183	CA209025-174-235	CA209025-174-235_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	32.953	Phase III_RCC_CA209025	REST OF WORLD	72	M	OTHER	1053_Marios_PD1_Inhib2_HP-S3733281-7.raw
SA089181	CA209025-180-937	CA209025-180-937_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	27.860	Phase III_RCC_CA209025	REST OF WORLD	62	M	WHITE	0878_Marios_PD1_Inhib2_HP-E9784760-7.raw
SA089176	CA209025-1-96	CA209025-1-96_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	51.384	Phase III_RCC_CA209025	US/CANADA	54	M	WHITE	1086_Marios_PD1_Inhib2_HP-AD185795-7.raw
SA089178	CA209025-20-946	CA209025-20-946_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	41.298	Phase III_RCC_CA209025	US/CANADA	55	M	WHITE	0558_Marios_PD1_Inhib2_HP-AF002811-9.raw
SA089177	CA209025-2-210	CA209025-2-210_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	31.967	Phase III_RCC_CA209025	WESTERN EUROPE	69	M	OTHER	0881_Marios_PD1_Inhib2_HP-E9657513-7.raw
SA089180	CA209025-2-792	CA209025-2-792_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	25.331	Phase III_RCC_CA209025	WESTERN EUROPE	68	F	WHITE	1218_Marios_PD1_Inhib2_HP-E9618949-7.raw
SA089175	CA209025-39-133	CA209025-39-133_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	39.951	Phase III_RCC_CA209025	WESTERN EUROPE	54	F	WHITE	0239_Marios_PD1_Inhib2_HP-E9204601-7.raw
SA089205	CA209025-42-441	CA209025-42-441_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	47.606	Phase III_RCC_CA209025	US/CANADA	65	F	WHITE	0720_Marios_PD1_Inhib2_HP-AE155083-7.raw
SA089200	CA209025-43-787	CA209025-43-787_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	26.809	Phase III_RCC_CA209025	US/CANADA	61	F	WHITE	0446_Marios_PD1_Inhib2_HP-AE794300-7.raw
SA089198	CA209025-50-281	CA209025-50-281_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	29.963	Phase III_RCC_CA209025	WESTERN EUROPE	61	M	WHITE	0965_Marios_PD1_Inhib2_HP-E9721147-7.raw
SA089204	CA209025-65-579	CA209025-65-579_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	45.733	Phase III_RCC_CA209025	WESTERN EUROPE	86	M	WHITE	1222_Marios_PD1_Inhib2_HP-EA048754-7.raw
SA089196	CA209025-82-690	CA209025-82-690_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	44.419	Phase III_RCC_CA209025	WESTERN EUROPE	41	M	WHITE	0926_Marios_PD1_Inhib2_HP-EA305476-7.raw
SA089195	CA209025-82-745	CA209025-82-745_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	44.090	Phase III_RCC_CA209025	WESTERN EUROPE	62	M	WHITE	0080_Marios_PD1_Inhib2_HP-EA305477-7.raw
SA089197	CA209025-84-861	CA209025-84-861_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	27.466	Phase III_RCC_CA209025	REST OF WORLD	59	M	WHITE	0608_Marios_PD1_Inhib2_HP-L1381828-7.raw
SA089194	CA209025-87-548	CA209025-87-548_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	46.554	Phase III_RCC_CA209025	WESTERN EUROPE	66	F	WHITE	0723_Marios_PD1_Inhib2_HP-E9774328-7.raw
SA089193	CA209025-89-33	CA209025-89-33_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	37.027	Phase III_RCC_CA209025	WESTERN EUROPE	55	M	WHITE	0589_Marios_PD1_Inhib2_HP-E9073345-7.raw
SA089191	CA209025-92-806	CA209025-92-806_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	27.236	Phase III_RCC_CA209025	WESTERN EUROPE	69	M	WHITE	1020_Marios_PD1_Inhib2_HP-E9123073-7.raw
SA089192	CA209025-93-212	CA209025-93-212_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	35.877	Phase III_RCC_CA209025	WESTERN EUROPE	47	F	WHITE	1038_Marios_PD1_Inhib2_HP-E9123037-7.raw
SA089199	CA209025-93-274	CA209025-93-274_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	48.493	Phase III_RCC_CA209025	WESTERN EUROPE	52	M	WHITE	0617_Marios_PD1_Inhib2_HP-E9791865-7.raw
SA089189	CA209025-9-649	CA209025-9-649_baseline	baseline	1	FAVORABLE	EVEROLIMUS	FALSE	26.152	Phase III_RCC_CA209025	US/CANADA	62	M	WHITE	1171_Marios_PD1_Inhib2_HP-AE556393-6.raw
SA089214	CA209025-103-747	CA209025-103-747_baseline	baseline	1	FAVORABLE	EVEROLIMUS	TRUE	43.992	Phase III_RCC_CA209025	REST OF WORLD	81	M	WHITE	0148_Marios_PD1_Inhib2_HP-E9648565-7.raw
SA089215	CA209025-1-1056	CA209025-1-1056_baseline	baseline	1	FAVORABLE	EVEROLIMUS	TRUE	22.801	Phase III_RCC_CA209025	US/CANADA	76	M	WHITE	0200_Marios_PD1_Inhib2_HP-AF439757-9.raw
SA089219	CA209025-111-657	CA209025-111-657_baseline	baseline	1	FAVORABLE	EVEROLIMUS	TRUE	25.692	Phase III_RCC_CA209025	REST OF WORLD	62	F	WHITE	0582_Marios_PD1_Inhib2_HP-EA003798-7.raw
SA089218	CA209025-138-699	CA209025-138-699_baseline	baseline	1	FAVORABLE	EVEROLIMUS	TRUE	43.532	Phase III_RCC_CA209025	US/CANADA	52	M	WHITE	0139_Marios_PD1_Inhib2_HP-AE428477-7.raw
SA089216	CA209025-139-741	CA209025-139-741_baseline	baseline	1	FAVORABLE	EVEROLIMUS	TRUE	27.368	Phase III_RCC_CA209025	US/CANADA	67	F	WHITE	0869_Marios_PD1_Inhib2_HP-AE861577-7.raw
SA089213	CA209025-139-775	CA209025-139-775_baseline	baseline	1	FAVORABLE	EVEROLIMUS	TRUE	43.598	Phase III_RCC_CA209025	US/CANADA	73	M	WHITE	0490_Marios_PD1_Inhib2_HP-AE645250-7.raw
SA089211	CA209025-158-77	CA209025-158-77_baseline	baseline	1	FAVORABLE	EVEROLIMUS	TRUE	35.220	Phase III_RCC_CA209025	REST OF WORLD	60	M	OTHER	0225_Marios_PD1_Inhib2_HP-S3473953-7.raw
SA089220	CA209025-2-67	CA209025-2-67_baseline	baseline	1	FAVORABLE	EVEROLIMUS	TRUE	33.380	Phase III_RCC_CA209025	WESTERN EUROPE	61	M	OTHER	0160_Marios_PD1_Inhib2_HP-E9130936-7.raw
SA089217	CA209025-41-455	CA209025-41-455_baseline	baseline	1	FAVORABLE	EVEROLIMUS	TRUE	36.928	Phase III_RCC_CA209025	US/CANADA	69	M	OTHER	0636_Marios_PD1_Inhib2_HP-AD604542-7.raw
SA089212	CA209025-44-464	CA209025-44-464_baseline	baseline	1	FAVORABLE	EVEROLIMUS	TRUE	27.959	Phase III_RCC_CA209025	US/CANADA	66	M	WHITE	0577_Marios_PD1_Inhib2_HP-AE002908-7.raw
SA089209	CA209025-47-1037	CA209025-47-1037_baseline	baseline	1	FAVORABLE	EVEROLIMUS	TRUE	40.476	Phase III_RCC_CA209025	US/CANADA	53	M	WHITE	0567_Marios_PD1_Inhib2_HP-AF016166-10.raw
SA089221	CA209025-58-162	CA209025-58-162_baseline	baseline	1	FAVORABLE	EVEROLIMUS	TRUE	50.858	Phase III_RCC_CA209025	WESTERN EUROPE	57	M	OTHER	0038_Marios_PD1_Inhib2_HP-E9425615-7.raw
SA089210	CA209025-86-735	CA209025-86-735_baseline	baseline	1	FAVORABLE	EVEROLIMUS	TRUE	44.090	Phase III_RCC_CA209025	WESTERN EUROPE	51	M	WHITE	0350_Marios_PD1_Inhib2_HP-E9164126-7.raw
SA089208	CA209025-87-229	CA209025-87-229_baseline	baseline	1	FAVORABLE	EVEROLIMUS	TRUE	33.643	Phase III_RCC_CA209025	WESTERN EUROPE	61	M	WHITE	0623_Marios_PD1_Inhib2_HP-E9103644-7.raw
SA089258	CA209025-101-142	CA209025-101-142_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	51.187	Phase III_RCC_CA209025	WESTERN EUROPE	73	M	WHITE	0634_Marios_PD1_Inhib2_HP-E9123031-7.raw
SA089256	CA209025-118-255	CA209025-118-255_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	49.380	Phase III_RCC_CA209025	WESTERN EUROPE	59	F	WHITE	0412_Marios_PD1_Inhib2_HP-E9712824-7.raw
SA089246	CA209025-13-181	CA209025-13-181_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	50.234	Phase III_RCC_CA209025	US/CANADA	61	M	WHITE	0466_Marios_PD1_Inhib2_HP-AD827408-7.raw
SA089245	CA209025-138-734	CA209025-138-734_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	44.682	Phase III_RCC_CA209025	US/CANADA	62	F	WHITE	1189_Marios_PD1_Inhib2_HP-AE428478-7.raw
SA089243	CA209025-139-1006	CA209025-139-1006_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	39.589	Phase III_RCC_CA209025	US/CANADA	46	M	WHITE	0920_Marios_PD1_Inhib2_HP-AF003923-9.raw
SA089252	CA209025-154-929	CA209025-154-929_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	42.481	Phase III_RCC_CA209025	REST OF WORLD	51	M	OTHER	1155_Marios_PD1_Inhib2_HP-S4107200-9.raw
SA089253	CA209025-156-1017	CA209025-156-1017_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	39.918	Phase III_RCC_CA209025	REST OF WORLD	59	M	OTHER	1050_Marios_PD1_Inhib2_HP-S4124106-9.raw
SA089251	CA209025-15-773	CA209025-15-773_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	44.090	Phase III_RCC_CA209025	US/CANADA	53	M	WHITE	0331_Marios_PD1_Inhib2_HP-AE562609-7.raw
SA089250	CA209025-15-99	CA209025-15-99_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	51.515	Phase III_RCC_CA209025	US/CANADA	51	M	WHITE	0734_Marios_PD1_Inhib2_HP-AD267739-7.raw
SA089254	CA209025-161-577	CA209025-161-577_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	45.339	Phase III_RCC_CA209025	REST OF WORLD	46	M	OTHER	0287_Marios_PD1_Inhib2_HP-S3672131-7.raw
SA089249	CA209025-161-974	CA209025-161-974_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	40.936	Phase III_RCC_CA209025	REST OF WORLD	69	F	OTHER	0517_Marios_PD1_Inhib2_HP-S4103669-8.raw
SA089248	CA209025-162-171	CA209025-162-171_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	50.037	Phase III_RCC_CA209025	REST OF WORLD	70	F	OTHER	1174_Marios_PD1_Inhib2_HP-S3475115-7.raw
SA089242	CA209025-169-660	CA209025-169-660_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	44.419	Phase III_RCC_CA209025	REST OF WORLD	63	M	OTHER	0842_Marios_PD1_Inhib2_HP-S3606414-7.raw
SA089257	CA209025-170-221	CA209025-170-221_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	50.201	Phase III_RCC_CA209025	REST OF WORLD	45	M	OTHER	0777_Marios_PD1_Inhib2_HP-S3474749-7.raw
SA089244	CA209025-17-1044	CA209025-17-1044_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	39.524	Phase III_RCC_CA209025	US/CANADA	53	M	WHITE	0378_Marios_PD1_Inhib2_HP-AE613960-7.raw
SA089263	CA209025-173-757	CA209025-173-757_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	22.111	Phase III_RCC_CA209025	REST OF WORLD	51	M	OTHER	0496_Marios_PD1_Inhib2_HP-S3575912-7.raw
SA089241	CA209025-174-1010	CA209025-174-1010_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	40.049	Phase III_RCC_CA209025	REST OF WORLD	70	M	OTHER	0982_Marios_PD1_Inhib2_HP-S4107168-9.raw
SA089247	CA209025-17-928	CA209025-17-928_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	42.283	Phase III_RCC_CA209025	US/CANADA	77	M	WHITE	1057_Marios_PD1_Inhib2_HP-AF015796-9.raw
SA089264	CA209025-18-954	CA209025-18-954_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	41.922	Phase III_RCC_CA209025	US/CANADA	43	M	OTHER	0678_Marios_PD1_Inhib2_HP-AF008928-9.raw
SA089265	CA209025-2-10	CA209025-2-10_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	53.848	Phase III_RCC_CA209025	WESTERN EUROPE	71	F	WHITE	0253_Marios_PD1_Inhib2_HP-E9064309-7.raw
SA089266	CA209025-21-1027	CA209025-21-1027_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	34.267	Phase III_RCC_CA209025	US/CANADA	69	F	WHITE	0934_Marios_PD1_Inhib2_HP-AF063577-9.raw
SA089260	CA209025-21-1039	CA209025-21-1039_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	31.803	Phase III_RCC_CA209025	US/CANADA	59	F	WHITE	0892_Marios_PD1_Inhib2_HP-AF063576-9.raw
SA089261	CA209025-21-849	CA209025-21-849_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	40.312	Phase III_RCC_CA209025	US/CANADA	52	F	WHITE	0783_Marios_PD1_Inhib2_HP-AE622889-10.raw
SA089259	CA209025-22-1000	CA209025-22-1000_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	40.969	Phase III_RCC_CA209025	US/CANADA	64	F	WHITE	0439_Marios_PD1_Inhib2_HP-AE302092-6.raw
SA089262	CA209025-23-8	CA209025-23-8_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	12.485	Phase III_RCC_CA209025	US/CANADA	46	M	WHITE	1002_Marios_PD1_Inhib2_HP-AD195648-7.raw
SA089255	CA209025-24-840	CA209025-24-840_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	42.842	Phase III_RCC_CA209025	US/CANADA	23	F	WHITE	0538_Marios_PD1_Inhib2_HP-AE003497-7.raw
SA089223	CA209025-29-1002	CA209025-29-1002_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	40.674	Phase III_RCC_CA209025	US/CANADA	60	M	WHITE	0482_Marios_PD1_Inhib2_HP-AF127960-9.raw
SA089224	CA209025-39-147	CA209025-39-147_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	50.201	Phase III_RCC_CA209025	WESTERN EUROPE	56	M	WHITE	1018_Marios_PD1_Inhib2_HP-E9432885-6.raw
SA089222	CA209025-41-979	CA209025-41-979_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	41.035	Phase III_RCC_CA209025	US/CANADA	57	M	OTHER	0583_Marios_PD1_Inhib2_HP-AE525980-7.raw
SA089226	CA209025-43-248	CA209025-43-248_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	28.780	Phase III_RCC_CA209025	US/CANADA	79	M	WHITE	0595_Marios_PD1_Inhib2_HP-AD452609-7.raw
SA089240	CA209025-43-743	CA209025-43-743_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	22.965	Phase III_RCC_CA209025	US/CANADA	44	M	WHITE	1076_Marios_PD1_Inhib2_HP-AE586111-7.raw
SA089236	CA209025-43-941	CA209025-43-941_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	22.012	Phase III_RCC_CA209025	US/CANADA	67	M	WHITE	0599_Marios_PD1_Inhib2_HP-AF003942-9.raw
SA089235	CA209025-44-643	CA209025-44-643_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	45.043	Phase III_RCC_CA209025	US/CANADA	56	M	WHITE	0721_Marios_PD1_Inhib2_HP-AE002907-7.raw
SA089227	CA209025-65-329	CA209025-65-329_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	48.066	Phase III_RCC_CA209025	WESTERN EUROPE	83	F	WHITE	0070_Marios_PD1_Inhib2_HP-EA048756-7.raw
SA089237	CA209025-6-586	CA209025-6-586_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	45.273	Phase III_RCC_CA209025	WESTERN EUROPE	63	M	WHITE	0745_Marios_PD1_Inhib2_HP-E9125345-7.raw
SA089238	CA209025-72-394	CA209025-72-394_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	47.934	Phase III_RCC_CA209025	WESTERN EUROPE	62	M	WHITE	0624_Marios_PD1_Inhib2_HP-E9145479-7.raw
SA089239	CA209025-73-511	CA209025-73-511_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	46.324	Phase III_RCC_CA209025	WESTERN EUROPE	55	M	OTHER	1115_Marios_PD1_Inhib2_HP-E9717900-7.raw
SA089234	CA209025-75-112	CA209025-75-112_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	51.220	Phase III_RCC_CA209025	WESTERN EUROPE	65	M	WHITE	0668_Marios_PD1_Inhib2_HP-E9479164-6.raw
SA089233	CA209025-82-338	CA209025-82-338_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	47.901	Phase III_RCC_CA209025	WESTERN EUROPE	68	M	WHITE	0586_Marios_PD1_Inhib2_HP-E9703898-7.raw
SA089230	CA209025-89-174	CA209025-89-174_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	50.398	Phase III_RCC_CA209025	WESTERN EUROPE	48	M	WHITE	0115_Marios_PD1_Inhib2_HP-E9073344-7.raw
SA089232	CA209025-89-725	CA209025-89-725_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	43.926	Phase III_RCC_CA209025	WESTERN EUROPE	45	M	WHITE	0342_Marios_PD1_Inhib2_HP-E9656487-7.raw
SA089229	CA209025-90-105	CA209025-90-105_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	50.727	Phase III_RCC_CA209025	WESTERN EUROPE	63	F	WHITE	0646_Marios_PD1_Inhib2_HP-E9103086-7.raw
SA089231	CA209025-9-756	CA209025-9-756_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	43.302	Phase III_RCC_CA209025	US/CANADA	63	M	WHITE	0512_Marios_PD1_Inhib2_HP-AE679322-8.raw
SA089225	CA209025-97-765	CA209025-97-765_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	44.058	Phase III_RCC_CA209025	REST OF WORLD	74	F	WHITE	0261_Marios_PD1_Inhib2_HP-S4008627-7.raw
SA089228	CA209025-9-892	CA209025-9-892_baseline	baseline	1	FAVORABLE	NIVOLUMAB	FALSE	43.072	Phase III_RCC_CA209025	US/CANADA	67	M	WHITE	1199_Marios_PD1_Inhib2_HP-AF002738-2.raw
SA089271	CA209025-111-299	CA209025-111-299_baseline	baseline	1	FAVORABLE	NIVOLUMAB	TRUE	47.639	Phase III_RCC_CA209025	REST OF WORLD	64	M	WHITE	0996_Marios_PD1_Inhib2_HP-EA003794-7.raw
SA089270	CA209025-114-813	CA209025-114-813_baseline	baseline	1	FAVORABLE	NIVOLUMAB	TRUE	43.926	Phase III_RCC_CA209025	WESTERN EUROPE	67	M	WHITE	0348_Marios_PD1_Inhib2_HP-EA341118-7.raw
SA089273	CA209025-139-1036	CA209025-139-1036_baseline	baseline	1	FAVORABLE	NIVOLUMAB	TRUE	38.571	Phase III_RCC_CA209025	US/CANADA	72	M	WHITE	0767_Marios_PD1_Inhib2_HP-AF003924-9.raw
SA089272	CA209025-139-610	CA209025-139-610_baseline	baseline	1	FAVORABLE	NIVOLUMAB	TRUE	44.649	Phase III_RCC_CA209025	US/CANADA	58	F	WHITE	0977_Marios_PD1_Inhib2_HP-AE052721-7.raw
SA089274	CA209025-161-518	CA209025-161-518_baseline	baseline	1	FAVORABLE	NIVOLUMAB	TRUE	45.667	Phase III_RCC_CA209025	REST OF WORLD	69	F	OTHER	0284_Marios_PD1_Inhib2_HP-S3672129-7.raw
SA089275	CA209025-17-154	CA209025-17-154_baseline	baseline	1	FAVORABLE	NIVOLUMAB	TRUE	51.055	Phase III_RCC_CA209025	US/CANADA	40	M	WHITE	0732_Marios_PD1_Inhib2_HP-AD577685-7.raw
SA089276	CA209025-17-94	CA209025-17-94_baseline	baseline	1	FAVORABLE	NIVOLUMAB	TRUE	51.220	Phase III_RCC_CA209025	US/CANADA	75	F	WHITE	0485_Marios_PD1_Inhib2_HP-AD577686-7.raw
SA089277	CA209025-2-401	CA209025-2-401_baseline	baseline	1	FAVORABLE	NIVOLUMAB	TRUE	46.719	Phase III_RCC_CA209025	WESTERN EUROPE	29	M	WHITE	0796_Marios_PD1_Inhib2_HP-E9618951-7.raw
SA089278	CA209025-33-466	CA209025-33-466_baseline	baseline	1	FAVORABLE	NIVOLUMAB	TRUE	47.146	Phase III_RCC_CA209025	WESTERN EUROPE	57	M	WHITE	0524_Marios_PD1_Inhib2_HP-E9811934-7.raw
SA089279	CA209025-65-340	CA209025-65-340_baseline	baseline	1	FAVORABLE	NIVOLUMAB	TRUE	47.672	Phase III_RCC_CA209025	WESTERN EUROPE	45	F	WHITE	0295_Marios_PD1_Inhib2_HP-EA048757-7.raw
SA089269	CA209025-93-836	CA209025-93-836_baseline	baseline	1	FAVORABLE	NIVOLUMAB	TRUE	42.743	Phase III_RCC_CA209025	WESTERN EUROPE	52	M	WHITE	0770_Marios_PD1_Inhib2_HP-EA214037-7.raw
SA089268	CA209025-95-167	CA209025-95-167_baseline	baseline	1	FAVORABLE	NIVOLUMAB	TRUE	49.807	Phase III_RCC_CA209025	REST OF WORLD	53	M	WHITE	0870_Marios_PD1_Inhib2_HP-S3447247-7.raw
SA089267	CA209025-97-264	CA209025-97-264_baseline	baseline	1	FAVORABLE	NIVOLUMAB	TRUE	48.197	Phase III_RCC_CA209025	REST OF WORLD	56	M	WHITE	0206_Marios_PD1_Inhib2_HP-S3708672-7.raw
SA089296	CA209025-104-911	CA209025-104-911_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	18.924	Phase III_RCC_CA209025	REST OF WORLD	79	M	WHITE	0999_Marios_PD1_Inhib2_HP-E9649574-7.raw
SA089295	CA209025-1-1023	CA209025-1-1023_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	40.214	Phase III_RCC_CA209025	US/CANADA	59	M	WHITE	0909_Marios_PD1_Inhib2_HP-AE471828-6.raw
SA089283	CA209025-111-738	CA209025-111-738_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	27.335	Phase III_RCC_CA209025	REST OF WORLD	67	M	WHITE	0109_Marios_PD1_Inhib2_HP-EA003796-7.raw
SA089284	CA209025-118-151	CA209025-118-151_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	35.844	Phase III_RCC_CA209025	WESTERN EUROPE	55	M	WHITE	0017_Marios_PD1_Inhib2_HP-E9314437-7.raw
SA089280	CA209025-118-164	CA209025-118-164_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	49.938	Phase III_RCC_CA209025	WESTERN EUROPE	66	M	WHITE	0076_Marios_PD1_Inhib2_HP-E9655432-7.raw
SA089286	CA209025-118-242	CA209025-118-242_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	49.216	Phase III_RCC_CA209025	WESTERN EUROPE	56	M	WHITE	1158_Marios_PD1_Inhib2_HP-E9655430-7.raw
SA089292	CA209025-118-768	CA209025-118-768_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	44.189	Phase III_RCC_CA209025	WESTERN EUROPE	60	M	WHITE	1101_Marios_PD1_Inhib2_HP-E9712821-13.raw
SA089293	CA209025-1-1	CA209025-1-1_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	39.557	Phase III_RCC_CA209025	US/CANADA	47	M	WHITE	0800_Marios_PD1_Inhib2_HP-AD185796-7.raw
SA089290	CA209025-125-637	CA209025-125-637_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	45.437	Phase III_RCC_CA209025	REST OF WORLD	51	M	WHITE	0326_Marios_PD1_Inhib2_HP-L1384311-7.raw
SA089294	CA209025-126-298	CA209025-126-298_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	23.491	Phase III_RCC_CA209025	WESTERN EUROPE	72	F	WHITE	1118_Marios_PD1_Inhib2_HP-E9755278-7.raw
SA089288	CA209025-131-1043	CA209025-131-1043_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	40.312	Phase III_RCC_CA209025	REST OF WORLD	62	F	WHITE	0506_Marios_PD1_Inhib2_HP-EA720987-9.raw
SA089291	CA209025-131-939	CA209025-131-939_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	18.628	Phase III_RCC_CA209025	REST OF WORLD	64	M	WHITE	0590_Marios_PD1_Inhib2_HP-E9786648-7.raw
SA089287	CA209025-139-144	CA209025-139-144_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	50.103	Phase III_RCC_CA209025	US/CANADA	65	M	WHITE	0018_Marios_PD1_Inhib2_HP-AD585852-7.raw
SA089285	CA209025-139-271	CA209025-139-271_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	48.657	Phase III_RCC_CA209025	US/CANADA	50	M	WHITE	0831_Marios_PD1_Inhib2_HP-AE052724-7.raw
SA089282	CA209025-139-895	CA209025-139-895_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	25.396	Phase III_RCC_CA209025	US/CANADA	63	M	WHITE	0773_Marios_PD1_Inhib2_HP-AF048311-9.raw
SA089281	CA209025-14-1070	CA209025-14-1070_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	38.505	Phase III_RCC_CA209025	US/CANADA	59	F	WHITE	1176_Marios_PD1_Inhib2_HP-AE902414-7.raw
SA089289	CA209025-149-672	CA209025-149-672_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	37.815	Phase III_RCC_CA209025	REST OF WORLD	67	M	WHITE	0622_Marios_PD1_Inhib2_HP-EA039695-7.raw
SA089317	CA209025-155-156	CA209025-155-156_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	50.201	Phase III_RCC_CA209025	REST OF WORLD	65	M	OTHER	0565_Marios_PD1_Inhib2_HP-S3578237-7.raw
SA089316	CA209025-160-158	CA209025-160-158_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	35.154	Phase III_RCC_CA209025	REST OF WORLD	75	M	OTHER	0010_Marios_PD1_Inhib2_HP-S3474786-7.raw
SA089315	CA209025-162-614	CA209025-162-614_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	44.977	Phase III_RCC_CA209025	REST OF WORLD	68	F	OTHER	0955_Marios_PD1_Inhib2_HP-S3667126-7.raw
SA089314	CA209025-163-382	CA209025-163-382_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	31.310	Phase III_RCC_CA209025	REST OF WORLD	68	M	OTHER	0014_Marios_PD1_Inhib2_HP-S3675225-7.raw
SA089319	CA209025-165-850	CA209025-165-850_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	43.039	Phase III_RCC_CA209025	REST OF WORLD	61	M	OTHER	0060_Marios_PD1_Inhib2_HP-S4035311-7.raw
SA089297	CA209025-17-556	CA209025-17-556_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	15.212	Phase III_RCC_CA209025	US/CANADA	43	M	WHITE	0437_Marios_PD1_Inhib2_HP-AE522913-7.raw
SA089318	CA209025-2-180	CA209025-2-180_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	37.224	Phase III_RCC_CA209025	WESTERN EUROPE	54	M	WHITE	0924_Marios_PD1_Inhib2_HP-E9657508-7.raw
SA089312	CA209025-21-927	CA209025-21-927_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	37.782	Phase III_RCC_CA209025	US/CANADA	72	F	WHITE	1137_Marios_PD1_Inhib2_HP-AF063579-9.raw
SA089320	CA209025-2-290	CA209025-2-290_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	30.160	Phase III_RCC_CA209025	WESTERN EUROPE	55	M	WHITE	0357_Marios_PD1_Inhib2_HP-E9657510-7.raw
SA089302	CA209025-23-536	CA209025-23-536_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	46.029	Phase III_RCC_CA209025	US/CANADA	56	M	WHITE	0779_Marios_PD1_Inhib2_HP-AE070739-7.raw
SA089303	CA209025-25-202	CA209025-25-202_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	49.380	Phase III_RCC_CA209025	US/CANADA	56	M	WHITE	0428_Marios_PD1_Inhib2_HP-AD775403-7.raw
SA089301	CA209025-38-430	CA209025-38-430_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	37.980	Phase III_RCC_CA209025	WESTERN EUROPE	53	M	WHITE	0054_Marios_PD1_Inhib2_HP-E9133654-7.raw
SA089298	CA209025-43-931	CA209025-43-931_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	33.643	Phase III_RCC_CA209025	US/CANADA	57	F	WHITE	0129_Marios_PD1_Inhib2_HP-AF003943-9.raw
SA089300	CA209025-4-533	CA209025-4-533_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	28.452	Phase III_RCC_CA209025	WESTERN EUROPE	64	F	WHITE	0075_Marios_PD1_Inhib2_HP-E9099272-7.raw
SA089299	CA209025-65-300	CA209025-65-300_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	29.470	Phase III_RCC_CA209025	WESTERN EUROPE	49	M	WHITE	0645_Marios_PD1_Inhib2_HP-EA002604-7.raw
SA089304	CA209025-65-608	CA209025-65-608_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	30.324	Phase III_RCC_CA209025	WESTERN EUROPE	80	F	WHITE	0463_Marios_PD1_Inhib2_HP-E9778361-7.raw
SA089305	CA209025-65-848	CA209025-65-848_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	0.493	Phase III_RCC_CA209025	WESTERN EUROPE	70	F	WHITE	0391_Marios_PD1_Inhib2_HP-EA399862-7.raw
SA089310	CA209025-75-262	CA209025-75-262_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	43.269	Phase III_RCC_CA209025	WESTERN EUROPE	67	F	WHITE	0923_Marios_PD1_Inhib2_HP-E9104439-7.raw
SA089311	CA209025-8-177	CA209025-8-177_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	33.380	Phase III_RCC_CA209025	WESTERN EUROPE	49	M	WHITE	1215_Marios_PD1_Inhib2_HP-E9125191-7.raw
SA089309	CA209025-84-390	CA209025-84-390_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	12.386	Phase III_RCC_CA209025	REST OF WORLD	77	F	WHITE	0662_Marios_PD1_Inhib2_HP-L1357307-7.raw
SA089313	CA209025-84-454	CA209025-84-454_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	30.292	Phase III_RCC_CA209025	REST OF WORLD	65	M	WHITE	0655_Marios_PD1_Inhib2_HP-L1371960-10.raw
SA089308	CA209025-85-683	CA209025-85-683_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	17.019	Phase III_RCC_CA209025	REST OF WORLD	53	F	WHITE	1035_Marios_PD1_Inhib2_HP-L1361776-11.raw
SA089307	CA209025-95-408	CA209025-95-408_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	47.934	Phase III_RCC_CA209025	REST OF WORLD	60	M	WHITE	1197_Marios_PD1_Inhib2_HP-S3792617-7.raw
SA089306	CA209025-9-896	CA209025-9-896_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	FALSE	42.842	Phase III_RCC_CA209025	US/CANADA	64	M	WHITE	0420_Marios_PD1_Inhib2_HP-AF002778-9.raw
SA089324	CA209025-104-900	CA209025-104-900_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	TRUE	18.924	Phase III_RCC_CA209025	REST OF WORLD	63	M	WHITE	0709_Marios_PD1_Inhib2_HP-E9649573-7.raw
SA089322	CA209025-158-654	CA209025-158-654_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	TRUE	32.493	Phase III_RCC_CA209025	REST OF WORLD	63	M	OTHER	0381_Marios_PD1_Inhib2_HP-S3746241-7.raw
SA089326	CA209025-166-287	CA209025-166-287_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	TRUE	31.310	Phase III_RCC_CA209025	REST OF WORLD	78	M	OTHER	1060_Marios_PD1_Inhib2_HP-S3508689-7.raw
SA089325	CA209025-185-805	CA209025-185-805_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	TRUE	31.113	Phase III_RCC_CA209025	US/CANADA	49	M	WHITE	1105_Marios_PD1_Inhib2_HP-AE722161-7.raw
SA089323	CA209025-20-81	CA209025-20-81_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	TRUE	33.840	Phase III_RCC_CA209025	US/CANADA	64	M	WHITE	0429_Marios_PD1_Inhib2_HP-AD452648-7.raw
SA089321	CA209025-33-250	CA209025-33-250_baseline	baseline	1	INTERMEDIATE	EVEROLIMUS	TRUE	35.581	Phase III_RCC_CA209025	WESTERN EUROPE	54	M	WHITE	0053_Marios_PD1_Inhib2_HP-E9101787-7.raw
SA089365	CA209025-108-362	CA209025-108-362_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	48.427	Phase III_RCC_CA209025	REST OF WORLD	70	F	WHITE	0504_Marios_PD1_Inhib2_HP-E9563929-7.raw
SA089364	CA209025-111-778	CA209025-111-778_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	43.992	Phase III_RCC_CA209025	REST OF WORLD	66	M	WHITE	0219_Marios_PD1_Inhib2_HP-EA003799-7.raw
SA089359	CA209025-11-687	CA209025-11-687_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	45.602	Phase III_RCC_CA209025	US/CANADA	43	M	WHITE	0012_Marios_PD1_Inhib2_HP-AE487819-7.raw
SA089367	CA209025-125-855	CA209025-125-855_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	43.762	Phase III_RCC_CA209025	REST OF WORLD	54	M	WHITE	0992_Marios_PD1_Inhib2_HP-L1392382-7.raw
SA089366	CA209025-12-64	CA209025-12-64_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	51.745	Phase III_RCC_CA209025	WESTERN EUROPE	67	M	WHITE	0580_Marios_PD1_Inhib2_HP-E9124673-7.raw
SA089369	CA209025-137-503	CA209025-137-503_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	46.949	Phase III_RCC_CA209025	WESTERN EUROPE	59	F	WHITE	1062_Marios_PD1_Inhib2_HP-E9106225-7.raw
SA089360	CA209025-138-700	CA209025-138-700_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	3.844	Phase III_RCC_CA209025	US/CANADA	72	M	WHITE	0822_Marios_PD1_Inhib2_HP-AE428476-7.raw
SA089361	CA209025-139-1049	CA209025-139-1049_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	38.637	Phase III_RCC_CA209025	US/CANADA	50	M	WHITE	0082_Marios_PD1_Inhib2_HP-AF438543-9.raw
SA089368	CA209025-139-152	CA209025-139-152_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	50.234	Phase III_RCC_CA209025	US/CANADA	48	M	WHITE	1065_Marios_PD1_Inhib2_HP-AD783000-7.raw
SA089373	CA209025-139-554	CA209025-139-554_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	46.062	Phase III_RCC_CA209025	US/CANADA	64	M	WHITE	0039_Marios_PD1_Inhib2_HP-AD782999-7.raw
SA089372	CA209025-139-776	CA209025-139-776_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	43.138	Phase III_RCC_CA209025	US/CANADA	73	M	WHITE	0410_Marios_PD1_Inhib2_HP-AE913731-7.raw
SA089371	CA209025-143-679	CA209025-143-679_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	44.452	Phase III_RCC_CA209025	US/CANADA	64	M	WHITE	1144_Marios_PD1_Inhib2_HP-AE602890-7.raw
SA089370	CA209025-144-372	CA209025-144-372_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	47.770	Phase III_RCC_CA209025	US/CANADA	62	M	WHITE	0203_Marios_PD1_Inhib2_HP-AD829005-7.raw
SA089358	CA209025-1-516	CA209025-1-516_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	46.095	Phase III_RCC_CA209025	US/CANADA	62	M	WHITE	0396_Marios_PD1_Inhib2_HP-AD709258-7.raw
SA089345	CA209025-153-718	CA209025-153-718_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	44.682	Phase III_RCC_CA209025	US/CANADA	66	M	WHITE	0003_Marios_PD1_Inhib2_HP-AE613290-7.raw
SA089336	CA209025-155-1020	CA209025-155-1020_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	39.951	Phase III_RCC_CA209025	REST OF WORLD	46	M	OTHER	0179_Marios_PD1_Inhib2_HP-S4103681-8.raw
SA089335	CA209025-157-237	CA209025-157-237_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	4.403	Phase III_RCC_CA209025	REST OF WORLD	79	F	OTHER	1123_Marios_PD1_Inhib2_HP-S3510222-7.raw
SA089337	CA209025-157-436	CA209025-157-436_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	46.324	Phase III_RCC_CA209025	REST OF WORLD	63	M	OTHER	0533_Marios_PD1_Inhib2_HP-S3510221-9.raw
SA089334	CA209025-159-777	CA209025-159-777_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	43.598	Phase III_RCC_CA209025	REST OF WORLD	73	M	OTHER	1095_Marios_PD1_Inhib2_HP-S3681809-7.raw
SA089340	CA209025-163-1012	CA209025-163-1012_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	40.411	Phase III_RCC_CA209025	REST OF WORLD	65	M	OTHER	0970_Marios_PD1_Inhib2_HP-S4211190-9.raw
SA089339	CA209025-163-425	CA209025-163-425_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	47.606	Phase III_RCC_CA209025	REST OF WORLD	63	M	OTHER	0264_Marios_PD1_Inhib2_HP-S3675226-7.raw
SA089341	CA209025-167-1011	CA209025-167-1011_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	39.819	Phase III_RCC_CA209025	REST OF WORLD	69	F	OTHER	0596_Marios_PD1_Inhib2_HP-S4110168-9.raw
SA089331	CA209025-174-203	CA209025-174-203_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	49.840	Phase III_RCC_CA209025	REST OF WORLD	74	M	OTHER	1131_Marios_PD1_Inhib2_HP-S3486353-7.raw
SA089362	CA209025-1-82	CA209025-1-82_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	51.581	Phase III_RCC_CA209025	US/CANADA	64	M	WHITE	0840_Marios_PD1_Inhib2_HP-AD176329-7.raw
SA089363	CA209025-1-961	CA209025-1-961_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	41.725	Phase III_RCC_CA209025	US/CANADA	69	M	WHITE	0270_Marios_PD1_Inhib2_HP-AF002674-9.raw
SA089327	CA209025-20-116	CA209025-20-116_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	50.858	Phase III_RCC_CA209025	US/CANADA	88	F	WHITE	0322_Marios_PD1_Inhib2_HP-AD612900-7.raw
SA089330	CA209025-20-753	CA209025-20-753_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	43.696	Phase III_RCC_CA209025	US/CANADA	83	M	WHITE	0019_Marios_PD1_Inhib2_HP-AE331983-7.raw
SA089332	CA209025-21-1065	CA209025-21-1065_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	38.932	Phase III_RCC_CA209025	US/CANADA	55	M	WHITE	0658_Marios_PD1_Inhib2_HP-AF002695-9.raw
SA089328	CA209025-2-356	CA209025-2-356_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	46.456	Phase III_RCC_CA209025	WESTERN EUROPE	71	F	WHITE	1208_Marios_PD1_Inhib2_HP-E9657511-7.raw
SA089333	CA209025-23-953	CA209025-23-953_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	41.363	Phase III_RCC_CA209025	US/CANADA	63	M	WHITE	1120_Marios_PD1_Inhib2_HP-AE886502-6.raw
SA089357	CA209025-26-491	CA209025-26-491_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	46.423	Phase III_RCC_CA209025	US/CANADA	52	M	WHITE	0172_Marios_PD1_Inhib2_HP-AD775604-6.raw
SA089329	CA209025-29-988	CA209025-29-988_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	40.772	Phase III_RCC_CA209025	US/CANADA	70	M	WHITE	0007_Marios_PD1_Inhib2_HP-AF127961-9.raw
SA089338	CA209025-35-674	CA209025-35-674_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	45.175	Phase III_RCC_CA209025	WESTERN EUROPE	50	M	WHITE	1068_Marios_PD1_Inhib2_HP-E9103731-7.raw
SA089356	CA209025-38-624	CA209025-38-624_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	45.207	Phase III_RCC_CA209025	WESTERN EUROPE	64	F	WHITE	0545_Marios_PD1_Inhib2_HP-EA295652-7.raw
SA089352	CA209025-55-172	CA209025-55-172_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	50.858	Phase III_RCC_CA209025	WESTERN EUROPE	73	M	WHITE	0738_Marios_PD1_Inhib2_HP-E9096030-7.raw
SA089351	CA209025-56-791	CA209025-56-791_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	43.696	Phase III_RCC_CA209025	WESTERN EUROPE	37	M	WHITE	0405_Marios_PD1_Inhib2_HP-E9106980-7.raw
SA089353	CA209025-66-488	CA209025-66-488_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	46.883	Phase III_RCC_CA209025	WESTERN EUROPE	44	M	WHITE	0324_Marios_PD1_Inhib2_HP-E9241872-7.raw
SA089354	CA209025-70-405	CA209025-70-405_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	47.869	Phase III_RCC_CA209025	REST OF WORLD	66	M	WHITE	0351_Marios_PD1_Inhib2_HP-EA088438-7.raw
SA089342	CA209025-71-635	CA209025-71-635_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	45.667	Phase III_RCC_CA209025	REST OF WORLD	64	M	WHITE	0403_Marios_PD1_Inhib2_HP-E9337921-7.raw
SA089350	CA209025-76-507	CA209025-76-507_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	46.456	Phase III_RCC_CA209025	US/CANADA	64	M	WHITE	0259_Marios_PD1_Inhib2_HP-AE442046-7.raw
SA089349	CA209025-79-465	CA209025-79-465_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	46.456	Phase III_RCC_CA209025	REST OF WORLD	70	M	WHITE	1107_Marios_PD1_Inhib2_HP-L1381836-7.raw
SA089344	CA209025-79-982	CA209025-79-982_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	17.840	Phase III_RCC_CA209025	REST OF WORLD	67	M	WHITE	0694_Marios_PD1_Inhib2_HP-L1443409-9.raw
SA089343	CA209025-82-208	CA209025-82-208_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	50.103	Phase III_RCC_CA209025	WESTERN EUROPE	59	F	WHITE	1192_Marios_PD1_Inhib2_HP-E9172457-7.raw
SA089346	CA209025-84-1041	CA209025-84-1041_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	39.031	Phase III_RCC_CA209025	REST OF WORLD	57	M	WHITE	0487_Marios_PD1_Inhib2_HP-L1443422-9.raw
SA089355	CA209025-84-535	CA209025-84-535_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	5.520	Phase III_RCC_CA209025	REST OF WORLD	50	M	WHITE	0166_Marios_PD1_Inhib2_HP-L1381809-7.raw
SA089347	CA209025-85-986	CA209025-85-986_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	41.035	Phase III_RCC_CA209025	REST OF WORLD	71	M	WHITE	0824_Marios_PD1_Inhib2_HP-L1497970-10.raw
SA089348	CA209025-9-589	CA209025-9-589_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	FALSE	45.536	Phase III_RCC_CA209025	US/CANADA	56	M	WHITE	0563_Marios_PD1_Inhib2_HP-AE556394-6.raw
SA089375	CA209025-126-31	CA209025-126-31_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	TRUE	53.947	Phase III_RCC_CA209025	WESTERN EUROPE	46	F	WHITE	1080_Marios_PD1_Inhib2_HP-E9123119-7.raw
SA089380	CA209025-139-143	CA209025-139-143_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	TRUE	50.366	Phase III_RCC_CA209025	US/CANADA	53	M	WHITE	1026_Marios_PD1_Inhib2_HP-AD783004-7.raw
SA089383	CA209025-14-1057	CA209025-14-1057_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	TRUE	39.129	Phase III_RCC_CA209025	US/CANADA	66	M	WHITE	0301_Marios_PD1_Inhib2_HP-AF015784-9.raw
SA089382	CA209025-142-593	CA209025-142-593_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	TRUE	46.029	Phase III_RCC_CA209025	US/CANADA	69	M	WHITE	0752_Marios_PD1_Inhib2_HP-AD744030-7.raw
SA089379	CA209025-156-606	CA209025-156-606_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	TRUE	45.207	Phase III_RCC_CA209025	REST OF WORLD	73	M	OTHER	0029_Marios_PD1_Inhib2_HP-S3877148-7.raw
SA089381	CA209025-17-496	CA209025-17-496_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	TRUE	0.953	Phase III_RCC_CA209025	US/CANADA	62	M	WHITE	0944_Marios_PD1_Inhib2_HP-AE302154-9.raw
SA089374	CA209025-20-1059	CA209025-20-1059_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	TRUE	38.899	Phase III_RCC_CA209025	US/CANADA	64	M	WHITE	0906_Marios_PD1_Inhib2_HP-AF002810-9.raw
SA089384	CA209025-29-1045	CA209025-29-1045_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	TRUE	38.735	Phase III_RCC_CA209025	US/CANADA	65	M	WHITE	0474_Marios_PD1_Inhib2_HP-AF360064-9.raw
SA089376	CA209025-44-944	CA209025-44-944_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	TRUE	41.265	Phase III_RCC_CA209025	US/CANADA	54	F	WHITE	0125_Marios_PD1_Inhib2_HP-AF016216-9.raw
SA089378	CA209025-49-66	CA209025-49-66_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	TRUE	52.074	Phase III_RCC_CA209025	US/CANADA	62	M	WHITE	1178_Marios_PD1_Inhib2_HP-AD193616-7.raw
SA089377	CA209025-84-384	CA209025-84-384_baseline	baseline	1	INTERMEDIATE	NIVOLUMAB	TRUE	47.244	Phase III_RCC_CA209025	REST OF WORLD	64	F	WHITE	0587_Marios_PD1_Inhib2_HP-L1357306-7.raw
SA089386	CA209025-20-913	CA209025-20-913_baseline	baseline	1	POOR	EVEROLIMUS	FALSE	25.593	Phase III_RCC_CA209025	US/CANADA	61	F	WHITE	0131_Marios_PD1_Inhib2_HP-AE710606-7.raw
SA089387	CA209025-20-976	CA209025-20-976_baseline	baseline	1	POOR	EVEROLIMUS	FALSE	23.688	Phase III_RCC_CA209025	US/CANADA	75	F	WHITE	0036_Marios_PD1_Inhib2_HP-AE710609-7.raw
SA089388	CA209025-21-1064	CA209025-21-1064_baseline	baseline	1	POOR	EVEROLIMUS	FALSE	27.006	Phase III_RCC_CA209025	US/CANADA	64	F	WHITE	1138_Marios_PD1_Inhib2_HP-AF002696-9.raw
SA089385	CA209025-79-1061	CA209025-79-1061_baseline	baseline	1	POOR	EVEROLIMUS	FALSE	24.246	Phase III_RCC_CA209025	REST OF WORLD	63	M	WHITE	1130_Marios_PD1_Inhib2_HP-L1478148-8.raw
SA089389	CA209025-89-415	CA209025-89-415_baseline	baseline	1	POOR	EVEROLIMUS	FALSE	30.029	Phase III_RCC_CA209025	WESTERN EUROPE	65	F	WHITE	1064_Marios_PD1_Inhib2_HP-E9656486-7.raw
SA089390	CA209025-151-363	CA209025-151-363_baseline	baseline	1	POOR	EVEROLIMUS	TRUE	47.869	Phase III_RCC_CA209025	REST OF WORLD	81	M	WHITE	0937_Marios_PD1_Inhib2_HP-E9540924-7.raw
SA089393	CA209025-12-428	CA209025-12-428_baseline	baseline	1	POOR	NIVOLUMAB	FALSE	46.982	Phase III_RCC_CA209025	WESTERN EUROPE	78	M	WHITE	0176_Marios_PD1_Inhib2_HP-E9108718-6.raw
SA089400	CA209025-131-640	CA209025-131-640_baseline	baseline	1	POOR	NIVOLUMAB	FALSE	3.680	Phase III_RCC_CA209025	REST OF WORLD	48	M	WHITE	0761_Marios_PD1_Inhib2_HP-E9786646-7.raw
SA089395	CA209025-139-324	CA209025-139-324_baseline	baseline	1	POOR	NIVOLUMAB	FALSE	11.006	Phase III_RCC_CA209025	US/CANADA	60	M	WHITE	0827_Marios_PD1_Inhib2_HP-AE052723-7.raw
SA089397	CA209025-141-666	CA209025-141-666_baseline	baseline	1	POOR	NIVOLUMAB	FALSE	43.959	Phase III_RCC_CA209025	US/CANADA	56	M	WHITE	0832_Marios_PD1_Inhib2_HP-AE630786-7.raw
SA089396	CA209025-165-758	CA209025-165-758_baseline	baseline	1	POOR	NIVOLUMAB	FALSE	44.616	Phase III_RCC_CA209025	REST OF WORLD	70	M	OTHER	0267_Marios_PD1_Inhib2_HP-S3717262-7.raw
SA089399	CA209025-25-396	CA209025-25-396_baseline	baseline	1	POOR	NIVOLUMAB	FALSE	47.376	Phase III_RCC_CA209025	US/CANADA	51	M	WHITE	0137_Marios_PD1_Inhib2_HP-AD775404-7.raw
SA089394	CA209025-28-951	CA209025-28-951_baseline	baseline	1	POOR	NIVOLUMAB	FALSE	41.429	Phase III_RCC_CA209025	US/CANADA	60	M	WHITE	0163_Marios_PD1_Inhib2_HP-AE477279-7.raw
SA089398	CA209025-29-921	CA209025-29-921_baseline	baseline	1	POOR	NIVOLUMAB	FALSE	42.053	Phase III_RCC_CA209025	US/CANADA	59	M	WHITE	0046_Marios_PD1_Inhib2_HP-AF008965-9.raw
SA089401	CA209025-39-467	CA209025-39-467_baseline	baseline	1	POOR	NIVOLUMAB	FALSE	46.982	Phase III_RCC_CA209025	WESTERN EUROPE	53	M	WHITE	0015_Marios_PD1_Inhib2_HP-E9493856-7.raw
SA089402	CA209025-4-26	CA209025-4-26_baseline	baseline	1	POOR	NIVOLUMAB	FALSE	53.980	Phase III_RCC_CA209025	WESTERN EUROPE	62	M	WHITE	0547_Marios_PD1_Inhib2_HP-E9108954-7.raw
SA089392	CA209025-4-468	CA209025-4-468_baseline	baseline	1	POOR	NIVOLUMAB	FALSE	47.310	Phase III_RCC_CA209025	WESTERN EUROPE	70	M	WHITE	1182_Marios_PD1_Inhib2_HP-E9108953-7.raw
SA089391	CA209025-9-1055	CA209025-9-1055_baseline	baseline	1	POOR	NIVOLUMAB	FALSE	39.097	Phase III_RCC_CA209025	US/CANADA	57	M	OTHER	1069_Marios_PD1_Inhib2_HP-AF002780-9.raw
SA089403	CA209025-13-360	CA209025-13-360_baseline	baseline	1	POOR	NIVOLUMAB	TRUE	47.212	Phase III_RCC_CA209025	US/CANADA	75	M	WHITE	1084_Marios_PD1_Inhib2_HP-AE059520-7.raw
SA089404	CA209025-9-870	CA209025-9-870_baseline	baseline	1	POOR	NIVOLUMAB	TRUE	43.039	Phase III_RCC_CA209025	US/CANADA	73	M	WHITE	0716_Marios_PD1_Inhib2_HP-AE556391-9.raw
SA088696	CA209025-108-737	CA209025-108-737_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	23.557	Phase III_RCC_CA209025	REST OF WORLD	69	M	WHITE	0306_Marios_PD1_Inhib2_HP-EA175142-7.raw
SA088686	CA209025-111-296	CA209025-111-296_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	26.612	Phase III_RCC_CA209025	REST OF WORLD	45	M	WHITE	0776_Marios_PD1_Inhib2_HP-EA003800-7.raw
SA088678	CA209025-118-427	CA209025-118-427_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	30.850	Phase III_RCC_CA209025	WESTERN EUROPE	62	M	WHITE	0610_Marios_PD1_Inhib2_HP-E9712822-7.raw
SA088684	CA209025-121-463	CA209025-121-463_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	35.680	Phase III_RCC_CA209025	REST OF WORLD	67	M	WHITE	0336_Marios_PD1_Inhib2_HP-L1370586-6.raw
SA088666	CA209025-1-27	CA209025-1-27_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	28.977	Phase III_RCC_CA209025	US/CANADA	72	M	WHITE	1023_Marios_PD1_Inhib2_HP-AD185798-7.raw
SA088676	CA209025-138-550	CA209025-138-550_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	19.548	Phase III_RCC_CA209025	US/CANADA	56	M	WHITE	0257_Marios_PD1_Inhib2_HP-AE428479-7.raw
SA088668	CA209025-139-153	CA209025-139-153_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	15.869	Phase III_RCC_CA209025	US/CANADA	66	M	WHITE	0847_Marios_PD1_Inhib2_HP-AD585850-7.raw
SA088674	CA209025-139-712	CA209025-139-712_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	8.476	Phase III_RCC_CA209025	US/CANADA	57	M	WHITE	0141_Marios_PD1_Inhib2_HP-AD783003-7.raw
SA088693	CA209025-139-990	CA209025-139-990_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	15.047	Phase III_RCC_CA209025	US/CANADA	67	F	WHITE	0632_Marios_PD1_Inhib2_HP-AF337223-9.raw
SA088679	CA209025-144-487	CA209025-144-487_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	42.185	Phase III_RCC_CA209025	US/CANADA	64	M	WHITE	0358_Marios_PD1_Inhib2_HP-AE506717-7.raw
SA088677	CA209025-144-717	CA209025-144-717_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	19.680	Phase III_RCC_CA209025	US/CANADA	52	M	WHITE	0925_Marios_PD1_Inhib2_HP-AE673799-7.raw
SA088698	CA209025-154-655	CA209025-154-655_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	25.725	Phase III_RCC_CA209025	REST OF WORLD	57	M	OTHER	1054_Marios_PD1_Inhib2_HP-S3704162-7.raw
SA088708	CA209025-158-244	CA209025-158-244_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	18.957	Phase III_RCC_CA209025	REST OF WORLD	72	M	OTHER	0117_Marios_PD1_Inhib2_HP-S3653085-7.raw
SA088709	CA209025-161-973	CA209025-161-973_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	32.526	Phase III_RCC_CA209025	REST OF WORLD	66	M	OTHER	0760_Marios_PD1_Inhib2_HP-S4144269-9.raw
SA088683	CA209025-172-651	CA209025-172-651_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	21.848	Phase III_RCC_CA209025	REST OF WORLD	77	F	OTHER	0805_Marios_PD1_Inhib2_HP-S3670414-7.raw
SA088681	CA209025-1-948	CA209025-1-948_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	12.550	Phase III_RCC_CA209025	US/CANADA	71	M	WHITE	1149_Marios_PD1_Inhib2_HP-AF002675-9.raw
SA088665	CA209025-20-1040	CA209025-20-1040_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	2.431	Phase III_RCC_CA209025	US/CANADA	51	F	WHITE	0337_Marios_PD1_Inhib2_HP-AF252764-9.raw
SA088669	CA209025-20-232	CA209025-20-232_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	17.610	Phase III_RCC_CA209025	US/CANADA	46	M	WHITE	0503_Marios_PD1_Inhib2_HP-AD612901-7.raw
SA088692	CA209025-2-11	CA209025-2-11_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	21.355	Phase III_RCC_CA209025	WESTERN EUROPE	55	M	WHITE	0508_Marios_PD1_Inhib2_HP-E9064308-7.raw
SA088688	CA209025-21-319	CA209025-21-319_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	26.021	Phase III_RCC_CA209025	US/CANADA	72	F	WHITE	0084_Marios_PD1_Inhib2_HP-AD601338-7.raw
SA088690	CA209025-21-907	CA209025-21-907_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	14.292	Phase III_RCC_CA209025	US/CANADA	56	F	WHITE	0093_Marios_PD1_Inhib2_HP-AE622887-10.raw
SA088680	CA209025-22-345	CA209025-22-345_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	34.793	Phase III_RCC_CA209025	US/CANADA	71	F	WHITE	0687_Marios_PD1_Inhib2_HP-AE198221-7.raw
SA088682	CA209025-23-54	CA209025-23-54_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	8.049	Phase III_RCC_CA209025	US/CANADA	70	M	WHITE	0074_Marios_PD1_Inhib2_HP-AD362184-7.raw
SA088664	CA209025-23-952	CA209025-23-952_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	12.255	Phase III_RCC_CA209025	US/CANADA	76	M	WHITE	0110_Marios_PD1_Inhib2_HP-AE886504-6.raw
SA088671	CA209025-2-801	CA209025-2-801_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	12.255	Phase III_RCC_CA209025	WESTERN EUROPE	38	M	WHITE	0928_Marios_PD1_Inhib2_HP-EA495435-7.raw
SA088670	CA209025-2-839	CA209025-2-839_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	18.103	Phase III_RCC_CA209025	WESTERN EUROPE	54	F	WHITE	0697_Marios_PD1_Inhib2_HP-EA495437-7.raw
SA088685	CA209025-30-419	CA209025-30-419_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	25.758	Phase III_RCC_CA209025	US/CANADA	50	F	WHITE	0974_Marios_PD1_Inhib2_HP-AD810796-7.raw
SA088689	CA209025-30-639	CA209025-30-639_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	32.756	Phase III_RCC_CA209025	US/CANADA	66	F	WHITE	0806_Marios_PD1_Inhib2_HP-AD810797-6.raw
SA088687	CA209025-33-670	CA209025-33-670_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	19.088	Phase III_RCC_CA209025	WESTERN EUROPE	54	F	WHITE	1087_Marios_PD1_Inhib2_HP-E9811936-7.raw
SA088667	CA209025-42-45	CA209025-42-45_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	43.368	Phase III_RCC_CA209025	US/CANADA	74	M	WHITE	0703_Marios_PD1_Inhib2_HP-AD452685-7.raw
SA088691	CA209025-42-962	CA209025-42-962_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	24.279	Phase III_RCC_CA209025	US/CANADA	63	M	WHITE	0274_Marios_PD1_Inhib2_HP-AF126070-9.raw
SA088699	CA209025-43-605	CA209025-43-605_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	19.943	Phase III_RCC_CA209025	US/CANADA	56	F	WHITE	0142_Marios_PD1_Inhib2_HP-AE427606-7.raw
SA088710	CA209025-43-897	CA209025-43-897_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	14.916	Phase III_RCC_CA209025	US/CANADA	63	F	WHITE	1116_Marios_PD1_Inhib2_HP-AE586110-7.raw
SA088713	CA209025-44-1009	CA209025-44-1009_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	4.074	Phase III_RCC_CA209025	US/CANADA	23	M	WHITE	0065_Marios_PD1_Inhib2_HP-AF016218-9.raw
SA088697	CA209025-48-502	CA209025-48-502_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	30.390	Phase III_RCC_CA209025	WESTERN EUROPE	82	F	WHITE	0073_Marios_PD1_Inhib2_HP-E9782205-7.raw
SA088703	CA209025-50-426	CA209025-50-426_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	8.345	Phase III_RCC_CA209025	WESTERN EUROPE	65	M	WHITE	1125_Marios_PD1_Inhib2_HP-E9721146-7.raw
SA088695	CA209025-5-662	CA209025-5-662_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	19.023	Phase III_RCC_CA209025	WESTERN EUROPE	54	M	WHITE	0426_Marios_PD1_Inhib2_HP-E9108658-7.raw
SA088712	CA209025-6-138	CA209025-6-138_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	26.908	Phase III_RCC_CA209025	WESTERN EUROPE	66	F	WHITE	0275_Marios_PD1_Inhib2_HP-E9125344-7.raw
SA088706	CA209025-62-727	CA209025-62-727_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	23.655	Phase III_RCC_CA209025	WESTERN EUROPE	61	M	WHITE	0927_Marios_PD1_Inhib2_HP-EA039957-7.raw
SA088694	CA209025-66-625	CA209025-66-625_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	35.450	Phase III_RCC_CA209025	WESTERN EUROPE	54	F	WHITE	1037_Marios_PD1_Inhib2_HP-EA239331-7.raw
SA088705	CA209025-69-297	CA209025-69-297_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	17.249	Phase III_RCC_CA209025	REST OF WORLD	65	F	WHITE	1122_Marios_PD1_Inhib2_HP-E9483501-7.raw
SA088702	CA209025-75-3	CA209025-75-3_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	21.224	Phase III_RCC_CA209025	WESTERN EUROPE	76	F	WHITE	0095_Marios_PD1_Inhib2_HP-E9064316-18.raw
SA088701	CA209025-79-1062	CA209025-79-1062_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	3.647	Phase III_RCC_CA209025	REST OF WORLD	62	F	WHITE	0364_Marios_PD1_Inhib2_HP-L1443408-8.raw
SA088704	CA209025-80-120	CA209025-80-120_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	27.795	Phase III_RCC_CA209025	WESTERN EUROPE	48	M	WHITE	0059_Marios_PD1_Inhib2_HP-E9433498-6.raw
SA088700	CA209025-80-439	CA209025-80-439_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	20.271	Phase III_RCC_CA209025	WESTERN EUROPE	82	M	WHITE	0978_Marios_PD1_Inhib2_HP-E9134599-7.raw
SA088707	CA209025-84-495	CA209025-84-495_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	3.581	Phase III_RCC_CA209025	REST OF WORLD	58	M	WHITE	1075_Marios_PD1_Inhib2_HP-L1371961-10.raw
SA088711	CA209025-89-173	CA209025-89-173_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	12.747	Phase III_RCC_CA209025	WESTERN EUROPE	59	F	WHITE	1074_Marios_PD1_Inhib2_HP-E9103840-7.raw
SA088714	CA209025-90-720	CA209025-90-720_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	22.702	Phase III_RCC_CA209025	WESTERN EUROPE	46	M	WHITE	0890_Marios_PD1_Inhib2_HP-E9665085-7.raw
SA088672	CA209025-93-558	CA209025-93-558_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	11.795	Phase III_RCC_CA209025	WESTERN EUROPE	70	F	WHITE	0453_Marios_PD1_Inhib2_HP-EA214039-7.raw
SA088673	CA209025-95-168	CA209025-95-168_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	13.470	Phase III_RCC_CA209025	REST OF WORLD	70	M	WHITE	0315_Marios_PD1_Inhib2_HP-S3447248-7.raw
SA088675	CA209025-97-260	CA209025-97-260_baseline	baseline	-	FAVORABLE	EVEROLIMUS	FALSE	6.439	Phase III_RCC_CA209025	REST OF WORLD	60	F	WHITE	0433_Marios_PD1_Inhib2_HP-S3447034-7.raw
SA088719	CA209025-13-228	CA209025-13-228_baseline	baseline	-	FAVORABLE	EVEROLIMUS	TRUE	19.318	Phase III_RCC_CA209025	US/CANADA	43	M	WHITE	1025_Marios_PD1_Inhib2_HP-AD452591-7.raw
SA088722	CA209025-138-872	CA209025-138-872_baseline	baseline	-	FAVORABLE	EVEROLIMUS	TRUE	25.856	Phase III_RCC_CA209025	US/CANADA	58	F	WHITE	1093_Marios_PD1_Inhib2_HP-AE726342-7.raw
SA088727	CA209025-139-431	CA209025-139-431_baseline	baseline	-	FAVORABLE	EVEROLIMUS	TRUE	23.327	Phase III_RCC_CA209025	US/CANADA	54	F	OTHER	0187_Marios_PD1_Inhib2_HP-AD783002-7.raw
SA088726	CA209025-148-879	CA209025-148-879_baseline	baseline	-	FAVORABLE	EVEROLIMUS	TRUE	1.446	Phase III_RCC_CA209025	REST OF WORLD	72	M	WHITE	0479_Marios_PD1_Inhib2_HP-E9541294-7.raw
SA088724	CA209025-149-256	CA209025-149-256_baseline	baseline	-	FAVORABLE	EVEROLIMUS	TRUE	24.345	Phase III_RCC_CA209025	REST OF WORLD	73	M	WHITE	0544_Marios_PD1_Inhib2_HP-E9540031-7.raw
SA088731	CA209025-168-424	CA209025-168-424_baseline	baseline	-	FAVORABLE	EVEROLIMUS	TRUE	30.719	Phase III_RCC_CA209025	REST OF WORLD	43	M	OTHER	0321_Marios_PD1_Inhib2_HP-S3700181-7.raw
SA088721	CA209025-17-95	CA209025-17-95_baseline	baseline	-	FAVORABLE	EVEROLIMUS	TRUE	17.216	Phase III_RCC_CA209025	US/CANADA	44	M	WHITE	0633_Marios_PD1_Inhib2_HP-AD577684-6.raw
SA088715	CA209025-184-352	CA209025-184-352_baseline	baseline	-	FAVORABLE	EVEROLIMUS	TRUE	42.218	Phase III_RCC_CA209025	US/CANADA	23	F	WHITE	0836_Marios_PD1_Inhib2_HP-AE142419-7.raw
SA088730	CA209025-20-659	CA209025-20-659_baseline	baseline	-	FAVORABLE	EVEROLIMUS	TRUE	26.579	Phase III_RCC_CA209025	US/CANADA	57	M	WHITE	0087_Marios_PD1_Inhib2_HP-AE710610-7.raw
SA088717	CA209025-20-88	CA209025-20-88_baseline	baseline	-	FAVORABLE	EVEROLIMUS	TRUE	13.733	Phase III_RCC_CA209025	US/CANADA	44	F	WHITE	0434_Marios_PD1_Inhib2_HP-AD452647-7.raw
SA088718	CA209025-28-584	CA209025-28-584_baseline	baseline	-	FAVORABLE	EVEROLIMUS	TRUE	18.694	Phase III_RCC_CA209025	US/CANADA	77	M	WHITE	0101_Marios_PD1_Inhib2_HP-AE477281-7.raw
SA088732	CA209025-29-4	CA209025-29-4_baseline	baseline	-	FAVORABLE	EVEROLIMUS	TRUE	16.099	Phase III_RCC_CA209025	US/CANADA	54	M	WHITE	0045_Marios_PD1_Inhib2_HP-AD185902-7.raw
SA088720	CA209025-31-421	CA209025-31-421_baseline	baseline	-	FAVORABLE	EVEROLIMUS	TRUE	13.832	Phase III_RCC_CA209025	US/CANADA	64	M	WHITE	0369_Marios_PD1_Inhib2_HP-AD452581-6.raw
SA088729	CA209025-62-602	CA209025-62-602_baseline	baseline	-	FAVORABLE	EVEROLIMUS	TRUE	11.828	Phase III_RCC_CA209025	WESTERN EUROPE	73	M	WHITE	0915_Marios_PD1_Inhib2_HP-EA297782-7.raw
SA088733	CA209025-64-663	CA209025-64-663_baseline	baseline	-	FAVORABLE	EVEROLIMUS	TRUE	6.472	Phase III_RCC_CA209025	WESTERN EUROPE	41	F	WHITE	1085_Marios_PD1_Inhib2_HP-E9485321-6.raw
SA088723	CA209025-69-696	CA209025-69-696_baseline	baseline	-	FAVORABLE	EVEROLIMUS	TRUE	2.103	Phase III_RCC_CA209025	REST OF WORLD	66	M	WHITE	0960_Marios_PD1_Inhib2_HP-E9483502-7.raw
SA088725	CA209025-85-880	CA209025-85-880_baseline	baseline	-	FAVORABLE	EVEROLIMUS	TRUE	3.285	Phase III_RCC_CA209025	REST OF WORLD	61	M	WHITE	0178_Marios_PD1_Inhib2_HP-L1361774-10.raw
SA088728	CA209025-87-402	CA209025-87-402_baseline	baseline	-	FAVORABLE	EVEROLIMUS	TRUE	31.901	Phase III_RCC_CA209025	WESTERN EUROPE	62	F	WHITE	0665_Marios_PD1_Inhib2_HP-E9774329-7.raw
SA088716	CA209025-87-899	CA209025-87-899_baseline	baseline	-	FAVORABLE	EVEROLIMUS	TRUE	5.585	Phase III_RCC_CA209025	WESTERN EUROPE	53	M	WHITE	0334_Marios_PD1_Inhib2_HP-E9774330-7.raw
SA088788	CA209025-1-1004	CA209025-1-1004_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	32.657	Phase III_RCC_CA209025	US/CANADA	58	M	WHITE	0415_Marios_PD1_Inhib2_HP-AF002677-9.raw
SA088769	CA209025-1-1030	CA209025-1-1030_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	23.951	Phase III_RCC_CA209025	US/CANADA	61	M	WHITE	0397_Marios_PD1_Inhib2_HP-AE663607-7.raw
SA088766	CA209025-1-117	CA209025-1-117_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	10.875	Phase III_RCC_CA209025	US/CANADA	37	F	WHITE	1019_Marios_PD1_Inhib2_HP-AD424474-7.raw
SA088758	CA209025-111-811	CA209025-111-811_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	11.302	Phase III_RCC_CA209025	REST OF WORLD	34	F	WHITE	1039_Marios_PD1_Inhib2_HP-E9720046-7.raw
SA088771	CA209025-11-240	CA209025-11-240_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	38.768	Phase III_RCC_CA209025	US/CANADA	51	M	WHITE	0435_Marios_PD1_Inhib2_HP-AD604108-7.raw
SA088757	CA209025-113-669	CA209025-113-669_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	6.604	Phase III_RCC_CA209025	WESTERN EUROPE	63	M	WHITE	0991_Marios_PD1_Inhib2_HP-E9717741-7.raw
SA088763	CA209025-118-207	CA209025-118-207_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	19.778	Phase III_RCC_CA209025	WESTERN EUROPE	64	M	WHITE	1112_Marios_PD1_Inhib2_HP-E9314448-7.raw
SA088765	CA209025-11-910	CA209025-11-910_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	8.674	Phase III_RCC_CA209025	US/CANADA	63	M	WHITE	0470_Marios_PD1_Inhib2_HP-AE330680-6.raw
SA088789	CA209025-1-205	CA209025-1-205_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	29.865	Phase III_RCC_CA209025	US/CANADA	45	M	WHITE	0189_Marios_PD1_Inhib2_HP-AD424473-7.raw
SA088761	CA209025-121-272	CA209025-121-272_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	31.836	Phase III_RCC_CA209025	REST OF WORLD	61	M	WHITE	1043_Marios_PD1_Inhib2_HP-L1305560-7.raw
SA088762	CA209025-12-838	CA209025-12-838_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	20.567	Phase III_RCC_CA209025	WESTERN EUROPE	35	M	WHITE	0025_Marios_PD1_Inhib2_HP-EA000635-7.raw
SA088774	CA209025-135-450	CA209025-135-450_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	17.971	Phase III_RCC_CA209025	REST OF WORLD	66	M	WHITE	0298_Marios_PD1_Inhib2_HP-L1366487-10.raw
SA088786	CA209025-138-1034	CA209025-138-1034_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	10.152	Phase III_RCC_CA209025	US/CANADA	52	M	WHITE	0154_Marios_PD1_Inhib2_HP-AF004062-9.raw
SA088784	CA209025-139-1015	CA209025-139-1015_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	14.916	Phase III_RCC_CA209025	US/CANADA	32	F	OTHER	0874_Marios_PD1_Inhib2_HP-AF048312-8.raw
SA088787	CA209025-139-665	CA209025-139-665_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	22.505	Phase III_RCC_CA209025	US/CANADA	63	M	WHITE	0837_Marios_PD1_Inhib2_HP-AE645252-7.raw
SA088790	CA209025-140-869	CA209025-140-869_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	2.464	Phase III_RCC_CA209025	US/CANADA	69	M	WHITE	0238_Marios_PD1_Inhib2_HP-AD828985-7.raw
SA088768	CA209025-1-417	CA209025-1-417_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	20.271	Phase III_RCC_CA209025	US/CANADA	66	F	WHITE	0888_Marios_PD1_Inhib2_HP-AD709256-6.raw
SA088770	CA209025-1-517	CA209025-1-517_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	2.563	Phase III_RCC_CA209025	US/CANADA	48	M	OTHER	0083_Marios_PD1_Inhib2_HP-AE471827-7.raw
SA088777	CA209025-159-114	CA209025-159-114_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	39.228	Phase III_RCC_CA209025	REST OF WORLD	66	F	OTHER	0149_Marios_PD1_Inhib2_HP-S3472022-7.raw
SA088776	CA209025-159-750	CA209025-159-750_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	27.433	Phase III_RCC_CA209025	REST OF WORLD	64	M	OTHER	1168_Marios_PD1_Inhib2_HP-S3681808-7.raw
SA088775	CA209025-159-91	CA209025-159-91_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	33.249	Phase III_RCC_CA209025	REST OF WORLD	70	F	OTHER	0817_Marios_PD1_Inhib2_HP-S3472021-7.raw
SA088779	CA209025-159-945	CA209025-159-945_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	26.842	Phase III_RCC_CA209025	REST OF WORLD	57	M	OTHER	0549_Marios_PD1_Inhib2_HP-S4107208-9.raw
SA088760	CA209025-166-161	CA209025-166-161_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	15.047	Phase III_RCC_CA209025	REST OF WORLD	64	M	OTHER	0161_Marios_PD1_Inhib2_HP-S3508687-7.raw
SA088734	CA209025-17-612	CA209025-17-612_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	13.010	Phase III_RCC_CA209025	US/CANADA	48	M	WHITE	0418_Marios_PD1_Inhib2_HP-AE522916-7.raw
SA088738	CA209025-21-442	CA209025-21-442_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	19.877	Phase III_RCC_CA209025	US/CANADA	50	F	WHITE	0056_Marios_PD1_Inhib2_HP-AE206902-7.raw
SA088751	CA209025-21-967	CA209025-21-967_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	18.530	Phase III_RCC_CA209025	US/CANADA	74	F	WHITE	0667_Marios_PD1_Inhib2_HP-AF063578-9.raw
SA088736	CA209025-2-24	CA209025-2-24_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	12.452	Phase III_RCC_CA209025	WESTERN EUROPE	52	F	WHITE	0535_Marios_PD1_Inhib2_HP-E9101710-8.raw
SA088753	CA209025-23-124	CA209025-23-124_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	29.470	Phase III_RCC_CA209025	US/CANADA	64	F	WHITE	0724_Marios_PD1_Inhib2_HP-AD490506-7.raw
SA088752	CA209025-23-684	CA209025-23-684_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	13.963	Phase III_RCC_CA209025	US/CANADA	60	F	WHITE	0736_Marios_PD1_Inhib2_HP-AE600725-7.raw
SA088754	CA209025-2-38	CA209025-2-38_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	20.895	Phase III_RCC_CA209025	WESTERN EUROPE	71	F	WHITE	0291_Marios_PD1_Inhib2_HP-E9130935-7.raw
SA088749	CA209025-2-477	CA209025-2-477_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	30.062	Phase III_RCC_CA209025	WESTERN EUROPE	70	M	WHITE	0308_Marios_PD1_Inhib2_HP-E9618953-7.raw
SA088741	CA209025-24-887	CA209025-24-887_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	27.696	Phase III_RCC_CA209025	US/CANADA	44	M	WHITE	0385_Marios_PD1_Inhib2_HP-AF009311-9.raw
SA088740	CA209025-25-165	CA209025-25-165_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	1.906	Phase III_RCC_CA209025	US/CANADA	57	F	WHITE	0642_Marios_PD1_Inhib2_HP-AD610056-7.raw
SA088748	CA209025-2-793	CA209025-2-793_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	31.179	Phase III_RCC_CA209025	WESTERN EUROPE	45	M	WHITE	0943_Marios_PD1_Inhib2_HP-EA495436-7.raw
SA088742	CA209025-29-1021	CA209025-29-1021_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	7.097	Phase III_RCC_CA209025	US/CANADA	49	F	WHITE	0031_Marios_PD1_Inhib2_HP-AF008967-9.raw
SA088743	CA209025-29-621	CA209025-29-621_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	18.234	Phase III_RCC_CA209025	US/CANADA	65	M	WHITE	0169_Marios_PD1_Inhib2_HP-AE294677-7.raw
SA088745	CA209025-29-626	CA209025-29-626_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	8.608	Phase III_RCC_CA209025	US/CANADA	48	M	WHITE	0359_Marios_PD1_Inhib2_HP-AE294680-7.raw
SA088739	CA209025-43-567	CA209025-43-567_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	10.152	Phase III_RCC_CA209025	US/CANADA	53	F	WHITE	0368_Marios_PD1_Inhib2_HP-AE427607-7.raw
SA088744	CA209025-4-759	CA209025-4-759_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	6.472	Phase III_RCC_CA209025	WESTERN EUROPE	51	M	WHITE	1140_Marios_PD1_Inhib2_HP-E9099304-2.raw
SA088746	CA209025-48-282	CA209025-48-282_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	29.602	Phase III_RCC_CA209025	WESTERN EUROPE	74	M	WHITE	0638_Marios_PD1_Inhib2_HP-EA044582-7.raw
SA088747	CA209025-48-285	CA209025-48-285_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	15.836	Phase III_RCC_CA209025	WESTERN EUROPE	52	M	WHITE	0626_Marios_PD1_Inhib2_HP-E9674322-7.raw
SA088750	CA209025-50-902	CA209025-50-902_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	35.581	Phase III_RCC_CA209025	WESTERN EUROPE	49	M	WHITE	0278_Marios_PD1_Inhib2_HP-EA412067-10.raw
SA088735	CA209025-59-159	CA209025-59-159_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	1.183	Phase III_RCC_CA209025	WESTERN EUROPE	78	F	WHITE	1088_Marios_PD1_Inhib2_HP-E9172350-7.raw
SA088737	CA209025-65-301	CA209025-65-301_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	30.784	Phase III_RCC_CA209025	WESTERN EUROPE	72	M	WHITE	0032_Marios_PD1_Inhib2_HP-EA002605-7.raw
SA088781	CA209025-66-544	CA209025-66-544_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	23.162	Phase III_RCC_CA209025	WESTERN EUROPE	63	M	WHITE	0527_Marios_PD1_Inhib2_HP-E9241873-7.raw
SA088783	CA209025-73-447	CA209025-73-447_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	33.643	Phase III_RCC_CA209025	WESTERN EUROPE	65	M	WHITE	0377_Marios_PD1_Inhib2_HP-E9073425-7.raw
SA088755	CA209025-75-113	CA209025-75-113_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	21.355	Phase III_RCC_CA209025	WESTERN EUROPE	70	F	WHITE	0938_Marios_PD1_Inhib2_HP-E9104437-7.raw
SA088785	CA209025-75-615	CA209025-75-615_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	31.047	Phase III_RCC_CA209025	WESTERN EUROPE	69	F	WHITE	0077_Marios_PD1_Inhib2_HP-E9479165-7.raw
SA088773	CA209025-79-373	CA209025-79-373_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	38.209	Phase III_RCC_CA209025	REST OF WORLD	62	M	WHITE	0289_Marios_PD1_Inhib2_HP-L1352789-6.raw
SA088764	CA209025-80-728	CA209025-80-728_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	25.988	Phase III_RCC_CA209025	WESTERN EUROPE	59	F	WHITE	0879_Marios_PD1_Inhib2_HP-EA083034-7.raw
SA088767	CA209025-82-378	CA209025-82-378_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	16.789	Phase III_RCC_CA209025	WESTERN EUROPE	47	F	WHITE	0311_Marios_PD1_Inhib2_HP-E9703897-7.raw
SA088772	CA209025-84-704	CA209025-84-704_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	19.055	Phase III_RCC_CA209025	REST OF WORLD	72	M	WHITE	0788_Marios_PD1_Inhib2_HP-L1381807-6.raw
SA088759	CA209025-8-677	CA209025-8-677_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	37.815	Phase III_RCC_CA209025	WESTERN EUROPE	69	M	WHITE	0520_Marios_PD1_Inhib2_HP-E9125189-7.raw
SA088756	CA209025-8-69	CA209025-8-69_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	24.148	Phase III_RCC_CA209025	WESTERN EUROPE	71	M	WHITE	1012_Marios_PD1_Inhib2_HP-E9108732-7.raw
SA088782	CA209025-87-234	CA209025-87-234_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	43.039	Phase III_RCC_CA209025	WESTERN EUROPE	37	M	WHITE	0214_Marios_PD1_Inhib2_HP-E9103643-7.raw
SA088778	CA209025-87-267	CA209025-87-267_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	14.883	Phase III_RCC_CA209025	WESTERN EUROPE	68	F	WHITE	1147_Marios_PD1_Inhib2_HP-E9103642-7.raw
SA088780	CA209025-96-498	CA209025-96-498_baseline	baseline	-	FAVORABLE	NIVOLUMAB	FALSE	32.164	Phase III_RCC_CA209025	REST OF WORLD	54	M	WHITE	0781_Marios_PD1_Inhib2_HP-S3740939-7.raw
SA088801	CA209025-139-784	CA209025-139-784_baseline	baseline	-	FAVORABLE	NIVOLUMAB	TRUE	43.499	Phase III_RCC_CA209025	US/CANADA	52	M	WHITE	0620_Marios_PD1_Inhib2_HP-AE645251-7.raw
SA088798	CA209025-139-978	CA209025-139-978_baseline	baseline	-	FAVORABLE	NIVOLUMAB	TRUE	31.343	Phase III_RCC_CA209025	US/CANADA	56	M	OTHER	0151_Marios_PD1_Inhib2_HP-AF048313-9.raw
SA088797	CA209025-147-367	CA209025-147-367_baseline	baseline	-	FAVORABLE	NIVOLUMAB	TRUE	36.205	Phase III_RCC_CA209025	US/CANADA	67	M	WHITE	0085_Marios_PD1_Inhib2_HP-AD673732-7.raw
SA088794	CA209025-158-680	CA209025-158-680_baseline	baseline	-	FAVORABLE	NIVOLUMAB	TRUE	18.103	Phase III_RCC_CA209025	REST OF WORLD	78	M	OTHER	0526_Marios_PD1_Inhib2_HP-S3746240-7.raw
SA088800	CA209025-1-618	CA209025-1-618_baseline	baseline	-	FAVORABLE	NIVOLUMAB	TRUE	15.376	Phase III_RCC_CA209025	US/CANADA	53	F	WHITE	0454_Marios_PD1_Inhib2_HP-AE471830-6.raw
SA088796	CA209025-17-1066	CA209025-17-1066_baseline	baseline	-	FAVORABLE	NIVOLUMAB	TRUE	25.626	Phase III_RCC_CA209025	US/CANADA	60	F	WHITE	0756_Marios_PD1_Inhib2_HP-AE613962-7.raw
SA088803	CA209025-17-328	CA209025-17-328_baseline	baseline	-	FAVORABLE	NIVOLUMAB	TRUE	27.828	Phase III_RCC_CA209025	US/CANADA	63	F	WHITE	0803_Marios_PD1_Inhib2_HP-AD749688-7.raw
SA088795	CA209025-17-473	CA209025-17-473_baseline	baseline	-	FAVORABLE	NIVOLUMAB	TRUE	7.524	Phase III_RCC_CA209025	US/CANADA	49	M	OTHER	0211_Marios_PD1_Inhib2_HP-AE302153-9.raw
SA088793	CA209025-22-935	CA209025-22-935_baseline	baseline	-	FAVORABLE	NIVOLUMAB	TRUE	24.772	Phase III_RCC_CA209025	US/CANADA	45	M	WHITE	1165_Marios_PD1_Inhib2_HP-AE302091-6.raw
SA088799	CA209025-25-197	CA209025-25-197_baseline	baseline	-	FAVORABLE	NIVOLUMAB	TRUE	34.530	Phase III_RCC_CA209025	US/CANADA	58	M	WHITE	0859_Marios_PD1_Inhib2_HP-AD775402-7.raw
SA088802	CA209025-26-693	CA209025-26-693_baseline	baseline	-	FAVORABLE	NIVOLUMAB	TRUE	31.343	Phase III_RCC_CA209025	US/CANADA	56	M	WHITE	0491_Marios_PD1_Inhib2_HP-AE438256-7.raw
SA088792	CA209025-30-418	CA209025-30-418_baseline	baseline	-	FAVORABLE	NIVOLUMAB	TRUE	44.058	Phase III_RCC_CA209025	US/CANADA	65	M	WHITE	0465_Marios_PD1_Inhib2_HP-AE355052-7.raw
SA088791	CA209025-3-871	CA209025-3-871_baseline	baseline	-	FAVORABLE	NIVOLUMAB	TRUE	7.064	Phase III_RCC_CA209025	WESTERN EUROPE	64	M	WHITE	0740_Marios_PD1_Inhib2_HP-E9064328-7.raw
SA088805	CA209025-63-607	CA209025-63-607_baseline	baseline	-	FAVORABLE	NIVOLUMAB	TRUE	12.518	Phase III_RCC_CA209025	WESTERN EUROPE	55	F	WHITE	0766_Marios_PD1_Inhib2_HP-E9528379-7.raw
SA088806	CA209025-74-194	CA209025-74-194_baseline	baseline	-	FAVORABLE	NIVOLUMAB	TRUE	13.799	Phase III_RCC_CA209025	WESTERN EUROPE	67	M	WHITE	0242_Marios_PD1_Inhib2_HP-E9103990-7.raw
SA088807	CA209025-75-191	CA209025-75-191_baseline	baseline	-	FAVORABLE	NIVOLUMAB	TRUE	42.185	Phase III_RCC_CA209025	WESTERN EUROPE	63	M	WHITE	0953_Marios_PD1_Inhib2_HP-E9104438-7.raw
SA088808	CA209025-75-84	CA209025-75-84_baseline	baseline	-	FAVORABLE	NIVOLUMAB	TRUE	44.583	Phase III_RCC_CA209025	WESTERN EUROPE	75	M	WHITE	0985_Marios_PD1_Inhib2_HP-E9064315-7.raw
SA088804	CA209025-90-703	CA209025-90-703_baseline	baseline	-	FAVORABLE	NIVOLUMAB	TRUE	14.259	Phase III_RCC_CA209025	WESTERN EUROPE	45	M	WHITE	0402_Marios_PD1_Inhib2_HP-E9634499-7.raw
SA088809	CA209025-94-851	CA209025-94-851_baseline	baseline	-	FAVORABLE	NIVOLUMAB	TRUE	23.688	Phase III_RCC_CA209025	REST OF WORLD	61	M	WHITE	0422_Marios_PD1_Inhib2_HP-S3884097-7.raw
SA088817	CA209025-102-279	CA209025-102-279_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	10.349	Phase III_RCC_CA209025	WESTERN EUROPE	66	M	WHITE	1151_Marios_PD1_Inhib2_HP-E9172289-6.raw
SA088863	CA209025-111-304	CA209025-111-304_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	7.819	Phase III_RCC_CA209025	REST OF WORLD	74	F	WHITE	0902_Marios_PD1_Inhib2_HP-EA003802-7.raw
SA088895	CA209025-112-175	CA209025-112-175_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	5.881	Phase III_RCC_CA209025	WESTERN EUROPE	38	M	WHITE	0159_Marios_PD1_Inhib2_HP-E9123049-7.raw
SA088890	CA209025-114-60	CA209025-114-60_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	1.938	Phase III_RCC_CA209025	WESTERN EUROPE	68	M	WHITE	1090_Marios_PD1_Inhib2_HP-E9123055-7.raw
SA088875	CA209025-11-829	CA209025-11-829_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	6.834	Phase III_RCC_CA209025	US/CANADA	58	M	WHITE	0328_Marios_PD1_Inhib2_HP-AE330678-6.raw
SA088842	CA209025-118-446	CA209025-118-446_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	3.417	Phase III_RCC_CA209025	WESTERN EUROPE	63	M	WHITE	0975_Marios_PD1_Inhib2_HP-E9712823-7.raw
SA088849	CA209025-119-246	CA209025-119-246_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	3.581	Phase III_RCC_CA209025	WESTERN EUROPE	55	M	WHITE	0168_Marios_PD1_Inhib2_HP-E9754089-7.raw
SA088866	CA209025-1-201	CA209025-1-201_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	8.049	Phase III_RCC_CA209025	US/CANADA	69	M	WHITE	0217_Marios_PD1_Inhib2_HP-AD424476-7.raw
SA088889	CA209025-124-763	CA209025-124-763_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	12.780	Phase III_RCC_CA209025	REST OF WORLD	60	M	WHITE	0863_Marios_PD1_Inhib2_HP-L1387364-10.raw
SA088898	CA209025-125-508	CA209025-125-508_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	11.006	Phase III_RCC_CA209025	REST OF WORLD	69	M	WHITE	0333_Marios_PD1_Inhib2_HP-L1366503-6.raw
SA088879	CA209025-126-230	CA209025-126-230_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	1.347	Phase III_RCC_CA209025	WESTERN EUROPE	84	M	WHITE	1056_Marios_PD1_Inhib2_HP-E9474282-7.raw
SA088845	CA209025-1-28	CA209025-1-28_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	16.131	Phase III_RCC_CA209025	US/CANADA	62	M	WHITE	0877_Marios_PD1_Inhib2_HP-AD185797-7.raw
SA088850	CA209025-1-326	CA209025-1-326_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	19.253	Phase III_RCC_CA209025	US/CANADA	69	F	WHITE	0744_Marios_PD1_Inhib2_HP-AD424472-7.raw
SA088894	CA209025-13-526	CA209025-13-526_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	35.088	Phase III_RCC_CA209025	US/CANADA	63	M	WHITE	1110_Marios_PD1_Inhib2_HP-AD827407-7.raw
SA088825	CA209025-137-55	CA209025-137-55_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	23.064	Phase III_RCC_CA209025	WESTERN EUROPE	55	M	WHITE	0613_Marios_PD1_Inhib2_HP-E9073336-7.raw
SA088841	CA209025-138-1069	CA209025-138-1069_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	7.359	Phase III_RCC_CA209025	US/CANADA	76	M	WHITE	0895_Marios_PD1_Inhib2_HP-AF004064-9.raw
SA088839	CA209025-138-398	CA209025-138-398_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	29.733	Phase III_RCC_CA209025	US/CANADA	71	M	WHITE	0660_Marios_PD1_Inhib2_HP-AE133962-7.raw
SA088810	CA209025-139-764	CA209025-139-764_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	18.826	Phase III_RCC_CA209025	US/CANADA	59	M	OTHER	0409_Marios_PD1_Inhib2_HP-AF048315-9.raw
SA088858	CA209025-139-796	CA209025-139-796_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	3.121	Phase III_RCC_CA209025	US/CANADA	69	F	WHITE	0644_Marios_PD1_Inhib2_HP-AE853232-7.raw
SA088818	CA209025-139-950	CA209025-139-950_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	11.860	Phase III_RCC_CA209025	US/CANADA	58	M	WHITE	0250_Marios_PD1_Inhib2_HP-AF048314-9.raw
SA088855	CA209025-141-370	CA209025-141-370_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	8.016	Phase III_RCC_CA209025	US/CANADA	64	M	WHITE	1113_Marios_PD1_Inhib2_HP-AD780393-7.raw
SA088813	CA209025-143-565	CA209025-143-565_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	2.760	Phase III_RCC_CA209025	US/CANADA	79	M	WHITE	0682_Marios_PD1_Inhib2_HP-AE459920-7.raw
SA088811	CA209025-145-391	CA209025-145-391_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	47.113	Phase III_RCC_CA209025	US/CANADA	85	F	WHITE	1204_Marios_PD1_Inhib2_HP-AD780353-7.raw
SA088872	CA209025-149-748	CA209025-149-748_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	7.425	Phase III_RCC_CA209025	REST OF WORLD	61	M	WHITE	0147_Marios_PD1_Inhib2_HP-EA039694-7.raw
SA088815	CA209025-14-996	CA209025-14-996_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	15.212	Phase III_RCC_CA209025	US/CANADA	60	M	WHITE	0670_Marios_PD1_Inhib2_HP-AE902413-6.raw
SA088881	CA209025-154-119	CA209025-154-119_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	17.708	Phase III_RCC_CA209025	REST OF WORLD	66	M	OTHER	0013_Marios_PD1_Inhib2_HP-S3470296-7.raw
SA088864	CA209025-155-858	CA209025-155-858_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	17.478	Phase III_RCC_CA209025	REST OF WORLD	58	F	OTHER	0846_Marios_PD1_Inhib2_HP-S4071079-7.raw
SA088847	CA209025-156-744	CA209025-156-744_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	25.199	Phase III_RCC_CA209025	REST OF WORLD	72	M	OTHER	0442_Marios_PD1_Inhib2_HP-S3877147-6.raw
SA088900	CA209025-1-71	CA209025-1-71_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	30.916	Phase III_RCC_CA209025	US/CANADA	52	M	WHITE	0917_Marios_PD1_Inhib2_HP-AD424471-8.raw
SA088826	CA209025-174-863	CA209025-174-863_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	4.632	Phase III_RCC_CA209025	REST OF WORLD	61	M	OTHER	1206_Marios_PD1_Inhib2_HP-S3949116-7.raw
SA088834	CA209025-180-1053	CA209025-180-1053_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	6.571	Phase III_RCC_CA209025	REST OF WORLD	59	F	WHITE	0529_Marios_PD1_Inhib2_HP-EB335372-8.raw
SA088844	CA209025-18-148	CA209025-18-148_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	10.513	Phase III_RCC_CA209025	US/CANADA	74	M	WHITE	0273_Marios_PD1_Inhib2_HP-AD498710-7.raw
SA088851	CA209025-182-701	CA209025-182-701_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	19.975	Phase III_RCC_CA209025	US/CANADA	82	M	WHITE	0747_Marios_PD1_Inhib2_HP-AE283064-7.raw
SA088827	CA209025-1-972	CA209025-1-972_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	14.686	Phase III_RCC_CA209025	US/CANADA	50	F	OTHER	1078_Marios_PD1_Inhib2_HP-AF002676-10.raw
SA088891	CA209025-20-1075	CA209025-20-1075_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	8.509	Phase III_RCC_CA209025	US/CANADA	58	M	WHITE	1127_Marios_PD1_Inhib2_HP-AF252767-9.raw
SA088888	CA209025-2-103	CA209025-2-103_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	10.119	Phase III_RCC_CA209025	WESTERN EUROPE	61	M	WHITE	0223_Marios_PD1_Inhib2_HP-E9425294-7.raw
SA088848	CA209025-21-380	CA209025-21-380_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	36.797	Phase III_RCC_CA209025	US/CANADA	60	M	WHITE	0684_Marios_PD1_Inhib2_HP-AD601336-7.raw
SA088836	CA209025-22-344	CA209025-22-344_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	11.860	Phase III_RCC_CA209025	US/CANADA	40	M	WHITE	0020_Marios_PD1_Inhib2_HP-AE198219-6.raw
SA088833	CA209025-23-196	CA209025-23-196_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	16.230	Phase III_RCC_CA209025	US/CANADA	65	M	WHITE	0799_Marios_PD1_Inhib2_HP-AD461613-7.raw
SA088860	CA209025-2-440	CA209025-2-440_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	7.589	Phase III_RCC_CA209025	WESTERN EUROPE	51	F	WHITE	0132_Marios_PD1_Inhib2_HP-E9618950-7.raw
SA088814	CA209025-25-135	CA209025-25-135_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	7.392	Phase III_RCC_CA209025	US/CANADA	66	M	WHITE	0981_Marios_PD1_Inhib2_HP-AD610058-7.raw
SA088821	CA209025-2-573	CA209025-2-573_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	20.041	Phase III_RCC_CA209025	WESTERN EUROPE	67	M	WHITE	0300_Marios_PD1_Inhib2_HP-E9618948-7.raw
SA088830	CA209025-27-513	CA209025-27-513_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	7.655	Phase III_RCC_CA209025	US/CANADA	60	M	WHITE	1082_Marios_PD1_Inhib2_HP-AE302625-7.raw
SA088887	CA209025-29-486	CA209025-29-486_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	19.910	Phase III_RCC_CA209025	US/CANADA	56	M	WHITE	0375_Marios_PD1_Inhib2_HP-AE294669-7.raw
SA088897	CA209025-29-51	CA209025-29-51_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	17.643	Phase III_RCC_CA209025	US/CANADA	67	F	WHITE	0912_Marios_PD1_Inhib2_HP-AD176340-6.raw
SA088893	CA209025-29-601	CA209025-29-601_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	6.965	Phase III_RCC_CA209025	US/CANADA	67	M	WHITE	0340_Marios_PD1_Inhib2_HP-AE294679-7.raw
SA088886	CA209025-33-29	CA209025-33-29_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	29.963	Phase III_RCC_CA209025	WESTERN EUROPE	58	M	WHITE	0353_Marios_PD1_Inhib2_HP-E9101786-7.raw
SA088823	CA209025-35-332	CA209025-35-332_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	19.910	Phase III_RCC_CA209025	WESTERN EUROPE	52	M	WHITE	0088_Marios_PD1_Inhib2_HP-E9103732-7.raw
SA088829	CA209025-38-514	CA209025-38-514_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	26.185	Phase III_RCC_CA209025	WESTERN EUROPE	63	M	WHITE	1041_Marios_PD1_Inhib2_HP-E9133655-7.raw
SA088831	CA209025-39-749	CA209025-39-749_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	17.906	Phase III_RCC_CA209025	WESTERN EUROPE	76	M	WHITE	0128_Marios_PD1_Inhib2_HP-E9432886-7.raw
SA088822	CA209025-41-980	CA209025-41-980_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	18.891	Phase III_RCC_CA209025	US/CANADA	54	M	OTHER	1128_Marios_PD1_Inhib2_HP-AF008938-9.raw
SA088856	CA209025-42-1051	CA209025-42-1051_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	5.322	Phase III_RCC_CA209025	US/CANADA	47	M	WHITE	0811_Marios_PD1_Inhib2_HP-AF126072-9.raw
SA088865	CA209025-42-959	CA209025-42-959_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	2.201	Phase III_RCC_CA209025	US/CANADA	54	F	WHITE	0839_Marios_PD1_Inhib2_HP-AF126071-9.raw
SA088835	CA209025-49-975	CA209025-49-975_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	22.078	Phase III_RCC_CA209025	US/CANADA	67	M	WHITE	0604_Marios_PD1_Inhib2_HP-AE673154-6.raw
SA088838	CA209025-50-825	CA209025-50-825_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	23.754	Phase III_RCC_CA209025	WESTERN EUROPE	58	M	WHITE	0855_Marios_PD1_Inhib2_HP-EA412066-6.raw
SA088824	CA209025-53-1003	CA209025-53-1003_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	5.355	Phase III_RCC_CA209025	US/CANADA	57	F	WHITE	1091_Marios_PD1_Inhib2_HP-AF016229-9.raw
SA088840	CA209025-56-592	CA209025-56-592_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	1.544	Phase III_RCC_CA209025	WESTERN EUROPE	72	M	WHITE	0102_Marios_PD1_Inhib2_HP-E9096038-7.raw
SA088880	CA209025-58-545	CA209025-58-545_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	25.725	Phase III_RCC_CA209025	WESTERN EUROPE	58	M	OTHER	0058_Marios_PD1_Inhib2_HP-EA103410-7.raw
SA088878	CA209025-59-412	CA209025-59-412_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	18.497	Phase III_RCC_CA209025	WESTERN EUROPE	55	F	WHITE	0236_Marios_PD1_Inhib2_HP-E9172349-7.raw
SA088877	CA209025-59-691	CA209025-59-691_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	6.932	Phase III_RCC_CA209025	WESTERN EUROPE	76	M	WHITE	0106_Marios_PD1_Inhib2_HP-EA185598-6.raw
SA088861	CA209025-61-189	CA209025-61-189_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	41.922	Phase III_RCC_CA209025	WESTERN EUROPE	78	M	WHITE	0190_Marios_PD1_Inhib2_HP-E9240778-6.raw
SA088868	CA209025-61-218	CA209025-61-218_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	6.374	Phase III_RCC_CA209025	WESTERN EUROPE	83	M	WHITE	0367_Marios_PD1_Inhib2_HP-E9667539-6.raw
SA088867	CA209025-62-108	CA209025-62-108_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	6.209	Phase III_RCC_CA209025	WESTERN EUROPE	71	M	WHITE	0068_Marios_PD1_Inhib2_HP-E9241306-7.raw
SA088882	CA209025-62-315	CA209025-62-315_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	5.750	Phase III_RCC_CA209025	WESTERN EUROPE	47	M	WHITE	1154_Marios_PD1_Inhib2_HP-EA015432-7.raw
SA088899	CA209025-62-78	CA209025-62-78_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	2.924	Phase III_RCC_CA209025	WESTERN EUROPE	60	F	WHITE	0089_Marios_PD1_Inhib2_HP-E9241305-7.raw
SA088883	CA209025-64-846	CA209025-64-846_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	11.663	Phase III_RCC_CA209025	WESTERN EUROPE	60	F	WHITE	0552_Marios_PD1_Inhib2_HP-E9485322-7.raw
SA088892	CA209025-65-437	CA209025-65-437_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	7.064	Phase III_RCC_CA209025	WESTERN EUROPE	62	M	WHITE	0067_Marios_PD1_Inhib2_HP-EA048753-6.raw
SA088857	CA209025-65-438	CA209025-65-438_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	9.856	Phase III_RCC_CA209025	WESTERN EUROPE	69	F	WHITE	0502_Marios_PD1_Inhib2_HP-E9778359-7.raw
SA088819	CA209025-70-414	CA209025-70-414_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	23.951	Phase III_RCC_CA209025	REST OF WORLD	65	M	WHITE	0751_Marios_PD1_Inhib2_HP-EA088437-7.raw
SA088812	CA209025-73-92	CA209025-73-92_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	17.971	Phase III_RCC_CA209025	WESTERN EUROPE	66	M	WHITE	1159_Marios_PD1_Inhib2_HP-E9106364-6.raw
SA088854	CA209025-75-675	CA209025-75-675_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	8.214	Phase III_RCC_CA209025	WESTERN EUROPE	76	M	WHITE	0072_Marios_PD1_Inhib2_HP-EA040851-7.raw
SA088853	CA209025-77-492	CA209025-77-492_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	15.212	Phase III_RCC_CA209025	REST OF WORLD	63	M	WHITE	0313_Marios_PD1_Inhib2_HP-L1381859-7.raw
SA088843	CA209025-78-1007	CA209025-78-1007_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	4.337	Phase III_RCC_CA209025	REST OF WORLD	51	M	WHITE	0797_Marios_PD1_Inhib2_HP-L1376090-7.raw
SA088832	CA209025-78-1014	CA209025-78-1014_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	5.618	Phase III_RCC_CA209025	REST OF WORLD	52	M	WHITE	0618_Marios_PD1_Inhib2_HP-L1479322-12.raw
SA088837	CA209025-78-627	CA209025-78-627_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	4.961	Phase III_RCC_CA209025	REST OF WORLD	71	M	WHITE	0894_Marios_PD1_Inhib2_HP-L1376089-6.raw
SA088828	CA209025-79-705	CA209025-79-705_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	13.405	Phase III_RCC_CA209025	REST OF WORLD	77	M	WHITE	0124_Marios_PD1_Inhib2_HP-L1381834-6.raw
SA088896	CA209025-80-19	CA209025-80-19_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	21.552	Phase III_RCC_CA209025	WESTERN EUROPE	70	M	WHITE	1164_Marios_PD1_Inhib2_HP-E9097389-7.raw
SA088884	CA209025-80-37	CA209025-80-37_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	26.218	Phase III_RCC_CA209025	WESTERN EUROPE	66	M	WHITE	0243_Marios_PD1_Inhib2_HP-E9097391-7.raw
SA088873	CA209025-84-349	CA209025-84-349_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	16.953	Phase III_RCC_CA209025	REST OF WORLD	70	F	WHITE	0681_Marios_PD1_Inhib2_HP-L1357305-7.raw
SA088846	CA209025-84-933	CA209025-84-933_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	25.528	Phase III_RCC_CA209025	REST OF WORLD	71	M	WHITE	0592_Marios_PD1_Inhib2_HP-L1443424-9.raw
SA088852	CA209025-85-971	CA209025-85-971_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	20.862	Phase III_RCC_CA209025	REST OF WORLD	76	M	WHITE	0556_Marios_PD1_Inhib2_HP-L1453006-10.raw
SA088820	CA209025-8-676	CA209025-8-676_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	22.801	Phase III_RCC_CA209025	WESTERN EUROPE	47	M	WHITE	0576_Marios_PD1_Inhib2_HP-E9108730-7.raw
SA088816	CA209025-89-336	CA209025-89-336_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	4.370	Phase III_RCC_CA209025	WESTERN EUROPE	55	M	WHITE	0064_Marios_PD1_Inhib2_HP-E9656483-7.raw
SA088885	CA209025-89-740	CA209025-89-740_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	25.758	Phase III_RCC_CA209025	WESTERN EUROPE	59	M	WHITE	0729_Marios_PD1_Inhib2_HP-EA511887-7.raw
SA088869	CA209025-90-799	CA209025-90-799_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	15.836	Phase III_RCC_CA209025	WESTERN EUROPE	65	M	WHITE	0123_Marios_PD1_Inhib2_HP-E9665082-7.raw
SA088874	CA209025-94-877	CA209025-94-877_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	19.187	Phase III_RCC_CA209025	REST OF WORLD	57	M	WHITE	1219_Marios_PD1_Inhib2_HP-S4102905-9.raw
SA088871	CA209025-95-707	CA209025-95-707_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	15.573	Phase III_RCC_CA209025	REST OF WORLD	52	M	WHITE	0677_Marios_PD1_Inhib2_HP-S3792613-7.raw
SA088901	CA209025-9-575	CA209025-9-575_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	3.318	Phase III_RCC_CA209025	US/CANADA	60	M	WHITE	1098_Marios_PD1_Inhib2_HP-AD611931-7.raw
SA088876	CA209025-96-819	CA209025-96-819_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	35.910	Phase III_RCC_CA209025	REST OF WORLD	68	M	WHITE	0175_Marios_PD1_Inhib2_HP-S3740940-7.raw
SA088870	CA209025-97-688	CA209025-97-688_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	2.760	Phase III_RCC_CA209025	REST OF WORLD	49	F	WHITE	0683_Marios_PD1_Inhib2_HP-S3722551-7.raw
SA088862	CA209025-98-527	CA209025-98-527_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	3.975	Phase III_RCC_CA209025	REST OF WORLD	68	M	WHITE	0376_Marios_PD1_Inhib2_HP-S3862085-7.raw
SA088859	CA209025-9-984	CA209025-9-984_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	FALSE	22.341	Phase III_RCC_CA209025	US/CANADA	74	F	WHITE	0958_Marios_PD1_Inhib2_HP-AF002779-9.raw
SA088919	CA209025-11-145	CA209025-11-145_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	TRUE	18.431	Phase III_RCC_CA209025	US/CANADA	67	M	OTHER	0794_Marios_PD1_Inhib2_HP-AD604106-7.raw
SA088903	CA209025-121-540	CA209025-121-540_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	TRUE	6.505	Phase III_RCC_CA209025	REST OF WORLD	44	F	WHITE	0553_Marios_PD1_Inhib2_HP-L1370587-6.raw
SA088909	CA209025-126-222	CA209025-126-222_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	TRUE	18.431	Phase III_RCC_CA209025	WESTERN EUROPE	75	M	WHITE	0438_Marios_PD1_Inhib2_HP-E9474281-7.raw
SA088925	CA209025-138-479	CA209025-138-479_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	TRUE	25.856	Phase III_RCC_CA209025	US/CANADA	64	M	WHITE	0258_Marios_PD1_Inhib2_HP-AE133961-7.raw
SA088906	CA209025-139-808	CA209025-139-808_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	TRUE	4.830	Phase III_RCC_CA209025	US/CANADA	70	M	WHITE	0408_Marios_PD1_Inhib2_HP-AE861579-7.raw
SA088922	CA209025-147-620	CA209025-147-620_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	TRUE	13.996	Phase III_RCC_CA209025	US/CANADA	71	F	WHITE	0339_Marios_PD1_Inhib2_HP-AD673733-6.raw
SA088910	CA209025-159-722	CA209025-159-722_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	TRUE	22.998	Phase III_RCC_CA209025	REST OF WORLD	72	M	OTHER	0327_Marios_PD1_Inhib2_HP-S3781279-7.raw
SA088924	CA209025-183-874	CA209025-183-874_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	TRUE	41.561	Phase III_RCC_CA209025	US/CANADA	62	M	WHITE	0910_Marios_PD1_Inhib2_HP-AE606326-6.raw
SA088917	CA209025-20-122	CA209025-20-122_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	TRUE	19.745	Phase III_RCC_CA209025	US/CANADA	72	M	WHITE	0240_Marios_PD1_Inhib2_HP-AD612902-7.raw
SA088914	CA209025-20-782	CA209025-20-782_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	TRUE	16.427	Phase III_RCC_CA209025	US/CANADA	72	M	WHITE	0370_Marios_PD1_Inhib2_HP-AE710607-7.raw
SA088904	CA209025-23-898	CA209025-23-898_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	TRUE	20.994	Phase III_RCC_CA209025	US/CANADA	73	F	WHITE	1049_Marios_PD1_Inhib2_HP-AF002747-9.raw
SA088905	CA209025-25-1028	CA209025-25-1028_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	TRUE	2.103	Phase III_RCC_CA209025	US/CANADA	67	F	WHITE	0202_Marios_PD1_Inhib2_HP-AF185748-9.raw
SA088907	CA209025-25-947	CA209025-25-947_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	TRUE	11.368	Phase III_RCC_CA209025	US/CANADA	69	F	WHITE	0090_Marios_PD1_Inhib2_HP-AF009252-9.raw
SA088908	CA209025-33-6	CA209025-33-6_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	TRUE	10.053	Phase III_RCC_CA209025	WESTERN EUROPE	73	M	WHITE	0208_Marios_PD1_Inhib2_HP-E9070703-27.raw
SA088902	CA209025-37-18	CA209025-37-18_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	TRUE	4.731	Phase III_RCC_CA209025	WESTERN EUROPE	58	M	WHITE	0447_Marios_PD1_Inhib2_HP-E9103769-7.raw
SA088916	CA209025-42-89	CA209025-42-89_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	TRUE	12.879	Phase III_RCC_CA209025	US/CANADA	46	M	WHITE	0548_Marios_PD1_Inhib2_HP-AD452684-7.raw
SA088913	CA209025-53-595	CA209025-53-595_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	TRUE	39.655	Phase III_RCC_CA209025	US/CANADA	43	F	WHITE	0575_Marios_PD1_Inhib2_HP-AE436649-7.raw
SA088912	CA209025-53-885	CA209025-53-885_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	TRUE	3.614	Phase III_RCC_CA209025	US/CANADA	54	M	OTHER	0392_Marios_PD1_Inhib2_HP-AF016230-9.raw
SA088918	CA209025-56-532	CA209025-56-532_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	TRUE	30.719	Phase III_RCC_CA209025	WESTERN EUROPE	43	M	WHITE	0691_Marios_PD1_Inhib2_HP-E9106982-11.raw
SA088921	CA209025-62-652	CA209025-62-652_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	TRUE	10.875	Phase III_RCC_CA209025	WESTERN EUROPE	52	M	WHITE	0897_Marios_PD1_Inhib2_HP-EA297778-7.raw
SA088915	CA209025-89-563	CA209025-89-563_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	TRUE	5.421	Phase III_RCC_CA209025	WESTERN EUROPE	60	M	WHITE	0569_Marios_PD1_Inhib2_HP-E9656485-7.raw
SA088923	CA209025-89-63	CA209025-89-63_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	TRUE	15.836	Phase III_RCC_CA209025	WESTERN EUROPE	63	M	WHITE	0026_Marios_PD1_Inhib2_HP-E9103841-7.raw
SA088920	CA209025-90-87	CA209025-90-87_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	TRUE	17.610	Phase III_RCC_CA209025	WESTERN EUROPE	51	M	WHITE	0055_Marios_PD1_Inhib2_HP-E9103088-7.raw
SA088911	CA209025-9-361	CA209025-9-361_baseline	baseline	-	INTERMEDIATE	EVEROLIMUS	TRUE	35.910	Phase III_RCC_CA209025	US/CANADA	51	M	OTHER	0105_Marios_PD1_Inhib2_HP-AD611930-7.raw
SA088957	CA209025-108-510	CA209025-108-510_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	3.910	Phase III_RCC_CA209025	REST OF WORLD	65	M	WHITE	0432_Marios_PD1_Inhib2_HP-EA185078-17.raw
SA088939	CA209025-1-1024	CA209025-1-1024_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	5.651	Phase III_RCC_CA209025	US/CANADA	78	F	WHITE	0814_Marios_PD1_Inhib2_HP-AE663608-7.raw
SA088932	CA209025-1-1071	CA209025-1-1071_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	20.567	Phase III_RCC_CA209025	US/CANADA	64	F	WHITE	0051_Marios_PD1_Inhib2_HP-AF439756-9.raw
SA088959	CA209025-11-1073	CA209025-11-1073_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	38.571	Phase III_RCC_CA209025	US/CANADA	59	M	WHITE	0867_Marios_PD1_Inhib2_HP-AF015814-9.raw
SA088947	CA209025-113-206	CA209025-113-206_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	18.267	Phase III_RCC_CA209025	WESTERN EUROPE	62	M	WHITE	1046_Marios_PD1_Inhib2_HP-E9414567-7.raw
SA088948	CA209025-113-280	CA209025-113-280_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	39.261	Phase III_RCC_CA209025	WESTERN EUROPE	70	M	WHITE	0792_Marios_PD1_Inhib2_HP-E9717740-7.raw
SA088949	CA209025-113-570	CA209025-113-570_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	27.893	Phase III_RCC_CA209025	WESTERN EUROPE	67	F	WHITE	0197_Marios_PD1_Inhib2_HP-E9717742-7.raw
SA088950	CA209025-118-163	CA209025-118-163_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	41.232	Phase III_RCC_CA209025	WESTERN EUROPE	64	M	WHITE	0710_Marios_PD1_Inhib2_HP-E9314438-7.raw
SA088956	CA209025-12-131	CA209025-12-131_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	12.715	Phase III_RCC_CA209025	WESTERN EUROPE	54	M	WHITE	0543_Marios_PD1_Inhib2_HP-E9124672-7.raw
SA088929	CA209025-126-101	CA209025-126-101_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	4.534	Phase III_RCC_CA209025	WESTERN EUROPE	56	M	WHITE	0949_Marios_PD1_Inhib2_HP-E9123120-7.raw
SA088937	CA209025-135-694	CA209025-135-694_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	38.407	Phase III_RCC_CA209025	REST OF WORLD	59	M	WHITE	0198_Marios_PD1_Inhib2_HP-L1379647-7.raw
SA088958	CA209025-135-884	CA209025-135-884_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	26.809	Phase III_RCC_CA209025	REST OF WORLD	49	M	WHITE	0049_Marios_PD1_Inhib2_HP-L1366489-10.raw
SA088955	CA209025-138-814	CA209025-138-814_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	26.842	Phase III_RCC_CA209025	US/CANADA	71	M	WHITE	0247_Marios_PD1_Inhib2_HP-AF004066-9.raw
SA088954	CA209025-138-847	CA209025-138-847_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	25.134	Phase III_RCC_CA209025	US/CANADA	76	M	WHITE	0967_Marios_PD1_Inhib2_HP-AE726338-7.raw
SA088936	CA209025-143-115	CA209025-143-115_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	23.228	Phase III_RCC_CA209025	US/CANADA	45	M	WHITE	0458_Marios_PD1_Inhib2_HP-AD645853-7.raw
SA088951	CA209025-143-423	CA209025-143-423_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	24.181	Phase III_RCC_CA209025	US/CANADA	56	M	WHITE	0191_Marios_PD1_Inhib2_HP-AD645855-7.raw
SA088977	CA209025-143-794	CA209025-143-794_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	20.370	Phase III_RCC_CA209025	US/CANADA	85	M	WHITE	0112_Marios_PD1_Inhib2_HP-AE794343-7.raw
SA089012	CA209025-149-646	CA209025-149-646_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	0.296	Phase III_RCC_CA209025	REST OF WORLD	71	M	WHITE	0987_Marios_PD1_Inhib2_HP-EA039696-7.raw
SA089015	CA209025-151-351	CA209025-151-351_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	35.121	Phase III_RCC_CA209025	REST OF WORLD	62	F	WHITE	0304_Marios_PD1_Inhib2_HP-E9540922-7.raw
SA089013	CA209025-15-379	CA209025-15-379_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	21.750	Phase III_RCC_CA209025	US/CANADA	64	M	WHITE	0698_Marios_PD1_Inhib2_HP-AE091504-7.raw
SA089014	CA209025-155-266	CA209025-155-266_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	23.622	Phase III_RCC_CA209025	REST OF WORLD	65	M	OTHER	1202_Marios_PD1_Inhib2_HP-S3578238-7.raw
SA089009	CA209025-155-632	CA209025-155-632_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	15.606	Phase III_RCC_CA209025	REST OF WORLD	42	M	OTHER	0388_Marios_PD1_Inhib2_HP-S3578236-7.raw
SA089008	CA209025-156-136	CA209025-156-136_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	45.897	Phase III_RCC_CA209025	REST OF WORLD	62	M	OTHER	1029_Marios_PD1_Inhib2_HP-S3509147-7.raw
SA088927	CA209025-1-5	CA209025-1-5_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	16.460	Phase III_RCC_CA209025	US/CANADA	78	F	WHITE	0749_Marios_PD1_Inhib2_HP-AD176328-7.raw
SA088926	CA209025-1-604	CA209025-1-604_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	9.889	Phase III_RCC_CA209025	US/CANADA	58	M	WHITE	1024_Marios_PD1_Inhib2_HP-AE471829-6.raw
SA089004	CA209025-163-542	CA209025-163-542_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	21.815	Phase III_RCC_CA209025	REST OF WORLD	81	M	OTHER	0663_Marios_PD1_Inhib2_HP-S3675224-7.raw
SA088933	CA209025-1-682	CA209025-1-682_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	35.975	Phase III_RCC_CA209025	US/CANADA	60	F	WHITE	0742_Marios_PD1_Inhib2_HP-AE471831-6.raw
SA088930	CA209025-1-716	CA209025-1-716_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	44.583	Phase III_RCC_CA209025	US/CANADA	58	M	WHITE	1072_Marios_PD1_Inhib2_HP-AE663606-7.raw
SA089016	CA209025-17-213	CA209025-17-213_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	12.945	Phase III_RCC_CA209025	US/CANADA	70	M	WHITE	0903_Marios_PD1_Inhib2_HP-AD749689-8.raw
SA089019	CA209025-17-327	CA209025-17-327_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	30.324	Phase III_RCC_CA209025	US/CANADA	47	M	WHITE	0062_Marios_PD1_Inhib2_HP-AD749690-7.raw
SA089020	CA209025-175-252	CA209025-175-252_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	0.887	Phase III_RCC_CA209025	WESTERN EUROPE	74	M	WHITE	0856_Marios_PD1_Inhib2_HP-E9123327-7.raw
SA088999	CA209025-179-484	CA209025-179-484_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	9.396	Phase III_RCC_CA209025	WESTERN EUROPE	52	M	WHITE	1213_Marios_PD1_Inhib2_HP-E9758912-7.raw
SA088974	CA209025-180-936	CA209025-180-936_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	23.195	Phase III_RCC_CA209025	REST OF WORLD	53	M	WHITE	0373_Marios_PD1_Inhib2_HP-E9784759-7.raw
SA088973	CA209025-185-983	CA209025-185-983_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	20.008	Phase III_RCC_CA209025	US/CANADA	53	F	WHITE	1007_Marios_PD1_Inhib2_HP-AF016204-8.raw
SA088931	CA209025-1-920	CA209025-1-920_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	14.029	Phase III_RCC_CA209025	US/CANADA	61	M	WHITE	1162_Marios_PD1_Inhib2_HP-AE846130-7.raw
SA088943	CA209025-1-932	CA209025-1-932_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	2.136	Phase III_RCC_CA209025	US/CANADA	65	M	WHITE	0107_Marios_PD1_Inhib2_HP-AE846131-7.raw
SA088953	CA209025-1-997	CA209025-1-997_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	20.534	Phase III_RCC_CA209025	US/CANADA	64	M	WHITE	0801_Marios_PD1_Inhib2_HP-AF002673-9.raw
SA088971	CA209025-20-59	CA209025-20-59_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	12.747	Phase III_RCC_CA209025	US/CANADA	64	M	OTHER	0861_Marios_PD1_Inhib2_HP-AD452646-6.raw
SA088970	CA209025-20-914	CA209025-20-914_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	9.725	Phase III_RCC_CA209025	US/CANADA	54	M	WHITE	0509_Marios_PD1_Inhib2_HP-AE062796-7.raw
SA088962	CA209025-21-307	CA209025-21-307_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	3.318	Phase III_RCC_CA209025	US/CANADA	61	F	WHITE	0216_Marios_PD1_Inhib2_HP-AD601337-7.raw
SA088972	CA209025-2-134	CA209025-2-134_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	21.914	Phase III_RCC_CA209025	WESTERN EUROPE	31	M	OTHER	1109_Marios_PD1_Inhib2_HP-E9425297-7.raw
SA088975	CA209025-2-199	CA209025-2-199_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	10.448	Phase III_RCC_CA209025	WESTERN EUROPE	36	M	WHITE	0009_Marios_PD1_Inhib2_HP-E9425293-7.raw
SA088981	CA209025-23-922	CA209025-23-922_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	22.111	Phase III_RCC_CA209025	US/CANADA	58	M	WHITE	0183_Marios_PD1_Inhib2_HP-AE886505-6.raw
SA088994	CA209025-25-1042	CA209025-25-1042_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	9.429	Phase III_RCC_CA209025	US/CANADA	75	M	WHITE	1210_Marios_PD1_Inhib2_HP-AF185746-9.raw
SA089000	CA209025-2-57	CA209025-2-57_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	40.016	Phase III_RCC_CA209025	WESTERN EUROPE	38	M	WHITE	0145_Marios_PD1_Inhib2_HP-E9130933-7.raw
SA088992	CA209025-26-559	CA209025-26-559_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	10.645	Phase III_RCC_CA209025	US/CANADA	51	M	WHITE	0997_Marios_PD1_Inhib2_HP-AE488971-7.raw
SA088995	CA209025-26-965	CA209025-26-965_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	14.390	Phase III_RCC_CA209025	US/CANADA	50	M	WHITE	0939_Marios_PD1_Inhib2_HP-AE588066-7.raw
SA088996	CA209025-27-915	CA209025-27-915_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	8.706	Phase III_RCC_CA209025	US/CANADA	74	M	WHITE	0230_Marios_PD1_Inhib2_HP-AE302624-7.raw
SA088991	CA209025-29-938	CA209025-29-938_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	9.988	Phase III_RCC_CA209025	US/CANADA	63	M	WHITE	1004_Marios_PD1_Inhib2_HP-AF008966-9.raw
SA088982	CA209025-31-317	CA209025-31-317_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	10.711	Phase III_RCC_CA209025	US/CANADA	64	F	WHITE	0900_Marios_PD1_Inhib2_HP-AD452570-7.raw
SA088990	CA209025-3-253	CA209025-3-253_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	22.209	Phase III_RCC_CA209025	WESTERN EUROPE	63	F	WHITE	0730_Marios_PD1_Inhib2_HP-E9101839-7.raw
SA088985	CA209025-33-12	CA209025-33-12_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	24.608	Phase III_RCC_CA209025	WESTERN EUROPE	59	M	WHITE	0293_Marios_PD1_Inhib2_HP-E9101785-7.raw
SA088986	CA209025-33-257	CA209025-33-257_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	38.801	Phase III_RCC_CA209025	WESTERN EUROPE	80	M	WHITE	0931_Marios_PD1_Inhib2_HP-E9102116-7.raw
SA088984	CA209025-3-346	CA209025-3-346_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	14.423	Phase III_RCC_CA209025	WESTERN EUROPE	68	M	WHITE	0605_Marios_PD1_Inhib2_HP-E9101838-7.raw
SA088989	CA209025-34-291	CA209025-34-291_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	9.988	Phase III_RCC_CA209025	WESTERN EUROPE	66	M	WHITE	0602_Marios_PD1_Inhib2_HP-E9167415-7.raw
SA088988	CA209025-37-93	CA209025-37-93_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	36.403	Phase III_RCC_CA209025	WESTERN EUROPE	57	M	WHITE	0531_Marios_PD1_Inhib2_HP-E9103771-7.raw
SA088987	CA209025-38-800	CA209025-38-800_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	15.212	Phase III_RCC_CA209025	WESTERN EUROPE	42	M	WHITE	0775_Marios_PD1_Inhib2_HP-EA295651-7.raw
SA088997	CA209025-42-46	CA209025-42-46_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	13.109	Phase III_RCC_CA209025	US/CANADA	70	M	WHITE	1152_Marios_PD1_Inhib2_HP-AD452686-7.raw
SA088998	CA209025-42-919	CA209025-42-919_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	23.359	Phase III_RCC_CA209025	US/CANADA	59	M	WHITE	0245_Marios_PD1_Inhib2_HP-AF008952-9.raw
SA088983	CA209025-4-815	CA209025-4-815_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	18.497	Phase III_RCC_CA209025	WESTERN EUROPE	44	M	WHITE	0848_Marios_PD1_Inhib2_HP-EA532286-9.raw
SA088980	CA209025-48-501	CA209025-48-501_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	12.813	Phase III_RCC_CA209025	WESTERN EUROPE	66	M	WHITE	0966_Marios_PD1_Inhib2_HP-EA044581-7.raw
SA088967	CA209025-48-582	CA209025-48-582_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	3.548	Phase III_RCC_CA209025	WESTERN EUROPE	61	M	WHITE	1194_Marios_PD1_Inhib2_HP-E9782204-7.raw
SA088968	CA209025-48-736	CA209025-48-736_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	23.195	Phase III_RCC_CA209025	WESTERN EUROPE	54	F	WHITE	0276_Marios_PD1_Inhib2_HP-EA044583-7.raw
SA088969	CA209025-49-39	CA209025-49-39_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	10.481	Phase III_RCC_CA209025	US/CANADA	64	M	WHITE	1047_Marios_PD1_Inhib2_HP-AD193615-7.raw
SA088966	CA209025-49-664	CA209025-49-664_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	41.528	Phase III_RCC_CA209025	US/CANADA	75	M	WHITE	0898_Marios_PD1_Inhib2_HP-AD577641-7.raw
SA088964	CA209025-49-79	CA209025-49-79_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	13.339	Phase III_RCC_CA209025	US/CANADA	39	F	WHITE	0143_Marios_PD1_Inhib2_HP-AD577640-7.raw
SA088978	CA209025-58-462	CA209025-58-462_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	4.205	Phase III_RCC_CA209025	WESTERN EUROPE	47	M	OTHER	0537_Marios_PD1_Inhib2_HP-E9097312-7.raw
SA088979	CA209025-58-739	CA209025-58-739_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	16.953	Phase III_RCC_CA209025	WESTERN EUROPE	65	F	OTHER	0021_Marios_PD1_Inhib2_HP-E9630285-7.raw
SA088976	CA209025-58-74	CA209025-58-74_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	15.376	Phase III_RCC_CA209025	WESTERN EUROPE	85	M	OTHER	0653_Marios_PD1_Inhib2_HP-E9097314-7.raw
SA089018	CA209025-62-523	CA209025-62-523_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	6.374	Phase III_RCC_CA209025	WESTERN EUROPE	64	M	WHITE	0652_Marios_PD1_Inhib2_HP-EA015429-8.raw
SA089006	CA209025-65-306	CA209025-65-306_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	20.797	Phase III_RCC_CA209025	WESTERN EUROPE	71	M	WHITE	0952_Marios_PD1_Inhib2_HP-EA002606-7.raw
SA089007	CA209025-65-553	CA209025-65-553_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	12.123	Phase III_RCC_CA209025	WESTERN EUROPE	66	M	WHITE	0407_Marios_PD1_Inhib2_HP-E9778360-7.raw
SA089017	CA209025-69-810	CA209025-69-810_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	17.084	Phase III_RCC_CA209025	REST OF WORLD	74	F	WHITE	0885_Marios_PD1_Inhib2_HP-EA350191-7.raw
SA089001	CA209025-70-617	CA209025-70-617_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	3.943	Phase III_RCC_CA209025	REST OF WORLD	78	F	WHITE	0476_Marios_PD1_Inhib2_HP-EA088439-7.raw
SA089002	CA209025-70-678	CA209025-70-678_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	19.647	Phase III_RCC_CA209025	REST OF WORLD	59	M	WHITE	0979_Marios_PD1_Inhib2_HP-E9784263-7.raw
SA089003	CA209025-70-845	CA209025-70-845_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	11.236	Phase III_RCC_CA209025	REST OF WORLD	60	M	WHITE	0872_Marios_PD1_Inhib2_HP-E9784261-7.raw
SA088961	CA209025-70-883	CA209025-70-883_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	25.528	Phase III_RCC_CA209025	REST OF WORLD	77	M	WHITE	0700_Marios_PD1_Inhib2_HP-EA088435-7.raw
SA089010	CA209025-72-211	CA209025-72-211_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	4.895	Phase III_RCC_CA209025	WESTERN EUROPE	84	M	WHITE	0672_Marios_PD1_Inhib2_HP-E9145478-7.raw
SA088941	CA209025-73-512	CA209025-73-512_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	11.565	Phase III_RCC_CA209025	WESTERN EUROPE	69	M	WHITE	0914_Marios_PD1_Inhib2_HP-E9717899-7.raw
SA088934	CA209025-73-645	CA209025-73-645_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	9.166	Phase III_RCC_CA209025	WESTERN EUROPE	67	M	WHITE	0656_Marios_PD1_Inhib2_HP-E9073424-7.raw
SA088942	CA209025-73-789	CA209025-73-789_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	3.943	Phase III_RCC_CA209025	WESTERN EUROPE	69	M	WHITE	0942_Marios_PD1_Inhib2_HP-E9717902-7.raw
SA088945	CA209025-75-321	CA209025-75-321_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	15.113	Phase III_RCC_CA209025	WESTERN EUROPE	36	M	WHITE	1160_Marios_PD1_Inhib2_HP-E9479160-7.raw
SA088935	CA209025-77-493	CA209025-77-493_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	3.680	Phase III_RCC_CA209025	REST OF WORLD	65	M	WHITE	0650_Marios_PD1_Inhib2_HP-L1384333-7.raw
SA088960	CA209025-80-184	CA209025-80-184_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	19.581	Phase III_RCC_CA209025	WESTERN EUROPE	63	M	WHITE	0648_Marios_PD1_Inhib2_HP-E9433488-6.raw
SA088944	CA209025-80-265	CA209025-80-265_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	16.920	Phase III_RCC_CA209025	WESTERN EUROPE	58	M	WHITE	0578_Marios_PD1_Inhib2_HP-E9097390-7.raw
SA088946	CA209025-80-656	CA209025-80-656_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	8.279	Phase III_RCC_CA209025	WESTERN EUROPE	66	M	WHITE	0808_Marios_PD1_Inhib2_HP-E9134600-7.raw
SA088952	CA209025-80-824	CA209025-80-824_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	14.982	Phase III_RCC_CA209025	WESTERN EUROPE	69	M	WHITE	1000_Marios_PD1_Inhib2_HP-EA083036-7.raw
SA088928	CA209025-82-506	CA209025-82-506_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	20.205	Phase III_RCC_CA209025	WESTERN EUROPE	64	M	WHITE	0675_Marios_PD1_Inhib2_HP-EA305475-6.raw
SA088938	CA209025-84-894	CA209025-84-894_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	5.651	Phase III_RCC_CA209025	REST OF WORLD	49	M	WHITE	0819_Marios_PD1_Inhib2_HP-L1381808-7.raw
SA088940	CA209025-90-247	CA209025-90-247_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	8.871	Phase III_RCC_CA209025	WESTERN EUROPE	60	F	WHITE	0103_Marios_PD1_Inhib2_HP-E9665084-7.raw
SA089011	CA209025-93-460	CA209025-93-460_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	13.865	Phase III_RCC_CA209025	WESTERN EUROPE	66	F	WHITE	0689_Marios_PD1_Inhib2_HP-E9791866-7.raw
SA089005	CA209025-95-318	CA209025-95-318_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	20.764	Phase III_RCC_CA209025	REST OF WORLD	70	M	WHITE	0763_Marios_PD1_Inhib2_HP-S3713044-7.raw
SA088963	CA209025-95-706	CA209025-95-706_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	2.004	Phase III_RCC_CA209025	REST OF WORLD	63	M	OTHER	1142_Marios_PD1_Inhib2_HP-S3792614-7.raw
SA088965	CA209025-95-721	CA209025-95-721_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	5.684	Phase III_RCC_CA209025	REST OF WORLD	49	M	WHITE	0572_Marios_PD1_Inhib2_HP-S3792616-7.raw
SA088993	CA209025-95-834	CA209025-95-834_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	FALSE	0.723	Phase III_RCC_CA209025	REST OF WORLD	56	F	WHITE	0229_Marios_PD1_Inhib2_HP-S4025566-7.raw
SA089021	CA209025-114-597	CA209025-114-597_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	43.105	Phase III_RCC_CA209025	WESTERN EUROPE	63	M	WHITE	0561_Marios_PD1_Inhib2_HP-EA341119-7.raw
SA089028	CA209025-126-149	CA209025-126-149_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	21.388	Phase III_RCC_CA209025	WESTERN EUROPE	59	M	WHITE	0310_Marios_PD1_Inhib2_HP-E9474280-7.raw
SA089023	CA209025-135-795	CA209025-135-795_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	17.314	Phase III_RCC_CA209025	REST OF WORLD	77	F	OTHER	1172_Marios_PD1_Inhib2_HP-L1379646-7.raw
SA089040	CA209025-138-480	CA209025-138-480_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	28.255	Phase III_RCC_CA209025	US/CANADA	60	M	WHITE	0611_Marios_PD1_Inhib2_HP-AE133960-7.raw
SA089041	CA209025-138-619	CA209025-138-619_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	16.723	Phase III_RCC_CA209025	US/CANADA	73	M	WHITE	0857_Marios_PD1_Inhib2_HP-AE428475-7.raw
SA089049	CA209025-139-864	CA209025-139-864_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	16.624	Phase III_RCC_CA209025	US/CANADA	68	M	WHITE	0936_Marios_PD1_Inhib2_HP-AF003920-9.raw
SA089034	CA209025-139-989	CA209025-139-989_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	26.086	Phase III_RCC_CA209025	US/CANADA	65	M	WHITE	0120_Marios_PD1_Inhib2_HP-AF003921-9.raw
SA089030	CA209025-158-183	CA209025-158-183_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	19.023	Phase III_RCC_CA209025	REST OF WORLD	51	F	OTHER	0945_Marios_PD1_Inhib2_HP-S3653084-7.raw
SA089048	CA209025-160-786	CA209025-160-786_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	8.904	Phase III_RCC_CA209025	REST OF WORLD	74	F	OTHER	0853_Marios_PD1_Inhib2_HP-S3717397-6.raw
SA089037	CA209025-164-901	CA209025-164-901_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	25.823	Phase III_RCC_CA209025	REST OF WORLD	65	F	OTHER	0354_Marios_PD1_Inhib2_HP-S4093204-9.raw
SA089038	CA209025-166-957	CA209025-166-957_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	13.963	Phase III_RCC_CA209025	REST OF WORLD	68	M	OTHER	1031_Marios_PD1_Inhib2_HP-S4152606-9.raw
SA089031	CA209025-173-377	CA209025-173-377_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	15.310	Phase III_RCC_CA209025	REST OF WORLD	64	M	OTHER	0419_Marios_PD1_Inhib2_HP-S3575911-7.raw
SA089043	CA209025-23-20	CA209025-23-20_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	43.335	Phase III_RCC_CA209025	US/CANADA	66	F	WHITE	0815_Marios_PD1_Inhib2_HP-AD195647-7.raw
SA089046	CA209025-23-72	CA209025-23-72_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	13.175	Phase III_RCC_CA209025	US/CANADA	77	M	WHITE	0516_Marios_PD1_Inhib2_HP-AD490505-6.raw
SA089025	CA209025-25-166	CA209025-25-166_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	12.090	Phase III_RCC_CA209025	US/CANADA	56	M	WHITE	0495_Marios_PD1_Inhib2_HP-AD775401-7.raw
SA089032	CA209025-27-906	CA209025-27-906_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	17.150	Phase III_RCC_CA209025	US/CANADA	66	M	WHITE	1185_Marios_PD1_Inhib2_HP-AE302623-7.raw
SA089036	CA209025-39-150	CA209025-39-150_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	14.324	Phase III_RCC_CA209025	WESTERN EUROPE	53	M	OTHER	1134_Marios_PD1_Inhib2_HP-E9432887-7.raw
SA089024	CA209025-44-785	CA209025-44-785_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	26.316	Phase III_RCC_CA209025	US/CANADA	70	M	WHITE	0096_Marios_PD1_Inhib2_HP-AE837371-7.raw
SA089045	CA209025-48-284	CA209025-48-284_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	15.836	Phase III_RCC_CA209025	WESTERN EUROPE	74	M	WHITE	0157_Marios_PD1_Inhib2_HP-E9674323-7.raw
SA089044	CA209025-48-500	CA209025-48-500_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	5.552	Phase III_RCC_CA209025	WESTERN EUROPE	69	M	WHITE	0027_Marios_PD1_Inhib2_HP-E9674321-7.raw
SA089042	CA209025-63-790	CA209025-63-790_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	8.706	Phase III_RCC_CA209025	WESTERN EUROPE	64	F	WHITE	0266_Marios_PD1_Inhib2_HP-E9528382-8.raw
SA089029	CA209025-79-73	CA209025-79-73_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	45.175	Phase III_RCC_CA209025	REST OF WORLD	48	F	WHITE	0988_Marios_PD1_Inhib2_HP-L1293268-6.raw
SA089047	CA209025-82-139	CA209025-82-139_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	4.370	Phase III_RCC_CA209025	WESTERN EUROPE	56	F	WHITE	0371_Marios_PD1_Inhib2_HP-E9172456-7.raw
SA089033	CA209025-82-355	CA209025-82-355_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	4.205	Phase III_RCC_CA209025	WESTERN EUROPE	62	M	WHITE	0100_Marios_PD1_Inhib2_HP-E9703900-6.raw
SA089039	CA209025-89-129	CA209025-89-129_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	4.304	Phase III_RCC_CA209025	WESTERN EUROPE	52	F	WHITE	0865_Marios_PD1_Inhib2_HP-E9526839-7.raw
SA089035	CA209025-90-30	CA209025-90-30_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	9.593	Phase III_RCC_CA209025	WESTERN EUROPE	74	F	WHITE	0383_Marios_PD1_Inhib2_HP-E9103087-7.raw
SA089026	CA209025-9-754	CA209025-9-754_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	34.037	Phase III_RCC_CA209025	US/CANADA	71	M	WHITE	1099_Marios_PD1_Inhib2_HP-AE556392-7.raw
SA089022	CA209025-97-569	CA209025-97-569_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	29.766	Phase III_RCC_CA209025	REST OF WORLD	65	M	OTHER	0499_Marios_PD1_Inhib2_HP-S3722553-7.raw
SA089027	CA209025-98-673	CA209025-98-673_baseline	baseline	-	INTERMEDIATE	NIVOLUMAB	TRUE	11.499	Phase III_RCC_CA209025	REST OF WORLD	76	F	WHITE	0882_Marios_PD1_Inhib2_HP-S3862083-7.raw
SA089078	CA209025-116-530	CA209025-116-530_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	15.639	Phase III_RCC_CA209025	REST OF WORLD	57	M	WHITE	0473_Marios_PD1_Inhib2_HP-E9567515-9.raw
SA089069	CA209025-118-160	CA209025-118-160_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	0.789	Phase III_RCC_CA209025	WESTERN EUROPE	64	M	WHITE	1067_Marios_PD1_Inhib2_HP-E9314436-7.raw
SA089086	CA209025-121-214	CA209025-121-214_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	11.499	Phase III_RCC_CA209025	REST OF WORLD	74	M	WHITE	1089_Marios_PD1_Inhib2_HP-L1305559-7.raw
SA089074	CA209025-125-525	CA209025-125-525_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	3.614	Phase III_RCC_CA209025	REST OF WORLD	64	F	WHITE	0092_Marios_PD1_Inhib2_HP-L1366505-7.raw
SA089067	CA209025-137-127	CA209025-137-127_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	7.852	Phase III_RCC_CA209025	WESTERN EUROPE	59	M	WHITE	0594_Marios_PD1_Inhib2_HP-E9073335-7.raw
SA089075	CA209025-139-1033	CA209025-139-1033_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	16.230	Phase III_RCC_CA209025	US/CANADA	49	M	WHITE	0174_Marios_PD1_Inhib2_HP-AF337221-9.raw
SA089077	CA209025-144-435	CA209025-144-435_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	14.522	Phase III_RCC_CA209025	US/CANADA	61	F	WHITE	0562_Marios_PD1_Inhib2_HP-AD829004-7.raw
SA089088	CA209025-149-251	CA209025-149-251_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	15.737	Phase III_RCC_CA209025	REST OF WORLD	73	M	WHITE	0282_Marios_PD1_Inhib2_HP-E9540033-7.raw
SA089051	CA209025-149-783	CA209025-149-783_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	2.661	Phase III_RCC_CA209025	REST OF WORLD	74	F	WHITE	0478_Marios_PD1_Inhib2_HP-E9540032-7.raw
SA089056	CA209025-151-490	CA209025-151-490_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	9.495	Phase III_RCC_CA209025	REST OF WORLD	67	F	WHITE	1036_Marios_PD1_Inhib2_HP-EA251051-7.raw
SA089061	CA209025-153-406	CA209025-153-406_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	5.092	Phase III_RCC_CA209025	US/CANADA	64	M	WHITE	0445_Marios_PD1_Inhib2_HP-AD780266-7.raw
SA089054	CA209025-15-555	CA209025-15-555_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	7.162	Phase III_RCC_CA209025	US/CANADA	41	F	WHITE	0444_Marios_PD1_Inhib2_HP-AE383168-7.raw
SA089064	CA209025-15-774	CA209025-15-774_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	6.407	Phase III_RCC_CA209025	US/CANADA	58	M	WHITE	0320_Marios_PD1_Inhib2_HP-AE383169-7.raw
SA089068	CA209025-172-354	CA209025-172-354_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	5.060	Phase III_RCC_CA209025	REST OF WORLD	81	F	OTHER	0366_Marios_PD1_Inhib2_HP-S3670415-7.raw
SA089087	CA209025-17-397	CA209025-17-397_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	18.793	Phase III_RCC_CA209025	US/CANADA	66	F	WHITE	0643_Marios_PD1_Inhib2_HP-AE104721-7.raw
SA089072	CA209025-22-1022	CA209025-22-1022_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	7.918	Phase III_RCC_CA209025	US/CANADA	36	M	WHITE	0023_Marios_PD1_Inhib2_HP-AF009294-9.raw
SA089084	CA209025-2-23	CA209025-2-23_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	13.799	Phase III_RCC_CA209025	WESTERN EUROPE	70	M	OTHER	1173_Marios_PD1_Inhib2_HP-E9101709-7.raw
SA089081	CA209025-2-746	CA209025-2-746_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	16.624	Phase III_RCC_CA209025	WESTERN EUROPE	62	F	WHITE	0462_Marios_PD1_Inhib2_HP-E9618952-7.raw
SA089070	CA209025-29-68	CA209025-29-68_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	3.811	Phase III_RCC_CA209025	US/CANADA	52	M	WHITE	0661_Marios_PD1_Inhib2_HP-AD176341-6.raw
SA089083	CA209025-36-310	CA209025-36-310_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	11.203	Phase III_RCC_CA209025	WESTERN EUROPE	66	M	WHITE	0916_Marios_PD1_Inhib2_HP-E9103752-7.raw
SA089085	CA209025-39-220	CA209025-39-220_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	12.090	Phase III_RCC_CA209025	WESTERN EUROPE	54	M	WHITE	1022_Marios_PD1_Inhib2_HP-E9432884-7.raw
SA089071	CA209025-42-1058	CA209025-42-1058_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	2.990	Phase III_RCC_CA209025	US/CANADA	61	M	WHITE	0186_Marios_PD1_Inhib2_HP-AF439245-9.raw
SA089079	CA209025-4-313	CA209025-4-313_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	22.768	Phase III_RCC_CA209025	WESTERN EUROPE	55	M	WHITE	0973_Marios_PD1_Inhib2_HP-E9099273-7.raw
SA089062	CA209025-43-917	CA209025-43-917_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	2.727	Phase III_RCC_CA209025	US/CANADA	55	M	WHITE	0754_Marios_PD1_Inhib2_HP-AF003941-9.raw
SA089073	CA209025-4-43	CA209025-4-43_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	8.476	Phase III_RCC_CA209025	WESTERN EUROPE	75	M	WHITE	1061_Marios_PD1_Inhib2_HP-E9108955-7.raw
SA089076	CA209025-4-731	CA209025-4-731_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	1.019	Phase III_RCC_CA209025	WESTERN EUROPE	52	M	WHITE	0079_Marios_PD1_Inhib2_HP-E9099271-7.raw
SA089063	CA209025-47-860	CA209025-47-860_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	2.826	Phase III_RCC_CA209025	US/CANADA	61	M	WHITE	1217_Marios_PD1_Inhib2_HP-AE679098-7.raw
SA089058	CA209025-5-35	CA209025-5-35_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	5.848	Phase III_RCC_CA209025	WESTERN EUROPE	65	F	WHITE	0688_Marios_PD1_Inhib2_HP-E9108657-7.raw
SA089053	CA209025-5-538	CA209025-5-538_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	5.191	Phase III_RCC_CA209025	WESTERN EUROPE	74	M	WHITE	0905_Marios_PD1_Inhib2_HP-E9125254-7.raw
SA089052	CA209025-58-457	CA209025-58-457_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	18.497	Phase III_RCC_CA209025	WESTERN EUROPE	65	M	OTHER	0349_Marios_PD1_Inhib2_HP-E9630287-7.raw
SA089060	CA209025-74-52	CA209025-74-52_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	9.692	Phase III_RCC_CA209025	WESTERN EUROPE	61	M	WHITE	0213_Marios_PD1_Inhib2_HP-E9103992-7.raw
SA089059	CA209025-75-520	CA209025-75-520_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	13.339	Phase III_RCC_CA209025	WESTERN EUROPE	66	F	WHITE	1034_Marios_PD1_Inhib2_HP-E9479162-7.raw
SA089065	CA209025-75-529	CA209025-75-529_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	5.027	Phase III_RCC_CA209025	WESTERN EUROPE	76	M	WHITE	0719_Marios_PD1_Inhib2_HP-E9479163-7.raw
SA089066	CA209025-78-726	CA209025-78-726_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	0.690	Phase III_RCC_CA209025	REST OF WORLD	56	M	WHITE	1042_Marios_PD1_Inhib2_HP-L1376088-6.raw
SA089055	CA209025-82-217	CA209025-82-217_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	4.403	Phase III_RCC_CA209025	WESTERN EUROPE	31	M	WHITE	0557_Marios_PD1_Inhib2_HP-E9703899-8.raw
SA089050	CA209025-93-187	CA209025-93-187_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	42.941	Phase III_RCC_CA209025	WESTERN EUROPE	76	M	WHITE	0071_Marios_PD1_Inhib2_HP-E9123036-7.raw
SA089057	CA209025-9-531	CA209025-9-531_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	9.002	Phase III_RCC_CA209025	US/CANADA	60	F	WHITE	0468_Marios_PD1_Inhib2_HP-AD611932-7.raw
SA089082	CA209025-95-613	CA209025-95-613_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	1.117	Phase III_RCC_CA209025	REST OF WORLD	58	M	WHITE	0676_Marios_PD1_Inhib2_HP-S3713042-7.raw
SA089080	CA209025-97-788	CA209025-97-788_baseline	baseline	-	POOR	EVEROLIMUS	FALSE	1.380	Phase III_RCC_CA209025	REST OF WORLD	64	M	WHITE	0207_Marios_PD1_Inhib2_HP-S4038602-7.raw
SA089091	CA209025-113-75	CA209025-113-75_baseline	baseline	-	POOR	EVEROLIMUS	TRUE	7.129	Phase III_RCC_CA209025	WESTERN EUROPE	74	M	WHITE	0314_Marios_PD1_Inhib2_HP-E9123068-7.raw
SA089104	CA209025-139-576	CA209025-139-576_baseline	baseline	-	POOR	EVEROLIMUS	TRUE	3.745	Phase III_RCC_CA209025	US/CANADA	66	M	WHITE	1104_Marios_PD1_Inhib2_HP-AD783001-7.raw
SA089095	CA209025-145-278	CA209025-145-278_baseline	baseline	-	POOR	EVEROLIMUS	TRUE	4.698	Phase III_RCC_CA209025	US/CANADA	62	M	WHITE	0361_Marios_PD1_Inhib2_HP-AD780352-7.raw
SA089101	CA209025-1-478	CA209025-1-478_baseline	baseline	-	POOR	EVEROLIMUS	TRUE	20.665	Phase III_RCC_CA209025	US/CANADA	52	M	WHITE	1180_Marios_PD1_Inhib2_HP-AD709259-7.raw
SA089105	CA209025-17-343	CA209025-17-343_baseline	baseline	-	POOR	EVEROLIMUS	TRUE	5.421	Phase III_RCC_CA209025	US/CANADA	61	M	OTHER	0414_Marios_PD1_Inhib2_HP-AE104720-7.raw
SA089103	CA209025-17-964	CA209025-17-964_baseline	baseline	-	POOR	EVEROLIMUS	TRUE	35.351	Phase III_RCC_CA209025	US/CANADA	70	M	WHITE	0727_Marios_PD1_Inhib2_HP-AF015797-9.raw
SA089096	CA209025-180-1001	CA209025-180-1001_baseline	baseline	-	POOR	EVEROLIMUS	TRUE	24.246	Phase III_RCC_CA209025	REST OF WORLD	80	F	WHITE	0962_Marios_PD1_Inhib2_HP-E9784758-7.raw
SA089092	CA209025-20-1031	CA209025-20-1031_baseline	baseline	-	POOR	EVEROLIMUS	TRUE	2.201	Phase III_RCC_CA209025	US/CANADA	73	F	WHITE	0714_Marios_PD1_Inhib2_HP-AF002812-9.raw
SA089094	CA209025-20-715	CA209025-20-715_baseline	baseline	-	POOR	EVEROLIMUS	TRUE	4.731	Phase III_RCC_CA209025	US/CANADA	73	M	WHITE	1055_Marios_PD1_Inhib2_HP-AE331982-7.raw
SA089090	CA209025-21-509	CA209025-21-509_baseline	baseline	-	POOR	EVEROLIMUS	TRUE	6.538	Phase III_RCC_CA209025	US/CANADA	60	M	WHITE	0793_Marios_PD1_Inhib2_HP-AE206901-7.raw
SA089093	CA209025-2-32	CA209025-2-32_baseline	baseline	-	POOR	EVEROLIMUS	TRUE	7.195	Phase III_RCC_CA209025	WESTERN EUROPE	65	M	WHITE	1028_Marios_PD1_Inhib2_HP-E9130937-7.raw
SA089098	CA209025-29-312	CA209025-29-312_baseline	baseline	-	POOR	EVEROLIMUS	TRUE	1.938	Phase III_RCC_CA209025	US/CANADA	60	F	WHITE	0401_Marios_PD1_Inhib2_HP-AD657189-7.raw
SA089106	CA209025-41-456	CA209025-41-456_baseline	baseline	-	POOR	EVEROLIMUS	TRUE	16.493	Phase III_RCC_CA209025	US/CANADA	75	F	WHITE	0237_Marios_PD1_Inhib2_HP-AF008940-18.raw
SA089100	CA209025-41-924	CA209025-41-924_baseline	baseline	-	POOR	EVEROLIMUS	TRUE	3.581	Phase III_RCC_CA209025	US/CANADA	63	M	WHITE	1198_Marios_PD1_Inhib2_HP-AE525981-7.raw
SA089097	CA209025-78-53	CA209025-78-53_baseline	baseline	-	POOR	EVEROLIMUS	TRUE	12.550	Phase III_RCC_CA209025	REST OF WORLD	59	M	WHITE	0555_Marios_PD1_Inhib2_HP-L1293251-7.raw
SA089089	CA209025-82-369	CA209025-82-369_baseline	baseline	-	POOR	EVEROLIMUS	TRUE	7.918	Phase III_RCC_CA209025	WESTERN EUROPE	65	M	WHITE	0469_Marios_PD1_Inhib2_HP-EA305474-7.raw
SA089099	CA209025-8-524	CA209025-8-524_baseline	baseline	-	POOR	EVEROLIMUS	TRUE	15.212	Phase III_RCC_CA209025	WESTERN EUROPE	48	M	WHITE	0341_Marios_PD1_Inhib2_HP-E9108731-7.raw
SA089102	CA209025-97-286	CA209025-97-286_baseline	baseline	-	POOR	EVEROLIMUS	TRUE	0.789	Phase III_RCC_CA209025	REST OF WORLD	62	F	WHITE	0956_Marios_PD1_Inhib2_HP-S3708671-7.raw
SA089113	CA209025-102-86	CA209025-102-86_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	11.729	Phase III_RCC_CA209025	WESTERN EUROPE	56	M	WHITE	0493_Marios_PD1_Inhib2_HP-E9172288-6.raw
SA089144	CA209025-113-50	CA209025-113-50_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	3.614	Phase III_RCC_CA209025	WESTERN EUROPE	60	M	WHITE	0218_Marios_PD1_Inhib2_HP-E9123067-7.raw
SA089129	CA209025-11-482	CA209025-11-482_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	4.501	Phase III_RCC_CA209025	US/CANADA	66	F	OTHER	0460_Marios_PD1_Inhib2_HP-AE330679-6.raw
SA089149	CA209025-119-192	CA209025-119-192_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	34.333	Phase III_RCC_CA209025	WESTERN EUROPE	66	F	WHITE	0685_Marios_PD1_Inhib2_HP-E9123042-7.raw
SA089131	CA209025-125-647	CA209025-125-647_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	35.253	Phase III_RCC_CA209025	REST OF WORLD	54	M	WHITE	0812_Marios_PD1_Inhib2_HP-L1392381-7.raw
SA089141	CA209025-12-65	CA209025-12-65_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	28.058	Phase III_RCC_CA209025	WESTERN EUROPE	60	M	WHITE	0704_Marios_PD1_Inhib2_HP-E9124674-7.raw
SA089133	CA209025-12-723	CA209025-12-723_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	18.234	Phase III_RCC_CA209025	WESTERN EUROPE	62	M	WHITE	0957_Marios_PD1_Inhib2_HP-E9108719-7.raw
SA089135	CA209025-13-111	CA209025-13-111_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	25.002	Phase III_RCC_CA209025	US/CANADA	60	M	WHITE	0570_Marios_PD1_Inhib2_HP-AD452590-7.raw
SA089145	CA209025-143-515	CA209025-143-515_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	9.068	Phase III_RCC_CA209025	US/CANADA	60	M	WHITE	0615_Marios_PD1_Inhib2_HP-AE459919-6.raw
SA089138	CA209025-144-451	CA209025-144-451_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	22.439	Phase III_RCC_CA209025	US/CANADA	57	M	WHITE	0251_Marios_PD1_Inhib2_HP-AD829003-7.raw
SA089139	CA209025-144-596	CA209025-144-596_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	22.867	Phase III_RCC_CA209025	US/CANADA	53	M	WHITE	0639_Marios_PD1_Inhib2_HP-AE506716-7.raw
SA089136	CA209025-153-416	CA209025-153-416_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	5.092	Phase III_RCC_CA209025	US/CANADA	66	M	WHITE	0963_Marios_PD1_Inhib2_HP-AD780265-7.raw
SA089134	CA209025-165-83	CA209025-165-83_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	27.368	Phase III_RCC_CA209025	REST OF WORLD	72	M	OTHER	0034_Marios_PD1_Inhib2_HP-S3475410-7.raw
SA089142	CA209025-17-541	CA209025-17-541_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	0.821	Phase III_RCC_CA209025	US/CANADA	79	M	WHITE	0790_Marios_PD1_Inhib2_HP-AG020731-2.raw
SA089152	CA209025-179-521	CA209025-179-521_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	6.439	Phase III_RCC_CA209025	WESTERN EUROPE	49	M	WHITE	1135_Marios_PD1_Inhib2_HP-E9758913-7.raw
SA089150	CA209025-17-981	CA209025-17-981_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	27.926	Phase III_RCC_CA209025	US/CANADA	57	M	WHITE	0628_Marios_PD1_Inhib2_HP-AF015798-9.raw
SA089146	CA209025-20-781	CA209025-20-781_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	36.961	Phase III_RCC_CA209025	US/CANADA	48	M	WHITE	0285_Marios_PD1_Inhib2_HP-AE710608-7.raw
SA089153	CA209025-21-1050	CA209025-21-1050_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	25.988	Phase III_RCC_CA209025	US/CANADA	65	M	WHITE	0450_Marios_PD1_Inhib2_HP-AF002693-9.raw
SA089114	CA209025-21-308	CA209025-21-308_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	18.300	Phase III_RCC_CA209025	US/CANADA	55	M	WHITE	0133_Marios_PD1_Inhib2_HP-AE206903-7.raw
SA089115	CA209025-21-311	CA209025-21-311_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	9.232	Phase III_RCC_CA209025	US/CANADA	68	M	WHITE	0425_Marios_PD1_Inhib2_HP-AE206905-7.raw
SA089111	CA209025-23-671	CA209025-23-671_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	1.774	Phase III_RCC_CA209025	US/CANADA	82	M	WHITE	0041_Marios_PD1_Inhib2_HP-AE600728-7.raw
SA089109	CA209025-23-9	CA209025-23-9_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	12.255	Phase III_RCC_CA209025	US/CANADA	69	M	WHITE	0448_Marios_PD1_Inhib2_HP-AD195646-7.raw
SA089110	CA209025-25-130	CA209025-25-130_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	13.602	Phase III_RCC_CA209025	US/CANADA	63	M	WHITE	0316_Marios_PD1_Inhib2_HP-AD610057-7.raw
SA089108	CA209025-25-987	CA209025-25-987_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	10.218	Phase III_RCC_CA209025	US/CANADA	85	M	WHITE	0193_Marios_PD1_Inhib2_HP-AF009253-9.raw
SA089117	CA209025-27-566	CA209025-27-566_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	9.593	Phase III_RCC_CA209025	US/CANADA	58	M	WHITE	0456_Marios_PD1_Inhib2_HP-AD451701-6.raw
SA089147	CA209025-2-76	CA209025-2-76_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	20.403	Phase III_RCC_CA209025	WESTERN EUROPE	48	F	WHITE	0135_Marios_PD1_Inhib2_HP-E9425295-7.raw
SA089127	CA209025-30-695	CA209025-30-695_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	9.528	Phase III_RCC_CA209025	US/CANADA	62	F	WHITE	0233_Marios_PD1_Inhib2_HP-AE355053-6.raw
SA089118	CA209025-33-7	CA209025-33-7_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	20.698	Phase III_RCC_CA209025	WESTERN EUROPE	30	F	WHITE	0541_Marios_PD1_Inhib2_HP-E9070705-7.raw
SA089119	CA209025-37-711	CA209025-37-711_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	1.741	Phase III_RCC_CA209025	WESTERN EUROPE	54	M	WHITE	1048_Marios_PD1_Inhib2_HP-E9774680-7.raw
SA089120	CA209025-39-102	CA209025-39-102_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	11.663	Phase III_RCC_CA209025	WESTERN EUROPE	68	M	WHITE	1010_Marios_PD1_Inhib2_HP-E9204600-7.raw
SA089126	CA209025-42-316	CA209025-42-316_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	6.538	Phase III_RCC_CA209025	US/CANADA	52	M	WHITE	0209_Marios_PD1_Inhib2_HP-AE155084-7.raw
SA089124	CA209025-42-622	CA209025-42-622_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	2.661	Phase III_RCC_CA209025	US/CANADA	59	M	WHITE	1209_Marios_PD1_Inhib2_HP-AE601506-7.raw
SA089122	CA209025-4-732	CA209025-4-732_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	1.577	Phase III_RCC_CA209025	WESTERN EUROPE	49	M	WHITE	0427_Marios_PD1_Inhib2_HP-E9099303-2.raw
SA089148	CA209025-62-225	CA209025-62-225_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	8.312	Phase III_RCC_CA209025	WESTERN EUROPE	42	M	WHITE	0395_Marios_PD1_Inhib2_HP-E9589114-7.raw
SA089132	CA209025-70-347	CA209025-70-347_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	42.382	Phase III_RCC_CA209025	REST OF WORLD	71	M	WHITE	0296_Marios_PD1_Inhib2_HP-EA088436-7.raw
SA089140	CA209025-71-709	CA209025-71-709_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	17.051	Phase III_RCC_CA209025	REST OF WORLD	68	M	WHITE	1183_Marios_PD1_Inhib2_HP-E9337920-7.raw
SA089137	CA209025-73-178	CA209025-73-178_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	15.343	Phase III_RCC_CA209025	WESTERN EUROPE	51	M	WHITE	0918_Marios_PD1_Inhib2_HP-E9106365-8.raw
SA089116	CA209025-82-200	CA209025-82-200_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	2.398	Phase III_RCC_CA209025	WESTERN EUROPE	61	F	WHITE	1216_Marios_PD1_Inhib2_HP-E9703902-7.raw
SA089107	CA209025-82-302	CA209025-82-302_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	5.027	Phase III_RCC_CA209025	WESTERN EUROPE	63	M	WHITE	0786_Marios_PD1_Inhib2_HP-E9703901-7.raw
SA089121	CA209025-85-940	CA209025-85-940_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	9.331	Phase III_RCC_CA209025	REST OF WORLD	76	M	WHITE	1103_Marios_PD1_Inhib2_HP-L1497969-9.raw
SA089130	CA209025-85-992	CA209025-85-992_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	13.339	Phase III_RCC_CA209025	REST OF WORLD	58	M	WHITE	1014_Marios_PD1_Inhib2_HP-L1497968-10.raw
SA089151	CA209025-8-628	CA209025-8-628_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	44.386	Phase III_RCC_CA209025	WESTERN EUROPE	73	M	WHITE	0480_Marios_PD1_Inhib2_HP-E9125190-7.raw
SA089125	CA209025-89-34	CA209025-89-34_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	48.526	Phase III_RCC_CA209025	WESTERN EUROPE	60	M	WHITE	0430_Marios_PD1_Inhib2_HP-E9103839-7.raw
SA089143	CA209025-95-320	CA209025-95-320_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	1.150	Phase III_RCC_CA209025	REST OF WORLD	80	M	WHITE	0961_Marios_PD1_Inhib2_HP-S3447249-7.raw
SA089128	CA209025-95-331	CA209025-95-331_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	46.686	Phase III_RCC_CA209025	REST OF WORLD	62	M	WHITE	0118_Marios_PD1_Inhib2_HP-S3713043-7.raw
SA089112	CA209025-95-681	CA209025-95-681_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	4.862	Phase III_RCC_CA209025	REST OF WORLD	66	M	WHITE	0521_Marios_PD1_Inhib2_HP-S3907393-7.raw
SA089123	CA209025-98-547	CA209025-98-547_baseline	baseline	-	POOR	NIVOLUMAB	FALSE	9.396	Phase III_RCC_CA209025	REST OF WORLD	48	F	WHITE	0692_Marios_PD1_Inhib2_HP-S3862084-7.raw
SA089164	CA209025-139-1025	CA209025-139-1025_baseline	baseline	-	POOR	NIVOLUMAB	TRUE	6.209	Phase III_RCC_CA209025	US/CANADA	72	F	WHITE	0850_Marios_PD1_Inhib2_HP-AF337224-9.raw
SA089154	CA209025-139-140	CA209025-139-140_baseline	baseline	-	POOR	NIVOLUMAB	TRUE	45.470	Phase III_RCC_CA209025	US/CANADA	70	M	WHITE	0255_Marios_PD1_Inhib2_HP-AD585851-7.raw
SA089155	CA209025-139-359	CA209025-139-359_baseline	baseline	-	POOR	NIVOLUMAB	TRUE	32.723	Phase III_RCC_CA209025	US/CANADA	61	M	WHITE	0947_Marios_PD1_Inhib2_HP-AE052722-7.raw
SA089161	CA209025-153-407	CA209025-153-407_baseline	baseline	-	POOR	NIVOLUMAB	TRUE	32.230	Phase III_RCC_CA209025	US/CANADA	45	M	WHITE	0607_Marios_PD1_Inhib2_HP-AD780267-7.raw
SA089159	CA209025-158-70	CA209025-158-70_baseline	baseline	-	POOR	NIVOLUMAB	TRUE	26.711	Phase III_RCC_CA209025	REST OF WORLD	39	F	OTHER	0001_Marios_PD1_Inhib2_HP-S3473952-7.raw
SA089166	CA209025-20-371	CA209025-20-371_baseline	baseline	-	POOR	NIVOLUMAB	TRUE	5.257	Phase III_RCC_CA209025	US/CANADA	43	M	WHITE	1196_Marios_PD1_Inhib2_HP-AE062797-7.raw
SA089168	CA209025-2-357	CA209025-2-357_baseline	baseline	-	POOR	NIVOLUMAB	TRUE	38.407	Phase III_RCC_CA209025	WESTERN EUROPE	60	M	WHITE	0241_Marios_PD1_Inhib2_HP-E9657509-7.raw
SA089165	CA209025-25-930	CA209025-25-930_baseline	baseline	-	POOR	NIVOLUMAB	TRUE	7.655	Phase III_RCC_CA209025	US/CANADA	56	M	WHITE	0042_Marios_PD1_Inhib2_HP-AF009251-9.raw
SA089167	CA209025-41-485	CA209025-41-485_baseline	baseline	-	POOR	NIVOLUMAB	TRUE	7.491	Phase III_RCC_CA209025	US/CANADA	71	M	WHITE	0344_Marios_PD1_Inhib2_HP-AD604553-11.raw
SA089162	CA209025-49-828	CA209025-49-828_baseline	baseline	-	POOR	NIVOLUMAB	TRUE	0.526	Phase III_RCC_CA209025	US/CANADA	41	F	WHITE	0560_Marios_PD1_Inhib2_HP-AE354851-10.raw
SA089163	CA209025-56-522	CA209025-56-522_baseline	baseline	-	POOR	NIVOLUMAB	TRUE	4.731	Phase III_RCC_CA209025	WESTERN EUROPE	40	M	WHITE	0829_Marios_PD1_Inhib2_HP-E9096039-7.raw
SA089157	CA209025-62-552	CA209025-62-552_baseline	baseline	-	POOR	NIVOLUMAB	TRUE	3.253	Phase III_RCC_CA209025	WESTERN EUROPE	50	M	WHITE	1221_Marios_PD1_Inhib2_HP-EA039954-7.raw
SA089158	CA209025-69-539	CA209025-69-539_baseline	baseline	-	POOR	NIVOLUMAB	TRUE	18.136	Phase III_RCC_CA209025	REST OF WORLD	54	F	WHITE	0280_Marios_PD1_Inhib2_HP-E9483500-7.raw
SA089160	CA209025-82-904	CA209025-82-904_baseline	baseline	-	POOR	NIVOLUMAB	TRUE	3.023	Phase III_RCC_CA209025	WESTERN EUROPE	51	F	WHITE	0400_Marios_PD1_Inhib2_HP-EA305478-7.raw
SA089156	CA209025-89-132	CA209025-89-132_baseline	baseline	-	POOR	NIVOLUMAB	TRUE	10.218	Phase III_RCC_CA209025	WESTERN EUROPE	64	M	WHITE	0222_Marios_PD1_Inhib2_HP-E9526838-7.raw
SA089498	CA209025-1-1048	CA209025-1-1048_week 4	week 4	1	FAVORABLE	EVEROLIMUS	FALSE	38.275	Phase III_RCC_CA209025	US/CANADA	56	M	WHITE	0226_Marios_PD1_Inhib2_HP-AF365618-8.raw
SA089495	CA209025-141-667	CA209025-141-667_week 4	week 4	1	FAVORABLE	EVEROLIMUS	FALSE	28.583	Phase III_RCC_CA209025	US/CANADA	70	M	WHITE	0363_Marios_PD1_Inhib2_HP-AE462189-7.raw
SA089492	CA209025-141-730	CA209025-141-730_week 4	week 4	1	FAVORABLE	EVEROLIMUS	FALSE	34.793	Phase III_RCC_CA209025	US/CANADA	53	M	WHITE	0713_Marios_PD1_Inhib2_HP-AE630797-8.raw
SA089496	CA209025-14-943	CA209025-14-943_week 4	week 4	1	FAVORABLE	EVEROLIMUS	FALSE	41.429	Phase III_RCC_CA209025	US/CANADA	75	F	WHITE	0930_Marios_PD1_Inhib2_HP-AF015791-8.raw
SA089493	CA209025-154-1019	CA209025-154-1019_week 4	week 4	1	FAVORABLE	EVEROLIMUS	FALSE	39.754	Phase III_RCC_CA209025	REST OF WORLD	70	M	OTHER	0708_Marios_PD1_Inhib2_HP-S4107204-8.raw
SA089500	CA209025-159-994	CA209025-159-994_week 4	week 4	1	FAVORABLE	EVEROLIMUS	FALSE	24.476	Phase III_RCC_CA209025	REST OF WORLD	60	F	OTHER	0318_Marios_PD1_Inhib2_HP-S4107214-8.raw
SA089497	CA209025-20-946	CA209025-20-946_week 4	week 4	1	FAVORABLE	EVEROLIMUS	FALSE	41.298	Phase III_RCC_CA209025	US/CANADA	55	M	WHITE	0559_Marios_PD1_Inhib2_HP-AF002819-8.raw
SA089494	CA209025-84-861	CA209025-84-861_week 4	week 4	1	FAVORABLE	EVEROLIMUS	FALSE	27.466	Phase III_RCC_CA209025	REST OF WORLD	59	M	WHITE	0609_Marios_PD1_Inhib2_HP-L1448904-12.raw
SA089499	CA209025-92-806	CA209025-92-806_week 4	week 4	1	FAVORABLE	EVEROLIMUS	FALSE	27.236	Phase III_RCC_CA209025	WESTERN EUROPE	69	M	WHITE	1021_Marios_PD1_Inhib2_HP-EA716002-8.raw
SA089502	CA209025-1-1056	CA209025-1-1056_week 4	week 4	1	FAVORABLE	EVEROLIMUS	TRUE	22.801	Phase III_RCC_CA209025	US/CANADA	76	M	WHITE	0201_Marios_PD1_Inhib2_HP-AF581650-8.raw
SA089501	CA209025-138-699	CA209025-138-699_week 4	week 4	1	FAVORABLE	EVEROLIMUS	TRUE	43.532	Phase III_RCC_CA209025	US/CANADA	52	M	WHITE	0140_Marios_PD1_Inhib2_HP-AE726357-6.raw
SA089503	CA209025-47-1037	CA209025-47-1037_week 4	week 4	1	FAVORABLE	EVEROLIMUS	TRUE	40.476	Phase III_RCC_CA209025	US/CANADA	53	M	WHITE	0568_Marios_PD1_Inhib2_HP-AF016172-8.raw
SA089506	CA209025-138-734	CA209025-138-734_week 4	week 4	1	FAVORABLE	NIVOLUMAB	FALSE	44.682	Phase III_RCC_CA209025	US/CANADA	62	F	WHITE	1190_Marios_PD1_Inhib2_HP-AE726356-6.raw
SA089520	CA209025-139-1006	CA209025-139-1006_week 4	week 4	1	FAVORABLE	NIVOLUMAB	FALSE	39.589	Phase III_RCC_CA209025	US/CANADA	46	M	WHITE	0921_Marios_PD1_Inhib2_HP-AF048325-8.raw
SA089515	CA209025-154-929	CA209025-154-929_week 4	week 4	1	FAVORABLE	NIVOLUMAB	FALSE	42.481	Phase III_RCC_CA209025	REST OF WORLD	51	M	OTHER	1156_Marios_PD1_Inhib2_HP-S4107203-8.raw
SA089509	CA209025-156-1017	CA209025-156-1017_week 4	week 4	1	FAVORABLE	NIVOLUMAB	FALSE	39.918	Phase III_RCC_CA209025	REST OF WORLD	59	M	OTHER	1052_Marios_PD1_Inhib2_HP-S4152615-7.raw
SA089516	CA209025-15-773	CA209025-15-773_week 4	week 4	1	FAVORABLE	NIVOLUMAB	FALSE	44.090	Phase III_RCC_CA209025	US/CANADA	53	M	WHITE	0330_Marios_PD1_Inhib2_HP-AE091510-8.raw
SA089507	CA209025-161-974	CA209025-161-974_week 4	week 4	1	FAVORABLE	NIVOLUMAB	FALSE	40.936	Phase III_RCC_CA209025	REST OF WORLD	69	F	OTHER	0518_Marios_PD1_Inhib2_HP-S4144272-8.raw
SA089511	CA209025-169-660	CA209025-169-660_week 4	week 4	1	FAVORABLE	NIVOLUMAB	FALSE	44.419	Phase III_RCC_CA209025	REST OF WORLD	63	M	OTHER	0844_Marios_PD1_Inhib2_HP-S4022646-7.raw
SA089514	CA209025-17-1044	CA209025-17-1044_week 4	week 4	1	FAVORABLE	NIVOLUMAB	FALSE	39.524	Phase III_RCC_CA209025	US/CANADA	53	M	WHITE	0380_Marios_PD1_Inhib2_HP-AG392084-34.raw
SA089510	CA209025-173-757	CA209025-173-757_week 4	week 4	1	FAVORABLE	NIVOLUMAB	FALSE	22.111	Phase III_RCC_CA209025	REST OF WORLD	51	M	OTHER	0497_Marios_PD1_Inhib2_HP-S4097411-8.raw
SA089513	CA209025-174-1010	CA209025-174-1010_week 4	week 4	1	FAVORABLE	NIVOLUMAB	FALSE	40.049	Phase III_RCC_CA209025	REST OF WORLD	70	M	OTHER	0983_Marios_PD1_Inhib2_HP-S4107173-8.raw
SA089512	CA209025-17-928	CA209025-17-928_week 4	week 4	1	FAVORABLE	NIVOLUMAB	FALSE	42.283	Phase III_RCC_CA209025	US/CANADA	77	M	WHITE	1059_Marios_PD1_Inhib2_HP-AF064095-8.raw
SA089508	CA209025-18-954	CA209025-18-954_week 4	week 4	1	FAVORABLE	NIVOLUMAB	FALSE	41.922	Phase III_RCC_CA209025	US/CANADA	43	M	OTHER	0679_Marios_PD1_Inhib2_HP-AF008932-8.raw
SA089522	CA209025-21-1027	CA209025-21-1027_week 4	week 4	1	FAVORABLE	NIVOLUMAB	FALSE	34.267	Phase III_RCC_CA209025	US/CANADA	69	F	WHITE	0935_Marios_PD1_Inhib2_HP-AF146084-8.raw
SA089521	CA209025-21-1039	CA209025-21-1039_week 4	week 4	1	FAVORABLE	NIVOLUMAB	FALSE	31.803	Phase III_RCC_CA209025	US/CANADA	59	F	WHITE	0891_Marios_PD1_Inhib2_HP-AF002705-8.raw
SA089517	CA209025-21-849	CA209025-21-849_week 4	week 4	1	FAVORABLE	NIVOLUMAB	FALSE	40.312	Phase III_RCC_CA209025	US/CANADA	52	F	WHITE	0784_Marios_PD1_Inhib2_HP-AF002704-8.raw
SA089519	CA209025-22-1000	CA209025-22-1000_week 4	week 4	1	FAVORABLE	NIVOLUMAB	FALSE	40.969	Phase III_RCC_CA209025	US/CANADA	64	F	WHITE	0440_Marios_PD1_Inhib2_HP-AF009300-8.raw
SA089524	CA209025-24-840	CA209025-24-840_week 4	week 4	1	FAVORABLE	NIVOLUMAB	FALSE	42.842	Phase III_RCC_CA209025	US/CANADA	23	F	WHITE	0539_Marios_PD1_Inhib2_HP-AF009316-8.raw
SA089505	CA209025-29-1002	CA209025-29-1002_week 4	week 4	1	FAVORABLE	NIVOLUMAB	FALSE	40.674	Phase III_RCC_CA209025	US/CANADA	60	M	WHITE	0483_Marios_PD1_Inhib2_HP-AF325370-8.raw
SA089504	CA209025-43-941	CA209025-43-941_week 4	week 4	1	FAVORABLE	NIVOLUMAB	FALSE	22.012	Phase III_RCC_CA209025	US/CANADA	67	M	WHITE	0600_Marios_PD1_Inhib2_HP-AF003952-8.raw
SA089518	CA209025-9-756	CA209025-9-756_week 4	week 4	1	FAVORABLE	NIVOLUMAB	FALSE	43.302	Phase III_RCC_CA209025	US/CANADA	63	M	WHITE	0513_Marios_PD1_Inhib2_HP-AF002787-8.raw
SA089523	CA209025-9-892	CA209025-9-892_week 4	week 4	1	FAVORABLE	NIVOLUMAB	FALSE	43.072	Phase III_RCC_CA209025	US/CANADA	67	M	WHITE	1201_Marios_PD1_Inhib2_HP-AF032142-8.raw
SA089527	CA209025-114-813	CA209025-114-813_week 4	week 4	1	FAVORABLE	NIVOLUMAB	TRUE	43.926	Phase III_RCC_CA209025	WESTERN EUROPE	67	M	WHITE	0346_Marios_PD1_Inhib2_HP-E9124387-6.raw
SA089526	CA209025-139-1036	CA209025-139-1036_week 4	week 4	1	FAVORABLE	NIVOLUMAB	TRUE	38.571	Phase III_RCC_CA209025	US/CANADA	72	M	WHITE	0769_Marios_PD1_Inhib2_HP-AF438567-8.raw
SA089525	CA209025-93-836	CA209025-93-836_week 4	week 4	1	FAVORABLE	NIVOLUMAB	TRUE	42.743	Phase III_RCC_CA209025	WESTERN EUROPE	52	M	WHITE	0771_Marios_PD1_Inhib2_HP-EA716174-8.raw
SA089529	CA209025-131-1043	CA209025-131-1043_week 4	week 4	1	INTERMEDIATE	EVEROLIMUS	FALSE	40.312	Phase III_RCC_CA209025	REST OF WORLD	62	F	WHITE	0507_Marios_PD1_Inhib2_HP-EA720992-8.raw
SA089530	CA209025-131-939	CA209025-131-939_week 4	week 4	1	INTERMEDIATE	EVEROLIMUS	FALSE	18.628	Phase III_RCC_CA209025	REST OF WORLD	64	M	WHITE	0591_Marios_PD1_Inhib2_HP-EA720994-8.raw
SA089531	CA209025-14-1070	CA209025-14-1070_week 4	week 4	1	INTERMEDIATE	EVEROLIMUS	FALSE	38.505	Phase III_RCC_CA209025	US/CANADA	59	F	WHITE	1177_Marios_PD1_Inhib2_HP-AF575413-8.raw
SA089532	CA209025-165-850	CA209025-165-850_week 4	week 4	1	INTERMEDIATE	EVEROLIMUS	FALSE	43.039	Phase III_RCC_CA209025	REST OF WORLD	61	M	OTHER	0061_Marios_PD1_Inhib2_HP-S4107194-8.raw
SA089533	CA209025-43-931	CA209025-43-931_week 4	week 4	1	INTERMEDIATE	EVEROLIMUS	FALSE	33.643	Phase III_RCC_CA209025	US/CANADA	57	F	WHITE	0130_Marios_PD1_Inhib2_HP-AF003954-8.raw
SA089528	CA209025-9-896	CA209025-9-896_week 4	week 4	1	INTERMEDIATE	EVEROLIMUS	FALSE	42.842	Phase III_RCC_CA209025	US/CANADA	64	M	WHITE	0421_Marios_PD1_Inhib2_HP-AF032141-8.raw
SA089535	CA209025-158-654	CA209025-158-654_week 4	week 4	1	INTERMEDIATE	EVEROLIMUS	TRUE	32.493	Phase III_RCC_CA209025	REST OF WORLD	63	M	OTHER	0382_Marios_PD1_Inhib2_HP-S4035153-7.raw
SA089534	CA209025-185-805	CA209025-185-805_week 4	week 4	1	INTERMEDIATE	EVEROLIMUS	TRUE	31.113	Phase III_RCC_CA209025	US/CANADA	49	M	WHITE	1106_Marios_PD1_Inhib2_HP-AF016210-8.raw
SA089538	CA209025-125-855	CA209025-125-855_week 4	week 4	1	INTERMEDIATE	NIVOLUMAB	FALSE	43.762	Phase III_RCC_CA209025	REST OF WORLD	54	M	WHITE	0993_Marios_PD1_Inhib2_HP-L1426707-9.raw
SA089543	CA209025-143-679	CA209025-143-679_week 4	week 4	1	INTERMEDIATE	NIVOLUMAB	FALSE	44.452	Phase III_RCC_CA209025	US/CANADA	64	M	WHITE	1145_Marios_PD1_Inhib2_HP-AE602895-16.raw
SA089546	CA209025-155-1020	CA209025-155-1020_week 4	week 4	1	INTERMEDIATE	NIVOLUMAB	FALSE	39.951	Phase III_RCC_CA209025	REST OF WORLD	46	M	OTHER	0180_Marios_PD1_Inhib2_HP-S4103686-7.raw
SA089537	CA209025-159-777	CA209025-159-777_week 4	week 4	1	INTERMEDIATE	NIVOLUMAB	FALSE	43.598	Phase III_RCC_CA209025	REST OF WORLD	73	M	OTHER	1096_Marios_PD1_Inhib2_HP-S4035170-7.raw
SA089539	CA209025-163-1012	CA209025-163-1012_week 4	week 4	1	INTERMEDIATE	NIVOLUMAB	FALSE	40.411	Phase III_RCC_CA209025	REST OF WORLD	65	M	OTHER	0971_Marios_PD1_Inhib2_HP-S4211195-8.raw
SA089544	CA209025-167-1011	CA209025-167-1011_week 4	week 4	1	INTERMEDIATE	NIVOLUMAB	FALSE	39.819	Phase III_RCC_CA209025	REST OF WORLD	69	F	OTHER	0597_Marios_PD1_Inhib2_HP-S4251324-8.raw
SA089536	CA209025-1-961	CA209025-1-961_week 4	week 4	1	INTERMEDIATE	NIVOLUMAB	FALSE	41.725	Phase III_RCC_CA209025	US/CANADA	69	M	WHITE	0271_Marios_PD1_Inhib2_HP-AF002687-9.raw
SA089540	CA209025-21-1065	CA209025-21-1065_week 4	week 4	1	INTERMEDIATE	NIVOLUMAB	FALSE	38.932	Phase III_RCC_CA209025	US/CANADA	55	M	WHITE	0659_Marios_PD1_Inhib2_HP-AF146083-8.raw
SA089541	CA209025-23-953	CA209025-23-953_week 4	week 4	1	INTERMEDIATE	NIVOLUMAB	FALSE	41.363	Phase III_RCC_CA209025	US/CANADA	63	M	WHITE	1119_Marios_PD1_Inhib2_HP-AE795125-9.raw
SA089545	CA209025-29-988	CA209025-29-988_week 4	week 4	1	INTERMEDIATE	NIVOLUMAB	FALSE	40.772	Phase III_RCC_CA209025	US/CANADA	70	M	WHITE	0005_Marios_PD1_Inhib2_HP-AF008971-8.raw
SA089542	CA209025-79-982	CA209025-79-982_week 4	week 4	1	INTERMEDIATE	NIVOLUMAB	FALSE	17.840	Phase III_RCC_CA209025	REST OF WORLD	67	M	WHITE	0695_Marios_PD1_Inhib2_HP-L1443412-7.raw
SA089548	CA209025-84-1041	CA209025-84-1041_week 4	week 4	1	INTERMEDIATE	NIVOLUMAB	FALSE	39.031	Phase III_RCC_CA209025	REST OF WORLD	57	M	WHITE	0488_Marios_PD1_Inhib2_HP-L1443430-8.raw
SA089547	CA209025-85-986	CA209025-85-986_week 4	week 4	1	INTERMEDIATE	NIVOLUMAB	FALSE	41.035	Phase III_RCC_CA209025	REST OF WORLD	71	M	WHITE	0825_Marios_PD1_Inhib2_HP-L1497978-11.raw
SA089549	CA209025-14-1057	CA209025-14-1057_week 4	week 4	1	INTERMEDIATE	NIVOLUMAB	TRUE	39.129	Phase III_RCC_CA209025	US/CANADA	66	M	WHITE	0302_Marios_PD1_Inhib2_HP-AF015789-8.raw
SA089550	CA209025-20-1059	CA209025-20-1059_week 4	week 4	1	INTERMEDIATE	NIVOLUMAB	TRUE	38.899	Phase III_RCC_CA209025	US/CANADA	64	M	WHITE	0907_Marios_PD1_Inhib2_HP-AF252786-8.raw
SA089551	CA209025-44-944	CA209025-44-944_week 4	week 4	1	INTERMEDIATE	NIVOLUMAB	TRUE	41.265	Phase III_RCC_CA209025	US/CANADA	54	F	WHITE	0126_Marios_PD1_Inhib2_HP-AF016224-8.raw
SA089553	CA209025-20-976	CA209025-20-976_week 4	week 4	1	POOR	EVEROLIMUS	FALSE	23.688	Phase III_RCC_CA209025	US/CANADA	75	F	WHITE	0037_Marios_PD1_Inhib2_HP-AF252783-8.raw
SA089554	CA209025-21-1064	CA209025-21-1064_week 4	week 4	1	POOR	EVEROLIMUS	FALSE	27.006	Phase III_RCC_CA209025	US/CANADA	64	F	WHITE	1139_Marios_PD1_Inhib2_HP-AF146081-8.raw
SA089552	CA209025-79-1061	CA209025-79-1061_week 4	week 4	1	POOR	EVEROLIMUS	FALSE	24.246	Phase III_RCC_CA209025	REST OF WORLD	63	M	WHITE	1129_Marios_PD1_Inhib2_HP-L1443413-7.raw
SA089559	CA209025-141-666	CA209025-141-666_week 4	week 4	1	POOR	NIVOLUMAB	FALSE	43.959	Phase III_RCC_CA209025	US/CANADA	56	M	WHITE	0833_Marios_PD1_Inhib2_HP-AE630795-6.raw
SA089555	CA209025-165-758	CA209025-165-758_week 4	week 4	1	POOR	NIVOLUMAB	FALSE	44.616	Phase III_RCC_CA209025	REST OF WORLD	70	M	OTHER	0268_Marios_PD1_Inhib2_HP-S4035312-7.raw
SA089556	CA209025-28-951	CA209025-28-951_week 4	week 4	1	POOR	NIVOLUMAB	FALSE	41.429	Phase III_RCC_CA209025	US/CANADA	60	M	WHITE	0164_Marios_PD1_Inhib2_HP-AF015542-8.raw
SA089557	CA209025-29-921	CA209025-29-921_week 4	week 4	1	POOR	NIVOLUMAB	FALSE	42.053	Phase III_RCC_CA209025	US/CANADA	59	M	WHITE	0047_Marios_PD1_Inhib2_HP-AF008973-8.raw
SA089558	CA209025-9-1055	CA209025-9-1055_week 4	week 4	1	POOR	NIVOLUMAB	FALSE	39.097	Phase III_RCC_CA209025	US/CANADA	57	M	OTHER	1070_Marios_PD1_Inhib2_HP-AF032140-8.raw
SA089560	CA209025-9-870	CA209025-9-870_week 4	week 4	1	POOR	NIVOLUMAB	TRUE	43.039	Phase III_RCC_CA209025	US/CANADA	73	M	WHITE	0717_Marios_PD1_Inhib2_HP-AF002790-8.raw
SA089414	CA209025-139-990	CA209025-139-990_week 4	week 4	-	FAVORABLE	EVEROLIMUS	FALSE	15.047	Phase III_RCC_CA209025	US/CANADA	67	F	WHITE	0631_Marios_PD1_Inhib2_HP-AF048321-8.raw
SA089409	CA209025-161-973	CA209025-161-973_week 4	week 4	-	FAVORABLE	EVEROLIMUS	FALSE	32.526	Phase III_RCC_CA209025	REST OF WORLD	66	M	OTHER	0759_Marios_PD1_Inhib2_HP-S4103671-7.raw
SA089413	CA209025-1-948	CA209025-1-948_week 4	week 4	-	FAVORABLE	EVEROLIMUS	FALSE	12.550	Phase III_RCC_CA209025	US/CANADA	71	M	WHITE	1150_Marios_PD1_Inhib2_HP-AF002686-8.raw
SA089407	CA209025-20-1040	CA209025-20-1040_week 4	week 4	-	FAVORABLE	EVEROLIMUS	FALSE	2.431	Phase III_RCC_CA209025	US/CANADA	51	F	WHITE	0338_Marios_PD1_Inhib2_HP-AF252787-8.raw
SA089406	CA209025-21-907	CA209025-21-907_week 4	week 4	-	FAVORABLE	EVEROLIMUS	FALSE	14.292	Phase III_RCC_CA209025	US/CANADA	56	F	WHITE	0094_Marios_PD1_Inhib2_HP-AF146086-8.raw
SA089405	CA209025-23-952	CA209025-23-952_week 4	week 4	-	FAVORABLE	EVEROLIMUS	FALSE	12.255	Phase III_RCC_CA209025	US/CANADA	76	M	WHITE	0111_Marios_PD1_Inhib2_HP-AF002758-8.raw
SA089408	CA209025-30-639	CA209025-30-639_week 4	week 4	-	FAVORABLE	EVEROLIMUS	FALSE	32.756	Phase III_RCC_CA209025	US/CANADA	66	F	WHITE	0807_Marios_PD1_Inhib2_HP-AD810805-4.raw
SA089412	CA209025-43-897	CA209025-43-897_week 4	week 4	-	FAVORABLE	EVEROLIMUS	FALSE	14.916	Phase III_RCC_CA209025	US/CANADA	63	F	WHITE	1117_Marios_PD1_Inhib2_HP-AF003951-8.raw
SA089411	CA209025-44-1009	CA209025-44-1009_week 4	week 4	-	FAVORABLE	EVEROLIMUS	FALSE	4.074	Phase III_RCC_CA209025	US/CANADA	23	M	WHITE	0066_Marios_PD1_Inhib2_HP-AF016223-8.raw
SA089410	CA209025-79-1062	CA209025-79-1062_week 4	week 4	-	FAVORABLE	EVEROLIMUS	FALSE	3.647	Phase III_RCC_CA209025	REST OF WORLD	62	F	WHITE	0365_Marios_PD1_Inhib2_HP-L1478158-8.raw
SA089415	CA209025-138-872	CA209025-138-872_week 4	week 4	-	FAVORABLE	EVEROLIMUS	TRUE	25.856	Phase III_RCC_CA209025	US/CANADA	58	F	WHITE	1094_Marios_PD1_Inhib2_HP-AF004073-8.raw
SA089421	CA209025-1-1004	CA209025-1-1004_week 4	week 4	-	FAVORABLE	NIVOLUMAB	FALSE	32.657	Phase III_RCC_CA209025	US/CANADA	58	M	WHITE	0417_Marios_PD1_Inhib2_HP-AF365619-8.raw
SA089416	CA209025-1-1030	CA209025-1-1030_week 4	week 4	-	FAVORABLE	NIVOLUMAB	FALSE	23.951	Phase III_RCC_CA209025	US/CANADA	61	M	WHITE	0398_Marios_PD1_Inhib2_HP-AF439760-8.raw
SA089418	CA209025-11-910	CA209025-11-910_week 4	week 4	-	FAVORABLE	NIVOLUMAB	FALSE	8.674	Phase III_RCC_CA209025	US/CANADA	63	M	WHITE	0471_Marios_PD1_Inhib2_HP-AF015820-8.raw
SA089422	CA209025-138-1034	CA209025-138-1034_week 4	week 4	-	FAVORABLE	NIVOLUMAB	FALSE	10.152	Phase III_RCC_CA209025	US/CANADA	52	M	WHITE	0155_Marios_PD1_Inhib2_HP-AF004072-8.raw
SA089425	CA209025-139-1015	CA209025-139-1015_week 4	week 4	-	FAVORABLE	NIVOLUMAB	FALSE	14.916	Phase III_RCC_CA209025	US/CANADA	32	F	OTHER	0875_Marios_PD1_Inhib2_HP-AF048323-8.raw
SA089417	CA209025-159-750	CA209025-159-750_week 4	week 4	-	FAVORABLE	NIVOLUMAB	FALSE	27.433	Phase III_RCC_CA209025	REST OF WORLD	64	M	OTHER	1169_Marios_PD1_Inhib2_HP-S4035169-6.raw
SA089423	CA209025-159-945	CA209025-159-945_week 4	week 4	-	FAVORABLE	NIVOLUMAB	FALSE	26.842	Phase III_RCC_CA209025	REST OF WORLD	57	M	OTHER	0550ri_Marios_PD1_Inhib2_HP-S4107213-8.raw
SA089424	CA209025-24-887	CA209025-24-887_week 4	week 4	-	FAVORABLE	NIVOLUMAB	FALSE	27.696	Phase III_RCC_CA209025	US/CANADA	44	M	WHITE	0386_Marios_PD1_Inhib2_HP-AF009315-8.raw
SA089419	CA209025-29-621	CA209025-29-621_week 4	week 4	-	FAVORABLE	NIVOLUMAB	FALSE	18.234	Phase III_RCC_CA209025	US/CANADA	65	M	WHITE	0170_Marios_PD1_Inhib2_HP-AE294697-2.raw
SA089420	CA209025-29-626	CA209025-29-626_week 4	week 4	-	FAVORABLE	NIVOLUMAB	FALSE	8.608	Phase III_RCC_CA209025	US/CANADA	48	M	WHITE	0360_Marios_PD1_Inhib2_HP-AE294698-2.raw
SA089429	CA209025-139-978	CA209025-139-978_week 4	week 4	-	FAVORABLE	NIVOLUMAB	TRUE	31.343	Phase III_RCC_CA209025	US/CANADA	56	M	OTHER	0152_Marios_PD1_Inhib2_HP-AF048322-8.raw
SA089427	CA209025-17-1066	CA209025-17-1066_week 4	week 4	-	FAVORABLE	NIVOLUMAB	TRUE	25.626	Phase III_RCC_CA209025	US/CANADA	60	F	WHITE	0757_Marios_PD1_Inhib2_HP-AF015802-8.raw
SA089426	CA209025-22-935	CA209025-22-935_week 4	week 4	-	FAVORABLE	NIVOLUMAB	TRUE	24.772	Phase III_RCC_CA209025	US/CANADA	45	M	WHITE	1166_Marios_PD1_Inhib2_HP-AF009299-8.raw
SA089428	CA209025-3-871	CA209025-3-871_week 4	week 4	-	FAVORABLE	NIVOLUMAB	TRUE	7.064	Phase III_RCC_CA209025	WESTERN EUROPE	64	M	WHITE	0741_Marios_PD1_Inhib2_HP-EA716458-8.raw
SA089430	CA209025-94-851	CA209025-94-851_week 4	week 4	-	FAVORABLE	NIVOLUMAB	TRUE	23.688	Phase III_RCC_CA209025	REST OF WORLD	61	M	WHITE	0423_Marios_PD1_Inhib2_HP-S4102912-8.raw
SA089443	CA209025-11-829	CA209025-11-829_week 4	week 4	-	INTERMEDIATE	EVEROLIMUS	FALSE	6.834	Phase III_RCC_CA209025	US/CANADA	58	M	WHITE	0329_Marios_PD1_Inhib2_HP-AE487824-2.raw
SA089445	CA209025-138-1069	CA209025-138-1069_week 4	week 4	-	INTERMEDIATE	EVEROLIMUS	FALSE	7.359	Phase III_RCC_CA209025	US/CANADA	76	M	WHITE	0896_Marios_PD1_Inhib2_HP-AF004074-8.raw
SA089438	CA209025-14-996	CA209025-14-996_week 4	week 4	-	INTERMEDIATE	EVEROLIMUS	FALSE	15.212	Phase III_RCC_CA209025	US/CANADA	60	M	WHITE	0671_Marios_PD1_Inhib2_HP-AF015790-8.raw
SA089446	CA209025-155-858	CA209025-155-858_week 4	week 4	-	INTERMEDIATE	EVEROLIMUS	FALSE	17.478	Phase III_RCC_CA209025	REST OF WORLD	58	F	OTHER	0845_Marios_PD1_Inhib2_HP-S3947232-6.raw
SA089439	CA209025-156-744	CA209025-156-744_week 4	week 4	-	INTERMEDIATE	EVEROLIMUS	FALSE	25.199	Phase III_RCC_CA209025	REST OF WORLD	72	M	OTHER	0443_Marios_PD1_Inhib2_HP-S4035151-7.raw
SA089437	CA209025-174-863	CA209025-174-863_week 4	week 4	-	INTERMEDIATE	EVEROLIMUS	FALSE	4.632	Phase III_RCC_CA209025	REST OF WORLD	61	M	OTHER	1207_Marios_PD1_Inhib2_HP-S4107175-8.raw
SA089436	CA209025-180-1053	CA209025-180-1053_week 4	week 4	-	INTERMEDIATE	EVEROLIMUS	FALSE	6.571	Phase III_RCC_CA209025	REST OF WORLD	59	F	WHITE	0530_Marios_PD1_Inhib2_HP-EB335385-8.raw
SA089440	CA209025-182-701	CA209025-182-701_week 4	week 4	-	INTERMEDIATE	EVEROLIMUS	FALSE	19.975	Phase III_RCC_CA209025	US/CANADA	82	M	WHITE	0748_Marios_PD1_Inhib2_HP-AE283074-7.raw
SA089435	CA209025-1-972	CA209025-1-972_week 4	week 4	-	INTERMEDIATE	EVEROLIMUS	FALSE	14.686	Phase III_RCC_CA209025	US/CANADA	50	F	OTHER	1079_Marios_PD1_Inhib2_HP-AF002683-8.raw
SA089441	CA209025-20-1075	CA209025-20-1075_week 4	week 4	-	INTERMEDIATE	EVEROLIMUS	FALSE	8.509	Phase III_RCC_CA209025	US/CANADA	58	M	WHITE	1126_Marios_PD1_Inhib2_HP-AF002821-8.raw
SA089444	CA209025-42-1051	CA209025-42-1051_week 4	week 4	-	INTERMEDIATE	EVEROLIMUS	FALSE	5.322	Phase III_RCC_CA209025	US/CANADA	47	M	WHITE	0810_Marios_PD1_Inhib2_HP-AF008957-8.raw
SA089442	CA209025-53-1003	CA209025-53-1003_week 4	week 4	-	INTERMEDIATE	EVEROLIMUS	FALSE	5.355	Phase III_RCC_CA209025	US/CANADA	57	F	WHITE	1092_Marios_PD1_Inhib2_HP-AF016234-8.raw
SA089432	CA209025-78-1007	CA209025-78-1007_week 4	week 4	-	INTERMEDIATE	EVEROLIMUS	FALSE	4.337	Phase III_RCC_CA209025	REST OF WORLD	51	M	WHITE	0798_Marios_PD1_Inhib2_HP-L1479331-12.raw
SA089431	CA209025-78-1014	CA209025-78-1014_week 4	week 4	-	INTERMEDIATE	EVEROLIMUS	FALSE	5.618	Phase III_RCC_CA209025	REST OF WORLD	52	M	WHITE	0619_Marios_PD1_Inhib2_HP-L1479330-11.raw
SA089434	CA209025-84-933	CA209025-84-933_week 4	week 4	-	INTERMEDIATE	EVEROLIMUS	FALSE	25.528	Phase III_RCC_CA209025	REST OF WORLD	71	M	WHITE	0593_Marios_PD1_Inhib2_HP-L1448902-11.raw
SA089433	CA209025-9-984	CA209025-9-984_week 4	week 4	-	INTERMEDIATE	EVEROLIMUS	FALSE	22.341	Phase III_RCC_CA209025	US/CANADA	74	F	WHITE	0959_Marios_PD1_Inhib2_HP-AF002788-8.raw
SA089449	CA209025-183-874	CA209025-183-874_week 4	week 4	-	INTERMEDIATE	EVEROLIMUS	TRUE	41.561	Phase III_RCC_CA209025	US/CANADA	62	M	WHITE	0911_Marios_PD1_Inhib2_HP-AF016138-8.raw
SA089448	CA209025-25-947	CA209025-25-947_week 4	week 4	-	INTERMEDIATE	EVEROLIMUS	TRUE	11.368	Phase III_RCC_CA209025	US/CANADA	69	F	WHITE	0091_Marios_PD1_Inhib2_HP-AF009257-8.raw
SA089447	CA209025-53-885	CA209025-53-885_week 4	week 4	-	INTERMEDIATE	EVEROLIMUS	TRUE	3.614	Phase III_RCC_CA209025	US/CANADA	54	M	OTHER	0393_Marios_PD1_Inhib2_HP-AF016235-8.raw
SA089456	CA209025-1-1071	CA209025-1-1071_week 4	week 4	-	INTERMEDIATE	NIVOLUMAB	FALSE	20.567	Phase III_RCC_CA209025	US/CANADA	64	F	WHITE	0052_Marios_PD1_Inhib2_HP-AF581651-8.raw
SA089455	CA209025-11-1073	CA209025-11-1073_week 4	week 4	-	INTERMEDIATE	NIVOLUMAB	FALSE	38.571	Phase III_RCC_CA209025	US/CANADA	59	M	WHITE	0868_Marios_PD1_Inhib2_HP-AF015819-8.raw
SA089453	CA209025-138-814	CA209025-138-814_week 4	week 4	-	INTERMEDIATE	NIVOLUMAB	FALSE	26.842	Phase III_RCC_CA209025	US/CANADA	71	M	WHITE	0248_Marios_PD1_Inhib2_HP-AF004075-8.raw
SA089454	CA209025-138-847	CA209025-138-847_week 4	week 4	-	INTERMEDIATE	NIVOLUMAB	FALSE	25.134	Phase III_RCC_CA209025	US/CANADA	76	M	WHITE	0968_Marios_PD1_Inhib2_HP-AF004076-8.raw
SA089450	CA209025-143-794	CA209025-143-794_week 4	week 4	-	INTERMEDIATE	NIVOLUMAB	FALSE	20.370	Phase III_RCC_CA209025	US/CANADA	85	M	WHITE	0113_Marios_PD1_Inhib2_HP-AF015778-8.raw
SA089465	CA209025-185-983	CA209025-185-983_week 4	week 4	-	INTERMEDIATE	NIVOLUMAB	FALSE	20.008	Phase III_RCC_CA209025	US/CANADA	53	F	WHITE	1008_Marios_PD1_Inhib2_HP-AF016211-8.raw
SA089451	CA209025-1-920	CA209025-1-920_week 4	week 4	-	INTERMEDIATE	NIVOLUMAB	FALSE	14.029	Phase III_RCC_CA209025	US/CANADA	61	M	WHITE	1163_Marios_PD1_Inhib2_HP-AF002684-9.raw
SA089452	CA209025-1-932	CA209025-1-932_week 4	week 4	-	INTERMEDIATE	NIVOLUMAB	FALSE	2.136	Phase III_RCC_CA209025	US/CANADA	65	M	WHITE	0108_Marios_PD1_Inhib2_HP-AF002685-9.raw
SA089463	CA209025-23-922	CA209025-23-922_week 4	week 4	-	INTERMEDIATE	NIVOLUMAB	FALSE	22.111	Phase III_RCC_CA209025	US/CANADA	58	M	WHITE	0182_Marios_PD1_Inhib2_HP-AE795128-4.raw
SA089462	CA209025-25-1042	CA209025-25-1042_week 4	week 4	-	INTERMEDIATE	NIVOLUMAB	FALSE	9.429	Phase III_RCC_CA209025	US/CANADA	75	M	WHITE	1211_Marios_PD1_Inhib2_HP-AF233273-8.raw
SA089469	CA209025-26-965	CA209025-26-965_week 4	week 4	-	INTERMEDIATE	NIVOLUMAB	FALSE	14.390	Phase III_RCC_CA209025	US/CANADA	50	M	WHITE	0940_Marios_PD1_Inhib2_HP-AF003892-8.raw
SA089464	CA209025-27-915	CA209025-27-915_week 4	week 4	-	INTERMEDIATE	NIVOLUMAB	FALSE	8.706	Phase III_RCC_CA209025	US/CANADA	74	M	WHITE	0231_Marios_PD1_Inhib2_HP-AF009271-7.raw
SA089457	CA209025-29-938	CA209025-29-938_week 4	week 4	-	INTERMEDIATE	NIVOLUMAB	FALSE	9.988	Phase III_RCC_CA209025	US/CANADA	63	M	WHITE	1005_Marios_PD1_Inhib2_HP-AF008972-8.raw
SA089468	CA209025-42-919	CA209025-42-919_week 4	week 4	-	INTERMEDIATE	NIVOLUMAB	FALSE	23.359	Phase III_RCC_CA209025	US/CANADA	59	M	WHITE	0246_Marios_PD1_Inhib2_HP-AF008959-8.raw
SA089467	CA209025-4-815	CA209025-4-815_week 4	week 4	-	INTERMEDIATE	NIVOLUMAB	FALSE	18.497	Phase III_RCC_CA209025	WESTERN EUROPE	44	M	WHITE	0849_Marios_PD1_Inhib2_HP-EA677535-8.raw
SA089459	CA209025-69-810	CA209025-69-810_week 4	week 4	-	INTERMEDIATE	NIVOLUMAB	FALSE	17.084	Phase III_RCC_CA209025	REST OF WORLD	74	F	WHITE	0886_Marios_PD1_Inhib2_HP-EA715962-8.raw
SA089460	CA209025-70-883	CA209025-70-883_week 4	week 4	-	INTERMEDIATE	NIVOLUMAB	FALSE	25.528	Phase III_RCC_CA209025	REST OF WORLD	77	M	WHITE	0701_Marios_PD1_Inhib2_HP-EA715505-8.raw
SA089461	CA209025-84-894	CA209025-84-894_week 4	week 4	-	INTERMEDIATE	NIVOLUMAB	FALSE	5.651	Phase III_RCC_CA209025	REST OF WORLD	49	M	WHITE	0820_Marios_PD1_Inhib2_HP-L1448903-11.raw
SA089466	CA209025-95-706	CA209025-95-706_week 4	week 4	-	INTERMEDIATE	NIVOLUMAB	FALSE	2.004	Phase III_RCC_CA209025	REST OF WORLD	63	M	OTHER	1143_Marios_PD1_Inhib2_HP-S3907410-7.raw
SA089458	CA209025-95-721	CA209025-95-721_week 4	week 4	-	INTERMEDIATE	NIVOLUMAB	FALSE	5.684	Phase III_RCC_CA209025	REST OF WORLD	49	M	WHITE	0573_Marios_PD1_Inhib2_HP-S3907411-7.raw
SA089470	CA209025-139-989	CA209025-139-989_week 4	week 4	-	INTERMEDIATE	NIVOLUMAB	TRUE	26.086	Phase III_RCC_CA209025	US/CANADA	65	M	WHITE	0121_Marios_PD1_Inhib2_HP-AF003934-8.raw
SA089476	CA209025-164-901	CA209025-164-901_week 4	week 4	-	INTERMEDIATE	NIVOLUMAB	TRUE	25.823	Phase III_RCC_CA209025	REST OF WORLD	65	F	OTHER	0355_Marios_PD1_Inhib2_HP-S4093208-8.raw
SA089474	CA209025-166-957	CA209025-166-957_week 4	week 4	-	INTERMEDIATE	NIVOLUMAB	TRUE	13.963	Phase III_RCC_CA209025	REST OF WORLD	68	M	OTHER	1032_Marios_PD1_Inhib2_HP-S4152610-8.raw
SA089472	CA209025-27-906	CA209025-27-906_week 4	week 4	-	INTERMEDIATE	NIVOLUMAB	TRUE	17.150	Phase III_RCC_CA209025	US/CANADA	66	M	WHITE	1186_Marios_PD1_Inhib2_HP-AF009273-8.raw
SA089473	CA209025-44-785	CA209025-44-785_week 4	week 4	-	INTERMEDIATE	NIVOLUMAB	TRUE	26.316	Phase III_RCC_CA209025	US/CANADA	70	M	WHITE	0097_Marios_PD1_Inhib2_HP-AF016222-8.raw
SA089471	CA209025-97-569	CA209025-97-569_week 4	week 4	-	INTERMEDIATE	NIVOLUMAB	TRUE	29.766	Phase III_RCC_CA209025	REST OF WORLD	65	M	OTHER	0501_Marios_PD1_Inhib2_HP-S4008628-7.raw
SA089475	CA209025-98-673	CA209025-98-673_week 4	week 4	-	INTERMEDIATE	NIVOLUMAB	TRUE	11.499	Phase III_RCC_CA209025	REST OF WORLD	76	F	WHITE	0884_Marios_PD1_Inhib2_HP-S4008444-7.raw
SA089479	CA209025-22-1022	CA209025-22-1022_week 4	week 4	-	POOR	EVEROLIMUS	FALSE	7.918	Phase III_RCC_CA209025	US/CANADA	36	M	WHITE	0024_Marios_PD1_Inhib2_HP-AF009298-8.raw
SA089477	CA209025-42-1058	CA209025-42-1058_week 4	week 4	-	POOR	EVEROLIMUS	FALSE	2.990	Phase III_RCC_CA209025	US/CANADA	61	M	WHITE	0185_Marios_PD1_Inhib2_HP-AF008958-8.raw
SA089478	CA209025-43-917	CA209025-43-917_week 4	week 4	-	POOR	EVEROLIMUS	FALSE	2.727	Phase III_RCC_CA209025	US/CANADA	55	M	WHITE	0755_Marios_PD1_Inhib2_HP-AF132622-8.raw
SA089480	CA209025-17-964	CA209025-17-964_week 4	week 4	-	POOR	EVEROLIMUS	TRUE	35.351	Phase III_RCC_CA209025	US/CANADA	70	M	WHITE	0728_Marios_PD1_Inhib2_HP-AF064096-8.raw
SA089481	CA209025-20-1031	CA209025-20-1031_week 4	week 4	-	POOR	EVEROLIMUS	TRUE	2.201	Phase III_RCC_CA209025	US/CANADA	73	F	WHITE	0715_Marios_PD1_Inhib2_HP-AF252784-8.raw
SA089489	CA209025-143-515	CA209025-143-515_week 4	week 4	-	POOR	NIVOLUMAB	FALSE	9.068	Phase III_RCC_CA209025	US/CANADA	60	M	WHITE	0614_Marios_PD1_Inhib2_HP-AD645863-9.raw
SA089482	CA209025-144-596	CA209025-144-596_week 4	week 4	-	POOR	NIVOLUMAB	FALSE	22.867	Phase III_RCC_CA209025	US/CANADA	53	M	WHITE	0640_Marios_PD1_Inhib2_HP-AE506727-9.raw
SA089484	CA209025-17-981	CA209025-17-981_week 4	week 4	-	POOR	NIVOLUMAB	FALSE	27.926	Phase III_RCC_CA209025	US/CANADA	57	M	WHITE	0629_Marios_PD1_Inhib2_HP-AF015803-8.raw
SA089486	CA209025-21-1050	CA209025-21-1050_week 4	week 4	-	POOR	NIVOLUMAB	FALSE	25.988	Phase III_RCC_CA209025	US/CANADA	65	M	WHITE	0451_Marios_PD1_Inhib2_HP-AF146082-8.raw
SA089487	CA209025-25-987	CA209025-25-987_week 4	week 4	-	POOR	NIVOLUMAB	FALSE	10.218	Phase III_RCC_CA209025	US/CANADA	85	M	WHITE	0194_Marios_PD1_Inhib2_HP-AF009258-8.raw
SA089483	CA209025-30-695	CA209025-30-695_week 4	week 4	-	POOR	NIVOLUMAB	FALSE	9.528	Phase III_RCC_CA209025	US/CANADA	62	F	WHITE	0234_Marios_PD1_Inhib2_HP-AE622838-6.raw
SA089485	CA209025-85-992	CA209025-85-992_week 4	week 4	-	POOR	NIVOLUMAB	FALSE	13.339	Phase III_RCC_CA209025	REST OF WORLD	58	M	WHITE	1015_Marios_PD1_Inhib2_HP-L1497981-11.raw
SA089488	CA209025-95-681	CA209025-95-681_week 4	week 4	-	POOR	NIVOLUMAB	FALSE	4.862	Phase III_RCC_CA209025	REST OF WORLD	66	M	WHITE	0522_Marios_PD1_Inhib2_HP-S4025567-7.raw
SA089491	CA209025-139-1025	CA209025-139-1025_week 4	week 4	-	POOR	NIVOLUMAB	TRUE	6.209	Phase III_RCC_CA209025	US/CANADA	72	F	WHITE	0851_Marios_PD1_Inhib2_HP-AF438569-8.raw
SA089490	CA209025-25-930	CA209025-25-930_week 4	week 4	-	POOR	NIVOLUMAB	TRUE	7.655	Phase III_RCC_CA209025	US/CANADA	56	M	WHITE	0043_Marios_PD1_Inhib2_HP-AF009259-8.raw
SA089804	CA209025-101-142	CA209025-101-142_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	51.187	Phase III_RCC_CA209025	WESTERN EUROPE	73	M	WHITE	0635_Marios_PD1_Inhib2_HP-E9124069-3.raw
SA089798	CA209025-118-255	CA209025-118-255_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	49.380	Phase III_RCC_CA209025	WESTERN EUROPE	59	F	WHITE	0413_Marios_PD1_Inhib2_HP-EA044208-6.raw
SA089785	CA209025-13-181	CA209025-13-181_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	50.234	Phase III_RCC_CA209025	US/CANADA	61	M	WHITE	0467_Marios_PD1_Inhib2_HP-AD827415-6.raw
SA089775	CA209025-138-734	CA209025-138-734_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	44.682	Phase III_RCC_CA209025	US/CANADA	62	F	WHITE	1191_Marios_PD1_Inhib2_HP-AF004078-8.raw
SA089777	CA209025-139-1006	CA209025-139-1006_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	39.589	Phase III_RCC_CA209025	US/CANADA	46	M	WHITE	0922_Marios_PD1_Inhib2_HP-AF268551-8.raw
SA089769	CA209025-154-929	CA209025-154-929_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	42.481	Phase III_RCC_CA209025	REST OF WORLD	51	M	OTHER	1157_Marios_PD1_Inhib2_HP-S4107205-8.raw
SA089788	CA209025-156-1017	CA209025-156-1017_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	39.918	Phase III_RCC_CA209025	REST OF WORLD	59	M	OTHER	1051_Marios_PD1_Inhib2_HP-S4124108-8.raw
SA089767	CA209025-15-773	CA209025-15-773_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	44.090	Phase III_RCC_CA209025	US/CANADA	53	M	WHITE	0332_Marios_PD1_Inhib2_HP-AF015893-8.raw
SA089765	CA209025-15-99	CA209025-15-99_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	51.515	Phase III_RCC_CA209025	US/CANADA	51	M	WHITE	0735_Marios_PD1_Inhib2_HP-AD267750-5.raw
SA089799	CA209025-161-577	CA209025-161-577_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	45.339	Phase III_RCC_CA209025	REST OF WORLD	46	M	OTHER	0288_Marios_PD1_Inhib2_HP-S3977260-6.raw
SA089792	CA209025-161-974	CA209025-161-974_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	40.936	Phase III_RCC_CA209025	REST OF WORLD	69	F	OTHER	0519_Marios_PD1_Inhib2_HP-S4144273-8.raw
SA089791	CA209025-162-171	CA209025-162-171_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	50.037	Phase III_RCC_CA209025	REST OF WORLD	70	F	OTHER	1175_Marios_PD1_Inhib2_HP-S3667134-6.raw
SA089796	CA209025-169-660	CA209025-169-660_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	44.419	Phase III_RCC_CA209025	REST OF WORLD	63	M	OTHER	0843_Marios_PD1_Inhib2_HP-S3606424-7.raw
SA089794	CA209025-170-221	CA209025-170-221_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	50.201	Phase III_RCC_CA209025	REST OF WORLD	45	M	OTHER	0778_Marios_PD1_Inhib2_HP-S3474759-6.raw
SA089795	CA209025-17-1044	CA209025-17-1044_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	39.524	Phase III_RCC_CA209025	US/CANADA	53	M	WHITE	0379_Marios_PD1_Inhib2_HP-AF565735-8.raw
SA089800	CA209025-173-757	CA209025-173-757_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	22.111	Phase III_RCC_CA209025	REST OF WORLD	51	M	OTHER	0498_Marios_PD1_Inhib2_HP-S4107189-8.raw
SA089790	CA209025-174-1010	CA209025-174-1010_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	40.049	Phase III_RCC_CA209025	REST OF WORLD	70	M	OTHER	0984_Marios_PD1_Inhib2_HP-S4107176-8.raw
SA089797	CA209025-17-928	CA209025-17-928_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	42.283	Phase III_RCC_CA209025	US/CANADA	77	M	WHITE	1058_Marios_PD1_Inhib2_HP-AF015807-8.raw
SA089801	CA209025-18-954	CA209025-18-954_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	41.922	Phase III_RCC_CA209025	US/CANADA	43	M	OTHER	0680_Marios_PD1_Inhib2_HP-AF008936-8.raw
SA089802	CA209025-2-10	CA209025-2-10_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	53.848	Phase III_RCC_CA209025	WESTERN EUROPE	71	F	WHITE	0254_Marios_PD1_Inhib2_HP-E9101725-5.raw
SA089772	CA209025-21-1027	CA209025-21-1027_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	34.267	Phase III_RCC_CA209025	US/CANADA	69	F	WHITE	0933_Marios_PD1_Inhib2_HP-AF002710-8.raw
SA089773	CA209025-21-1039	CA209025-21-1039_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	31.803	Phase III_RCC_CA209025	US/CANADA	59	F	WHITE	0893_Marios_PD1_Inhib2_HP-AF412017-8.raw
SA089764	CA209025-21-849	CA209025-21-849_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	40.312	Phase III_RCC_CA209025	US/CANADA	52	F	WHITE	0785_Marios_PD1_Inhib2_HP-AF002709-8.raw
SA089787	CA209025-22-1000	CA209025-22-1000_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	40.969	Phase III_RCC_CA209025	US/CANADA	64	F	WHITE	0441_Marios_PD1_Inhib2_HP-AF009301-8.raw
SA089782	CA209025-23-8	CA209025-23-8_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	12.485	Phase III_RCC_CA209025	US/CANADA	46	M	WHITE	1003_Marios_PD1_Inhib2_HP-AD195657-6.raw
SA089786	CA209025-24-840	CA209025-24-840_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	42.842	Phase III_RCC_CA209025	US/CANADA	23	F	WHITE	0540_Marios_PD1_Inhib2_HP-AF009320-8.raw
SA089778	CA209025-29-1002	CA209025-29-1002_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	40.674	Phase III_RCC_CA209025	US/CANADA	60	M	WHITE	0484_Marios_PD1_Inhib2_HP-AF360077-8.raw
SA089774	CA209025-39-147	CA209025-39-147_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	50.201	Phase III_RCC_CA209025	WESTERN EUROPE	56	M	WHITE	1017_Marios_PD1_Inhib2_HP-E9210503-6.raw
SA089768	CA209025-41-979	CA209025-41-979_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	41.035	Phase III_RCC_CA209025	US/CANADA	57	M	OTHER	0584_Marios_PD1_Inhib2_HP-AF008949-8.raw
SA089771	CA209025-43-743	CA209025-43-743_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	22.965	Phase III_RCC_CA209025	US/CANADA	44	M	WHITE	1077_Marios_PD1_Inhib2_HP-AF003959-8.raw
SA089770	CA209025-43-941	CA209025-43-941_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	22.012	Phase III_RCC_CA209025	US/CANADA	67	M	WHITE	0601_Marios_PD1_Inhib2_HP-AF132628-8.raw
SA089803	CA209025-44-643	CA209025-44-643_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	45.043	Phase III_RCC_CA209025	US/CANADA	56	M	WHITE	0722_Marios_PD1_Inhib2_HP-AF016226-8.raw
SA089783	CA209025-65-329	CA209025-65-329_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	48.066	Phase III_RCC_CA209025	WESTERN EUROPE	83	F	WHITE	0069_Marios_PD1_Inhib2_HP-E9778373-6.raw
SA089805	CA209025-6-586	CA209025-6-586_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	45.273	Phase III_RCC_CA209025	WESTERN EUROPE	63	M	WHITE	0746_Marios_PD1_Inhib2_HP-E9125363-6.raw
SA089793	CA209025-72-394	CA209025-72-394_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	47.934	Phase III_RCC_CA209025	WESTERN EUROPE	62	M	WHITE	0625_Marios_PD1_Inhib2_HP-E9145492-6.raw
SA089806	CA209025-73-511	CA209025-73-511_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	46.324	Phase III_RCC_CA209025	WESTERN EUROPE	55	M	OTHER	1114_Marios_PD1_Inhib2_HP-E9106381-6.raw
SA089807	CA209025-75-112	CA209025-75-112_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	51.220	Phase III_RCC_CA209025	WESTERN EUROPE	65	M	WHITE	0669_Marios_PD1_Inhib2_HP-E9479246-6.raw
SA089789	CA209025-82-338	CA209025-82-338_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	47.901	Phase III_RCC_CA209025	WESTERN EUROPE	68	M	WHITE	0585_Marios_PD1_Inhib2_HP-E9190486-6.raw
SA089766	CA209025-89-174	CA209025-89-174_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	50.398	Phase III_RCC_CA209025	WESTERN EUROPE	48	M	WHITE	0116_Marios_PD1_Inhib2_HP-E9656500-6.raw
SA089784	CA209025-89-725	CA209025-89-725_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	43.926	Phase III_RCC_CA209025	WESTERN EUROPE	45	M	WHITE	0343_Marios_PD1_Inhib2_HP-EA563624-6.raw
SA089776	CA209025-90-105	CA209025-90-105_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	50.727	Phase III_RCC_CA209025	WESTERN EUROPE	63	F	WHITE	0647_Marios_PD1_Inhib2_HP-E9103106-6.raw
SA089781	CA209025-9-756	CA209025-9-756_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	43.302	Phase III_RCC_CA209025	US/CANADA	63	M	WHITE	0514_Marios_PD1_Inhib2_HP-AF032147-8.raw
SA089779	CA209025-97-765	CA209025-97-765_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	44.058	Phase III_RCC_CA209025	REST OF WORLD	74	F	WHITE	0262_Marios_PD1_Inhib2_HP-S4110448-8.raw
SA089780	CA209025-9-892	CA209025-9-892_week 8	week 8	1	FAVORABLE	NIVOLUMAB	FALSE	43.072	Phase III_RCC_CA209025	US/CANADA	67	M	WHITE	1200_Marios_PD1_Inhib2_HP-AF002793-8.raw
SA089819	CA209025-111-299	CA209025-111-299_week 8	week 8	1	FAVORABLE	NIVOLUMAB	TRUE	47.639	Phase III_RCC_CA209025	REST OF WORLD	64	M	WHITE	0995_Marios_PD1_Inhib2_HP-E9720055-8.raw
SA089808	CA209025-114-813	CA209025-114-813_week 8	week 8	1	FAVORABLE	NIVOLUMAB	TRUE	43.926	Phase III_RCC_CA209025	WESTERN EUROPE	67	M	WHITE	0347_Marios_PD1_Inhib2_HP-E9124391-5.raw
SA089813	CA209025-139-1036	CA209025-139-1036_week 8	week 8	1	FAVORABLE	NIVOLUMAB	TRUE	38.571	Phase III_RCC_CA209025	US/CANADA	72	M	WHITE	0768_Marios_PD1_Inhib2_HP-AF268546-8.raw
SA089809	CA209025-139-610	CA209025-139-610_week 8	week 8	1	FAVORABLE	NIVOLUMAB	TRUE	44.649	Phase III_RCC_CA209025	US/CANADA	58	F	WHITE	0976_Marios_PD1_Inhib2_HP-AD783027-6.raw
SA089817	CA209025-161-518	CA209025-161-518_week 8	week 8	1	FAVORABLE	NIVOLUMAB	TRUE	45.667	Phase III_RCC_CA209025	REST OF WORLD	69	F	OTHER	0283_Marios_PD1_Inhib2_HP-S3474403-6.raw
SA089810	CA209025-17-154	CA209025-17-154_week 8	week 8	1	FAVORABLE	NIVOLUMAB	TRUE	51.055	Phase III_RCC_CA209025	US/CANADA	40	M	WHITE	0733_Marios_PD1_Inhib2_HP-AE104730-6.raw
SA089814	CA209025-17-94	CA209025-17-94_week 8	week 8	1	FAVORABLE	NIVOLUMAB	TRUE	51.220	Phase III_RCC_CA209025	US/CANADA	75	F	WHITE	0486_Marios_PD1_Inhib2_HP-AD577697-6.raw
SA089818	CA209025-2-401	CA209025-2-401_week 8	week 8	1	FAVORABLE	NIVOLUMAB	TRUE	46.719	Phase III_RCC_CA209025	WESTERN EUROPE	29	M	WHITE	0795_Marios_PD1_Inhib2_HP-E9130957-6.raw
SA089815	CA209025-33-466	CA209025-33-466_week 8	week 8	1	FAVORABLE	NIVOLUMAB	TRUE	47.146	Phase III_RCC_CA209025	WESTERN EUROPE	57	M	WHITE	0525_Marios_PD1_Inhib2_HP-E9811948-6.raw
SA089816	CA209025-93-836	CA209025-93-836_week 8	week 8	1	FAVORABLE	NIVOLUMAB	TRUE	42.743	Phase III_RCC_CA209025	WESTERN EUROPE	52	M	WHITE	0772_Marios_PD1_Inhib2_HP-EA716175-8.raw
SA089811	CA209025-95-167	CA209025-95-167_week 8	week 8	1	FAVORABLE	NIVOLUMAB	TRUE	49.807	Phase III_RCC_CA209025	REST OF WORLD	53	M	WHITE	0871_Marios_PD1_Inhib2_HP-S3713049-6.raw
SA089812	CA209025-97-264	CA209025-97-264_week 8	week 8	1	FAVORABLE	NIVOLUMAB	TRUE	48.197	Phase III_RCC_CA209025	REST OF WORLD	56	M	WHITE	0205_Marios_PD1_Inhib2_HP-S3447041-6.raw
SA089824	CA209025-108-362	CA209025-108-362_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	48.427	Phase III_RCC_CA209025	REST OF WORLD	70	F	WHITE	0505_Marios_PD1_Inhib2_HP-EA175154-6.raw
SA089823	CA209025-111-778	CA209025-111-778_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	43.992	Phase III_RCC_CA209025	REST OF WORLD	66	M	WHITE	0220_Marios_PD1_Inhib2_HP-EA717427-8.raw
SA089822	CA209025-11-687	CA209025-11-687_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	45.602	Phase III_RCC_CA209025	US/CANADA	43	M	WHITE	0011_Marios_PD1_Inhib2_HP-AE330691-6.raw
SA089826	CA209025-125-855	CA209025-125-855_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	43.762	Phase III_RCC_CA209025	REST OF WORLD	54	M	WHITE	0994_Marios_PD1_Inhib2_HP-L1443357-23.raw
SA089827	CA209025-12-64	CA209025-12-64_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	51.745	Phase III_RCC_CA209025	WESTERN EUROPE	67	M	WHITE	0581_Marios_PD1_Inhib2_HP-E9124688-6.raw
SA089828	CA209025-137-503	CA209025-137-503_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	46.949	Phase III_RCC_CA209025	WESTERN EUROPE	59	F	WHITE	1063_Marios_PD1_Inhib2_HP-E9106244-6.raw
SA089820	CA209025-138-700	CA209025-138-700_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	3.844	Phase III_RCC_CA209025	US/CANADA	72	M	WHITE	0823_Marios_PD1_Inhib2_HP-AE726358-6.raw
SA089835	CA209025-139-1049	CA209025-139-1049_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	38.637	Phase III_RCC_CA209025	US/CANADA	50	M	WHITE	0081_Marios_PD1_Inhib2_HP-AF268550-8.raw
SA089853	CA209025-139-152	CA209025-139-152_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	50.234	Phase III_RCC_CA209025	US/CANADA	48	M	WHITE	1066_Marios_PD1_Inhib2_HP-AD783024-6.raw
SA089855	CA209025-139-554	CA209025-139-554_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	46.062	Phase III_RCC_CA209025	US/CANADA	64	M	WHITE	0040_Marios_PD1_Inhib2_HP-AE490136-6.raw
SA089854	CA209025-139-776	CA209025-139-776_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	43.138	Phase III_RCC_CA209025	US/CANADA	73	M	WHITE	0411_Marios_PD1_Inhib2_HP-AF003939-8.raw
SA089858	CA209025-143-679	CA209025-143-679_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	44.452	Phase III_RCC_CA209025	US/CANADA	64	M	WHITE	1146_Marios_PD1_Inhib2_HP-AF015782-8.raw
SA089856	CA209025-144-372	CA209025-144-372_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	47.770	Phase III_RCC_CA209025	US/CANADA	62	M	WHITE	0204_Marios_PD1_Inhib2_HP-AD829014-6.raw
SA089852	CA209025-153-718	CA209025-153-718_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	44.682	Phase III_RCC_CA209025	US/CANADA	66	M	WHITE	0004_Marios_PD1_Inhib2_HP-AF015773-8.raw
SA089851	CA209025-155-1020	CA209025-155-1020_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	39.951	Phase III_RCC_CA209025	REST OF WORLD	46	M	OTHER	0181_Marios_PD1_Inhib2_HP-S4103687-8.raw
SA089860	CA209025-157-237	CA209025-157-237_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	4.403	Phase III_RCC_CA209025	REST OF WORLD	79	F	OTHER	1124_Marios_PD1_Inhib2_HP-S3510232-6.raw
SA089859	CA209025-157-436	CA209025-157-436_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	46.324	Phase III_RCC_CA209025	REST OF WORLD	63	M	OTHER	0534_Marios_PD1_Inhib2_HP-S3797351-6.raw
SA089857	CA209025-159-777	CA209025-159-777_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	43.598	Phase III_RCC_CA209025	REST OF WORLD	73	M	OTHER	1097_Marios_PD1_Inhib2_HP-S4107216-8.raw
SA089849	CA209025-163-1012	CA209025-163-1012_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	40.411	Phase III_RCC_CA209025	REST OF WORLD	65	M	OTHER	0972_Marios_PD1_Inhib2_HP-S4211196-8.raw
SA089836	CA209025-163-425	CA209025-163-425_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	47.606	Phase III_RCC_CA209025	REST OF WORLD	63	M	OTHER	0263_Marios_PD1_Inhib2_HP-S3472425-6.raw
SA089837	CA209025-167-1011	CA209025-167-1011_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	39.819	Phase III_RCC_CA209025	REST OF WORLD	69	F	OTHER	0598_Marios_PD1_Inhib2_HP-S4251325-7.raw
SA089838	CA209025-174-203	CA209025-174-203_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	49.840	Phase III_RCC_CA209025	REST OF WORLD	74	M	OTHER	1132_Marios_PD1_Inhib2_HP-S3733291-6.raw
SA089825	CA209025-1-82	CA209025-1-82_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	51.581	Phase III_RCC_CA209025	US/CANADA	64	M	WHITE	0841_Marios_PD1_Inhib2_HP-AD709268-6.raw
SA089821	CA209025-1-961	CA209025-1-961_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	41.725	Phase III_RCC_CA209025	US/CANADA	69	M	WHITE	0272_Marios_PD1_Inhib2_HP-AF365620-8.raw
SA089850	CA209025-20-116	CA209025-20-116_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	50.858	Phase III_RCC_CA209025	US/CANADA	88	F	WHITE	0323_Marios_PD1_Inhib2_HP-AE062808-6.raw
SA089834	CA209025-23-953	CA209025-23-953_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	41.363	Phase III_RCC_CA209025	US/CANADA	63	M	WHITE	1121_Marios_PD1_Inhib2_HP-AF002760-7.raw
SA089830	CA209025-26-491	CA209025-26-491_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	46.423	Phase III_RCC_CA209025	US/CANADA	52	M	WHITE	0173_Marios_PD1_Inhib2_HP-AE588070-6.raw
SA089831	CA209025-29-988	CA209025-29-988_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	40.772	Phase III_RCC_CA209025	US/CANADA	70	M	WHITE	0006_Marios_PD1_Inhib2_HP-AF008975-8.raw
SA089832	CA209025-55-172	CA209025-55-172_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	50.858	Phase III_RCC_CA209025	WESTERN EUROPE	73	M	WHITE	0739_Marios_PD1_Inhib2_HP-E9106097-6.raw
SA089833	CA209025-56-791	CA209025-56-791_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	43.696	Phase III_RCC_CA209025	WESTERN EUROPE	37	M	WHITE	0406_Marios_PD1_Inhib2_HP-E9106999-6.raw
SA089839	CA209025-66-488	CA209025-66-488_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	46.883	Phase III_RCC_CA209025	WESTERN EUROPE	44	M	WHITE	0325_Marios_PD1_Inhib2_HP-E9241889-6.raw
SA089840	CA209025-70-405	CA209025-70-405_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	47.869	Phase III_RCC_CA209025	REST OF WORLD	66	M	WHITE	0352_Marios_PD1_Inhib2_HP-EA088460-6.raw
SA089846	CA209025-71-635	CA209025-71-635_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	45.667	Phase III_RCC_CA209025	REST OF WORLD	64	M	WHITE	0404_Marios_PD1_Inhib2_HP-E9337930-6.raw
SA089847	CA209025-76-507	CA209025-76-507_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	46.456	Phase III_RCC_CA209025	US/CANADA	64	M	WHITE	0260_Marios_PD1_Inhib2_HP-AE442058-6.raw
SA089848	CA209025-79-465	CA209025-79-465_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	46.456	Phase III_RCC_CA209025	REST OF WORLD	70	M	WHITE	1108_Marios_PD1_Inhib2_HP-L1381844-5.raw
SA089845	CA209025-79-982	CA209025-79-982_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	17.840	Phase III_RCC_CA209025	REST OF WORLD	67	M	WHITE	0696_Marios_PD1_Inhib2_HP-L1443415-8.raw
SA089844	CA209025-82-208	CA209025-82-208_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	50.103	Phase III_RCC_CA209025	WESTERN EUROPE	59	F	WHITE	1193_Marios_PD1_Inhib2_HP-E9190488-6.raw
SA089841	CA209025-84-1041	CA209025-84-1041_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	39.031	Phase III_RCC_CA209025	REST OF WORLD	57	M	WHITE	0489_Marios_PD1_Inhib2_HP-L1448925-10.raw
SA089842	CA209025-84-535	CA209025-84-535_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	5.520	Phase III_RCC_CA209025	REST OF WORLD	50	M	WHITE	0167_Marios_PD1_Inhib2_HP-L1381827-7.raw
SA089829	CA209025-85-986	CA209025-85-986_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	41.035	Phase III_RCC_CA209025	REST OF WORLD	71	M	WHITE	0826_Marios_PD1_Inhib2_HP-L1497987-11.raw
SA089843	CA209025-9-589	CA209025-9-589_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	FALSE	45.536	Phase III_RCC_CA209025	US/CANADA	56	M	WHITE	0564_Marios_PD1_Inhib2_HP-AE556402-6.raw
SA089869	CA209025-126-31	CA209025-126-31_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	TRUE	53.947	Phase III_RCC_CA209025	WESTERN EUROPE	46	F	WHITE	1081_Marios_PD1_Inhib2_HP-E9124110-6.raw
SA089867	CA209025-139-143	CA209025-139-143_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	TRUE	50.366	Phase III_RCC_CA209025	US/CANADA	53	M	WHITE	1027_Marios_PD1_Inhib2_HP-AD783025-6.raw
SA089862	CA209025-14-1057	CA209025-14-1057_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	TRUE	39.129	Phase III_RCC_CA209025	US/CANADA	66	M	WHITE	0303_Marios_PD1_Inhib2_HP-AF015792-8.raw
SA089868	CA209025-142-593	CA209025-142-593_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	TRUE	46.029	Phase III_RCC_CA209025	US/CANADA	69	M	WHITE	0753_Marios_PD1_Inhib2_HP-AE691891-6.raw
SA089865	CA209025-156-606	CA209025-156-606_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	TRUE	45.207	Phase III_RCC_CA209025	REST OF WORLD	73	M	OTHER	0030_Marios_PD1_Inhib2_HP-S4035150-7.raw
SA089866	CA209025-20-1059	CA209025-20-1059_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	TRUE	38.899	Phase III_RCC_CA209025	US/CANADA	64	M	WHITE	0908_Marios_PD1_Inhib2_HP-AF273575-8.raw
SA089864	CA209025-29-1045	CA209025-29-1045_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	TRUE	38.735	Phase III_RCC_CA209025	US/CANADA	65	M	WHITE	0475_Marios_PD1_Inhib2_HP-AF616669-8.raw
SA089861	CA209025-44-944	CA209025-44-944_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	TRUE	41.265	Phase III_RCC_CA209025	US/CANADA	54	F	WHITE	0127_Marios_PD1_Inhib2_HP-AF261222-8.raw
SA089863	CA209025-49-66	CA209025-49-66_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	TRUE	52.074	Phase III_RCC_CA209025	US/CANADA	62	M	WHITE	1179_Marios_PD1_Inhib2_HP-AD577644-10.raw
SA089870	CA209025-84-384	CA209025-84-384_week 8	week 8	1	INTERMEDIATE	NIVOLUMAB	TRUE	47.244	Phase III_RCC_CA209025	REST OF WORLD	64	F	WHITE	0588_Marios_PD1_Inhib2_HP-L1357316-6.raw
SA089881	CA209025-12-428	CA209025-12-428_week 8	week 8	1	POOR	NIVOLUMAB	FALSE	46.982	Phase III_RCC_CA209025	WESTERN EUROPE	78	M	WHITE	0177_Marios_PD1_Inhib2_HP-EA246338-6.raw
SA089880	CA209025-131-640	CA209025-131-640_week 8	week 8	1	POOR	NIVOLUMAB	FALSE	3.680	Phase III_RCC_CA209025	REST OF WORLD	48	M	WHITE	0762_Marios_PD1_Inhib2_HP-E9786657-6.raw
SA089873	CA209025-139-324	CA209025-139-324_week 8	week 8	1	POOR	NIVOLUMAB	FALSE	11.006	Phase III_RCC_CA209025	US/CANADA	60	M	WHITE	0828_Marios_PD1_Inhib2_HP-AE490133-6.raw
SA089871	CA209025-141-666	CA209025-141-666_week 8	week 8	1	POOR	NIVOLUMAB	FALSE	43.959	Phase III_RCC_CA209025	US/CANADA	56	M	WHITE	0834_Marios_PD1_Inhib2_HP-AF003916-8.raw
SA089877	CA209025-165-758	CA209025-165-758_week 8	week 8	1	POOR	NIVOLUMAB	FALSE	44.616	Phase III_RCC_CA209025	REST OF WORLD	70	M	OTHER	0269_Marios_PD1_Inhib2_HP-S4107197-8.raw
SA089876	CA209025-25-396	CA209025-25-396_week 8	week 8	1	POOR	NIVOLUMAB	FALSE	47.376	Phase III_RCC_CA209025	US/CANADA	51	M	WHITE	0138_Marios_PD1_Inhib2_HP-AE435301-6.raw
SA089875	CA209025-28-951	CA209025-28-951_week 8	week 8	1	POOR	NIVOLUMAB	FALSE	41.429	Phase III_RCC_CA209025	US/CANADA	60	M	WHITE	0165_Marios_PD1_Inhib2_HP-AF015543-8.raw
SA089878	CA209025-29-921	CA209025-29-921_week 8	week 8	1	POOR	NIVOLUMAB	FALSE	42.053	Phase III_RCC_CA209025	US/CANADA	59	M	WHITE	0048_Marios_PD1_Inhib2_HP-AF008974-13.raw
SA089879	CA209025-39-467	CA209025-39-467_week 8	week 8	1	POOR	NIVOLUMAB	FALSE	46.982	Phase III_RCC_CA209025	WESTERN EUROPE	53	M	WHITE	0016_Marios_PD1_Inhib2_HP-EA217029-6.raw
SA089882	CA209025-4-26	CA209025-4-26_week 8	week 8	1	POOR	NIVOLUMAB	FALSE	53.980	Phase III_RCC_CA209025	WESTERN EUROPE	62	M	WHITE	0546_Marios_PD1_Inhib2_HP-E9099289-6.raw
SA089874	CA209025-4-468	CA209025-4-468_week 8	week 8	1	POOR	NIVOLUMAB	FALSE	47.310	Phase III_RCC_CA209025	WESTERN EUROPE	70	M	WHITE	1181_Marios_PD1_Inhib2_HP-E9099290-6.raw
SA089872	CA209025-9-1055	CA209025-9-1055_week 8	week 8	1	POOR	NIVOLUMAB	FALSE	39.097	Phase III_RCC_CA209025	US/CANADA	57	M	OTHER	1071_Marios_PD1_Inhib2_HP-AF032149-8.raw
SA089884	CA209025-13-360	CA209025-13-360_week 8	week 8	1	POOR	NIVOLUMAB	TRUE	47.212	Phase III_RCC_CA209025	US/CANADA	75	M	WHITE	1083_Marios_PD1_Inhib2_HP-AD827416-6.raw
SA089883	CA209025-9-870	CA209025-9-870_week 8	week 8	1	POOR	NIVOLUMAB	TRUE	43.039	Phase III_RCC_CA209025	US/CANADA	73	M	WHITE	0718_Marios_PD1_Inhib2_HP-AF002792-8.raw
SA089594	CA209025-1-1004	CA209025-1-1004_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	32.657	Phase III_RCC_CA209025	US/CANADA	58	M	WHITE	0416_Marios_PD1_Inhib2_HP-AF002690-12.raw
SA089591	CA209025-1-1030	CA209025-1-1030_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	23.951	Phase III_RCC_CA209025	US/CANADA	61	M	WHITE	0399_Marios_PD1_Inhib2_HP-AF581653-8.raw
SA089599	CA209025-111-811	CA209025-111-811_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	11.302	Phase III_RCC_CA209025	REST OF WORLD	34	F	WHITE	1040_Marios_PD1_Inhib2_HP-EA717425-8.raw
SA089561	CA209025-11-240	CA209025-11-240_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	38.768	Phase III_RCC_CA209025	US/CANADA	51	M	WHITE	0436_Marios_PD1_Inhib2_HP-AD604118-7.raw
SA089588	CA209025-113-669	CA209025-113-669_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	6.604	Phase III_RCC_CA209025	WESTERN EUROPE	63	M	WHITE	0990_Marios_PD1_Inhib2_HP-E9123616-6.raw
SA089577	CA209025-118-207	CA209025-118-207_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	19.778	Phase III_RCC_CA209025	WESTERN EUROPE	64	M	WHITE	1111_Marios_PD1_Inhib2_HP-E9314447-6.raw
SA089595	CA209025-11-910	CA209025-11-910_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	8.674	Phase III_RCC_CA209025	US/CANADA	63	M	WHITE	0472_Marios_PD1_Inhib2_HP-AF015821-8.raw
SA089567	CA209025-1-205	CA209025-1-205_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	29.865	Phase III_RCC_CA209025	US/CANADA	45	M	WHITE	0188_Marios_PD1_Inhib2_HP-AD185807-6.raw
SA089572	CA209025-121-272	CA209025-121-272_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	31.836	Phase III_RCC_CA209025	REST OF WORLD	61	M	WHITE	1044_Marios_PD1_Inhib2_HP-L1370589-6.raw
SA089597	CA209025-135-450	CA209025-135-450_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	17.971	Phase III_RCC_CA209025	REST OF WORLD	66	M	WHITE	0299_Marios_PD1_Inhib2_HP-L1379655-6.raw
SA089592	CA209025-138-1034	CA209025-138-1034_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	10.152	Phase III_RCC_CA209025	US/CANADA	52	M	WHITE	0156_Marios_PD1_Inhib2_HP-AF004077-8.raw
SA089601	CA209025-139-1015	CA209025-139-1015_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	14.916	Phase III_RCC_CA209025	US/CANADA	32	F	OTHER	0876_Marios_PD1_Inhib2_HP-AF438575-8.raw
SA089593	CA209025-139-665	CA209025-139-665_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	22.505	Phase III_RCC_CA209025	US/CANADA	63	M	WHITE	0838_Marios_PD1_Inhib2_HP-AF048328-8.raw
SA089569	CA209025-1-417	CA209025-1-417_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	20.271	Phase III_RCC_CA209025	US/CANADA	66	F	WHITE	0889_Marios_PD1_Inhib2_HP-AE471842-6.raw
SA089570	CA209025-159-114	CA209025-159-114_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	39.228	Phase III_RCC_CA209025	REST OF WORLD	66	F	OTHER	0150_Marios_PD1_Inhib2_HP-S3681816-6.raw
SA089589	CA209025-159-750	CA209025-159-750_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	27.433	Phase III_RCC_CA209025	REST OF WORLD	64	M	OTHER	1170_Marios_PD1_Inhib2_HP-S4107215-8.raw
SA089585	CA209025-159-91	CA209025-159-91_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	33.249	Phase III_RCC_CA209025	REST OF WORLD	70	F	OTHER	0818_Marios_PD1_Inhib2_HP-S3472031-6.raw
SA089586	CA209025-159-945	CA209025-159-945_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	26.842	Phase III_RCC_CA209025	REST OF WORLD	57	M	OTHER	0551_Marios_PD1_Inhib2_HP-S4107217-8.raw
SA089582	CA209025-166-161	CA209025-166-161_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	15.047	Phase III_RCC_CA209025	REST OF WORLD	64	M	OTHER	0162_Marios_PD1_Inhib2_HP-S3508698-6.raw
SA089584	CA209025-21-442	CA209025-21-442_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	19.877	Phase III_RCC_CA209025	US/CANADA	50	F	WHITE	0057_Marios_PD1_Inhib2_HP-AE206928-6.raw
SA089564	CA209025-21-967	CA209025-21-967_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	18.530	Phase III_RCC_CA209025	US/CANADA	74	F	WHITE	0666_Marios_PD1_Inhib2_HP-AF002708-8.raw
SA089575	CA209025-2-24	CA209025-2-24_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	12.452	Phase III_RCC_CA209025	WESTERN EUROPE	52	F	WHITE	0536_Marios_PD1_Inhib2_HP-E9101728-6.raw
SA089573	CA209025-23-124	CA209025-23-124_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	29.470	Phase III_RCC_CA209025	US/CANADA	64	F	WHITE	0725_Marios_PD1_Inhib2_HP-AE070746-6.raw
SA089571	CA209025-23-684	CA209025-23-684_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	13.963	Phase III_RCC_CA209025	US/CANADA	60	F	WHITE	0737_Marios_PD1_Inhib2_HP-AE822134-6.raw
SA089581	CA209025-2-38	CA209025-2-38_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	20.895	Phase III_RCC_CA209025	WESTERN EUROPE	71	F	WHITE	0292_Marios_PD1_Inhib2_HP-E9130958-5.raw
SA089587	CA209025-2-477	CA209025-2-477_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	30.062	Phase III_RCC_CA209025	WESTERN EUROPE	70	M	WHITE	0307_Marios_PD1_Inhib2_HP-E9130956-5.raw
SA089590	CA209025-24-887	CA209025-24-887_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	27.696	Phase III_RCC_CA209025	US/CANADA	44	M	WHITE	0387_Marios_PD1_Inhib2_HP-AF009319-8.raw
SA089596	CA209025-29-621	CA209025-29-621_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	18.234	Phase III_RCC_CA209025	US/CANADA	65	M	WHITE	0171_Marios_PD1_Inhib2_HP-AE613362-6.raw
SA089563	CA209025-4-759	CA209025-4-759_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	6.472	Phase III_RCC_CA209025	WESTERN EUROPE	51	M	WHITE	1141_Marios_PD1_Inhib2_HP-EA677539-8.raw
SA089576	CA209025-48-285	CA209025-48-285_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	15.836	Phase III_RCC_CA209025	WESTERN EUROPE	52	M	WHITE	0627_Marios_PD1_Inhib2_HP-EA344249-6.raw
SA089580	CA209025-50-902	CA209025-50-902_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	35.581	Phase III_RCC_CA209025	WESTERN EUROPE	49	M	WHITE	0279_Marios_PD1_Inhib2_HP-EA722886-8.raw
SA089579	CA209025-65-301	CA209025-65-301_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	30.784	Phase III_RCC_CA209025	WESTERN EUROPE	72	M	WHITE	0033_Marios_PD1_Inhib2_HP-EA002609-6.raw
SA089578	CA209025-66-544	CA209025-66-544_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	23.162	Phase III_RCC_CA209025	WESTERN EUROPE	63	M	WHITE	0528_Marios_PD1_Inhib2_HP-E9241890-6.raw
SA089574	CA209025-75-615	CA209025-75-615_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	31.047	Phase III_RCC_CA209025	WESTERN EUROPE	69	F	WHITE	0078_Marios_PD1_Inhib2_HP-EA040892-6.raw
SA089583	CA209025-79-373	CA209025-79-373_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	38.209	Phase III_RCC_CA209025	REST OF WORLD	62	M	WHITE	0290_Marios_PD1_Inhib2_HP-L1381843-5.raw
SA089565	CA209025-80-728	CA209025-80-728_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	25.988	Phase III_RCC_CA209025	WESTERN EUROPE	59	F	WHITE	0880_Marios_PD1_Inhib2_HP-EA083054-6.raw
SA089566	CA209025-82-378	CA209025-82-378_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	16.789	Phase III_RCC_CA209025	WESTERN EUROPE	47	F	WHITE	0312_Marios_PD1_Inhib2_HP-E9703918-6.raw
SA089568	CA209025-84-704	CA209025-84-704_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	19.055	Phase III_RCC_CA209025	REST OF WORLD	72	M	WHITE	0789_Marios_PD1_Inhib2_HP-L1443435-8.raw
SA089562	CA209025-8-69	CA209025-8-69_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	24.148	Phase III_RCC_CA209025	WESTERN EUROPE	71	M	WHITE	1013_Marios_PD1_Inhib2_HP-E9125205-6.raw
SA089602	CA209025-87-234	CA209025-87-234_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	43.039	Phase III_RCC_CA209025	WESTERN EUROPE	37	M	WHITE	0215_Marios_PD1_Inhib2_HP-E9774340-6.raw
SA089600	CA209025-87-267	CA209025-87-267_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	14.883	Phase III_RCC_CA209025	WESTERN EUROPE	68	F	WHITE	1148_Marios_PD1_Inhib2_HP-E9774341-19.raw
SA089598	CA209025-96-498	CA209025-96-498_week 8	week 8	-	FAVORABLE	NIVOLUMAB	FALSE	32.164	Phase III_RCC_CA209025	REST OF WORLD	54	M	WHITE	0780_Marios_PD1_Inhib2_HP-S3447224-6.raw
SA089611	CA209025-139-784	CA209025-139-784_week 8	week 8	-	FAVORABLE	NIVOLUMAB	TRUE	43.499	Phase III_RCC_CA209025	US/CANADA	52	M	WHITE	0621_Marios_PD1_Inhib2_HP-AF003938-8.raw
SA089606	CA209025-139-978	CA209025-139-978_week 8	week 8	-	FAVORABLE	NIVOLUMAB	TRUE	31.343	Phase III_RCC_CA209025	US/CANADA	56	M	OTHER	0153_Marios_PD1_Inhib2_HP-AF048329-8.raw
SA089615	CA209025-147-367	CA209025-147-367_week 8	week 8	-	FAVORABLE	NIVOLUMAB	TRUE	36.205	Phase III_RCC_CA209025	US/CANADA	67	M	WHITE	0086_Marios_PD1_Inhib2_HP-AD673742-6.raw
SA089617	CA209025-1-618	CA209025-1-618_week 8	week 8	-	FAVORABLE	NIVOLUMAB	TRUE	15.376	Phase III_RCC_CA209025	US/CANADA	53	F	WHITE	0455_Marios_PD1_Inhib2_HP-AE471844-6.raw
SA089612	CA209025-17-1066	CA209025-17-1066_week 8	week 8	-	FAVORABLE	NIVOLUMAB	TRUE	25.626	Phase III_RCC_CA209025	US/CANADA	60	F	WHITE	0758_Marios_PD1_Inhib2_HP-AF692201-8.raw
SA089607	CA209025-17-328	CA209025-17-328_week 8	week 8	-	FAVORABLE	NIVOLUMAB	TRUE	27.828	Phase III_RCC_CA209025	US/CANADA	63	F	WHITE	0804_Marios_PD1_Inhib2_HP-AE104728-6.raw
SA089605	CA209025-17-473	CA209025-17-473_week 8	week 8	-	FAVORABLE	NIVOLUMAB	TRUE	7.524	Phase III_RCC_CA209025	US/CANADA	49	M	OTHER	0212_Marios_PD1_Inhib2_HP-AE302162-8.raw
SA089616	CA209025-22-935	CA209025-22-935_week 8	week 8	-	FAVORABLE	NIVOLUMAB	TRUE	24.772	Phase III_RCC_CA209025	US/CANADA	45	M	WHITE	1167_Marios_PD1_Inhib2_HP-AF009303-8.raw
SA089609	CA209025-25-197	CA209025-25-197_week 8	week 8	-	FAVORABLE	NIVOLUMAB	TRUE	34.530	Phase III_RCC_CA209025	US/CANADA	58	M	WHITE	0860_Marios_PD1_Inhib2_HP-AE371901-6.raw
SA089610	CA209025-26-693	CA209025-26-693_week 8	week 8	-	FAVORABLE	NIVOLUMAB	TRUE	31.343	Phase III_RCC_CA209025	US/CANADA	56	M	WHITE	0492_Marios_PD1_Inhib2_HP-AF003894-8.raw
SA089614	CA209025-30-418	CA209025-30-418_week 8	week 8	-	FAVORABLE	NIVOLUMAB	TRUE	44.058	Phase III_RCC_CA209025	US/CANADA	65	M	WHITE	0464_Marios_PD1_Inhib2_HP-AD810806-5.raw
SA089608	CA209025-63-607	CA209025-63-607_week 8	week 8	-	FAVORABLE	NIVOLUMAB	TRUE	12.518	Phase III_RCC_CA209025	WESTERN EUROPE	55	F	WHITE	0765_Marios_PD1_Inhib2_HP-E9241182-6.raw
SA089613	CA209025-75-191	CA209025-75-191_week 8	week 8	-	FAVORABLE	NIVOLUMAB	TRUE	42.185	Phase III_RCC_CA209025	WESTERN EUROPE	63	M	WHITE	0954_Marios_PD1_Inhib2_HP-E9479242-8.raw
SA089603	CA209025-75-84	CA209025-75-84_week 8	week 8	-	FAVORABLE	NIVOLUMAB	TRUE	44.583	Phase III_RCC_CA209025	WESTERN EUROPE	75	M	WHITE	0986_Marios_PD1_Inhib2_HP-E9479245-6.raw
SA089604	CA209025-94-851	CA209025-94-851_week 8	week 8	-	FAVORABLE	NIVOLUMAB	TRUE	23.688	Phase III_RCC_CA209025	REST OF WORLD	61	M	WHITE	0424_Marios_PD1_Inhib2_HP-S4102914-8.raw
SA089650	CA209025-1-1071	CA209025-1-1071_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	20.567	Phase III_RCC_CA209025	US/CANADA	64	F	WHITE	0050_Marios_PD1_Inhib2_HP-AF002688-13.raw
SA089642	CA209025-11-1073	CA209025-11-1073_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	38.571	Phase III_RCC_CA209025	US/CANADA	59	M	WHITE	0866_Marios_PD1_Inhib2_HP-AE487826-6.raw
SA089633	CA209025-113-206	CA209025-113-206_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	18.267	Phase III_RCC_CA209025	WESTERN EUROPE	62	M	WHITE	1045_Marios_PD1_Inhib2_HP-E9123619-6.raw
SA089634	CA209025-113-280	CA209025-113-280_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	39.261	Phase III_RCC_CA209025	WESTERN EUROPE	70	M	WHITE	0791_Marios_PD1_Inhib2_HP-E9123618-6.raw
SA089631	CA209025-113-570	CA209025-113-570_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	27.893	Phase III_RCC_CA209025	WESTERN EUROPE	67	F	WHITE	0196_Marios_PD1_Inhib2_HP-E9123617-6.raw
SA089688	CA209025-118-163	CA209025-118-163_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	41.232	Phase III_RCC_CA209025	WESTERN EUROPE	64	M	WHITE	0711_Marios_PD1_Inhib2_HP-EA044209-6.raw
SA089653	CA209025-126-101	CA209025-126-101_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	4.534	Phase III_RCC_CA209025	WESTERN EUROPE	56	M	WHITE	0950_Marios_PD1_Inhib2_HP-E9124113-6.raw
SA089670	CA209025-135-694	CA209025-135-694_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	38.407	Phase III_RCC_CA209025	REST OF WORLD	59	M	WHITE	0199_Marios_PD1_Inhib2_HP-L1379654-6.raw
SA089665	CA209025-138-814	CA209025-138-814_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	26.842	Phase III_RCC_CA209025	US/CANADA	71	M	WHITE	0249_Marios_PD1_Inhib2_HP-AF004081-8.raw
SA089664	CA209025-138-847	CA209025-138-847_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	25.134	Phase III_RCC_CA209025	US/CANADA	76	M	WHITE	0969_Marios_PD1_Inhib2_HP-AF004079-8.raw
SA089649	CA209025-143-115	CA209025-143-115_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	23.228	Phase III_RCC_CA209025	US/CANADA	45	M	WHITE	0459_Marios_PD1_Inhib2_HP-AD645865-6.raw
SA089669	CA209025-143-423	CA209025-143-423_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	24.181	Phase III_RCC_CA209025	US/CANADA	56	M	WHITE	0192_Marios_PD1_Inhib2_HP-AE077157-6.raw
SA089668	CA209025-143-794	CA209025-143-794_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	20.370	Phase III_RCC_CA209025	US/CANADA	85	M	WHITE	0114_Marios_PD1_Inhib2_HP-AF015781-8.raw
SA089660	CA209025-151-351	CA209025-151-351_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	35.121	Phase III_RCC_CA209025	REST OF WORLD	62	F	WHITE	0305_Marios_PD1_Inhib2_HP-EA251059-6.raw
SA089661	CA209025-15-379	CA209025-15-379_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	21.750	Phase III_RCC_CA209025	US/CANADA	64	M	WHITE	0699_Marios_PD1_Inhib2_HP-AE562616-6.raw
SA089652	CA209025-155-266	CA209025-155-266_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	23.622	Phase III_RCC_CA209025	REST OF WORLD	65	M	OTHER	1203_Marios_PD1_Inhib2_HP-S3795568-6.raw
SA089655	CA209025-155-632	CA209025-155-632_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	15.606	Phase III_RCC_CA209025	REST OF WORLD	42	M	OTHER	0389_Marios_PD1_Inhib2_HP-S3947233-6.raw
SA089659	CA209025-156-136	CA209025-156-136_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	45.897	Phase III_RCC_CA209025	REST OF WORLD	62	M	OTHER	1030_Marios_PD1_Inhib2_HP-S3509157-6.raw
SA089658	CA209025-1-5	CA209025-1-5_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	16.460	Phase III_RCC_CA209025	US/CANADA	78	F	WHITE	0750_Marios_PD1_Inhib2_HP-AD375474-6.raw
SA089689	CA209025-163-542	CA209025-163-542_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	21.815	Phase III_RCC_CA209025	REST OF WORLD	81	M	OTHER	0664_Marios_PD1_Inhib2_HP-S3940117-6.raw
SA089686	CA209025-1-682	CA209025-1-682_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	35.975	Phase III_RCC_CA209025	US/CANADA	60	F	WHITE	0743_Marios_PD1_Inhib2_HP-AE724953-6.raw
SA089685	CA209025-1-716	CA209025-1-716_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	44.583	Phase III_RCC_CA209025	US/CANADA	58	M	WHITE	1073_Marios_PD1_Inhib2_HP-AE724955-6.raw
SA089679	CA209025-17-213	CA209025-17-213_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	12.945	Phase III_RCC_CA209025	US/CANADA	70	M	WHITE	0904_Marios_PD1_Inhib2_HP-AE104726-6.raw
SA089678	CA209025-17-327	CA209025-17-327_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	30.324	Phase III_RCC_CA209025	US/CANADA	47	M	WHITE	0063_Marios_PD1_Inhib2_HP-AE302160-7.raw
SA089684	CA209025-179-484	CA209025-179-484_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	9.396	Phase III_RCC_CA209025	WESTERN EUROPE	52	M	WHITE	1214_Marios_PD1_Inhib2_HP-EA277677-6.raw
SA089627	CA209025-179-598	CA209025-179-598_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	6.045	Phase III_RCC_CA209025	WESTERN EUROPE	63	M	WHITE	0566_Marios_PD1_Inhib2_HP-E9758923-6.raw
SA089626	CA209025-180-936	CA209025-180-936_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	23.195	Phase III_RCC_CA209025	REST OF WORLD	53	M	WHITE	0374_Marios_PD1_Inhib2_HP-E9784769-6.raw
SA089628	CA209025-185-983	CA209025-185-983_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	20.008	Phase III_RCC_CA209025	US/CANADA	53	F	WHITE	1009_Marios_PD1_Inhib2_HP-AF016215-8.raw
SA089680	CA209025-1-997	CA209025-1-997_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	20.534	Phase III_RCC_CA209025	US/CANADA	64	M	WHITE	0802_Marios_PD1_Inhib2_HP-AF365621-8.raw
SA089646	CA209025-20-59	CA209025-20-59_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	12.747	Phase III_RCC_CA209025	US/CANADA	64	M	OTHER	0862_Marios_PD1_Inhib2_HP-AD612912-6.raw
SA089639	CA209025-20-914	CA209025-20-914_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	9.725	Phase III_RCC_CA209025	US/CANADA	54	M	WHITE	0510_Marios_PD1_Inhib2_HP-AE710626-6.raw
SA089620	CA209025-2-199	CA209025-2-199_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	10.448	Phase III_RCC_CA209025	WESTERN EUROPE	36	M	WHITE	0008_Marios_PD1_Inhib2_HP-E9130960-6.raw
SA089621	CA209025-23-922	CA209025-23-922_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	22.111	Phase III_RCC_CA209025	US/CANADA	58	M	WHITE	0184_Marios_PD1_Inhib2_HP-AF002762-8.raw
SA089638	CA209025-25-1042	CA209025-25-1042_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	9.429	Phase III_RCC_CA209025	US/CANADA	75	M	WHITE	1212_Marios_PD1_Inhib2_HP-AF565867-8.raw
SA089647	CA209025-2-57	CA209025-2-57_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	40.016	Phase III_RCC_CA209025	WESTERN EUROPE	38	M	WHITE	0146_Marios_PD1_Inhib2_HP-E9657535-6.raw
SA089648	CA209025-26-559	CA209025-26-559_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	10.645	Phase III_RCC_CA209025	US/CANADA	51	M	WHITE	0998_Marios_PD1_Inhib2_HP-AE488975-6.raw
SA089618	CA209025-26-965	CA209025-26-965_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	14.390	Phase III_RCC_CA209025	US/CANADA	50	M	WHITE	0941_Marios_PD1_Inhib2_HP-AF003898-8.raw
SA089643	CA209025-27-915	CA209025-27-915_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	8.706	Phase III_RCC_CA209025	US/CANADA	74	M	WHITE	0232_Marios_PD1_Inhib2_HP-AF009274-8.raw
SA089637	CA209025-29-938	CA209025-29-938_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	9.988	Phase III_RCC_CA209025	US/CANADA	63	M	WHITE	1006_Marios_PD1_Inhib2_HP-AF008976-8.raw
SA089636	CA209025-31-317	CA209025-31-317_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	10.711	Phase III_RCC_CA209025	US/CANADA	64	F	WHITE	0901_Marios_PD1_Inhib2_HP-AE467065-6.raw
SA089641	CA209025-3-253	CA209025-3-253_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	22.209	Phase III_RCC_CA209025	WESTERN EUROPE	63	F	WHITE	0731_Marios_PD1_Inhib2_HP-E9101854-6.raw
SA089625	CA209025-33-12	CA209025-33-12_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	24.608	Phase III_RCC_CA209025	WESTERN EUROPE	59	M	WHITE	0294_Marios_PD1_Inhib2_HP-E9101801-6.raw
SA089629	CA209025-33-257	CA209025-33-257_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	38.801	Phase III_RCC_CA209025	WESTERN EUROPE	80	M	WHITE	0932_Marios_PD1_Inhib2_HP-E9811947-6.raw
SA089622	CA209025-3-346	CA209025-3-346_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	14.423	Phase III_RCC_CA209025	WESTERN EUROPE	68	M	WHITE	0606_Marios_PD1_Inhib2_HP-E9101855-6.raw
SA089644	CA209025-37-93	CA209025-37-93_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	36.403	Phase III_RCC_CA209025	WESTERN EUROPE	57	M	WHITE	0532_Marios_PD1_Inhib2_HP-E9135875-6.raw
SA089645	CA209025-38-800	CA209025-38-800_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	15.212	Phase III_RCC_CA209025	WESTERN EUROPE	42	M	WHITE	0774_Marios_PD1_Inhib2_HP-E9134933-6.raw
SA089635	CA209025-42-46	CA209025-42-46_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	13.109	Phase III_RCC_CA209025	US/CANADA	70	M	WHITE	1153_Marios_PD1_Inhib2_HP-AD452695-6.raw
SA089640	CA209025-42-919	CA209025-42-919_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	23.359	Phase III_RCC_CA209025	US/CANADA	59	M	WHITE	0244_Marios_PD1_Inhib2_HP-AE601514-6.raw
SA089630	CA209025-48-582	CA209025-48-582_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	3.548	Phase III_RCC_CA209025	WESTERN EUROPE	61	M	WHITE	1195_Marios_PD1_Inhib2_HP-EA344251-6.raw
SA089623	CA209025-48-736	CA209025-48-736_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	23.195	Phase III_RCC_CA209025	WESTERN EUROPE	54	F	WHITE	0277_Marios_PD1_Inhib2_HP-EA344250-6.raw
SA089619	CA209025-49-664	CA209025-49-664_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	41.528	Phase III_RCC_CA209025	US/CANADA	75	M	WHITE	0899_Marios_PD1_Inhib2_HP-AE673153-6.raw
SA089632	CA209025-49-79	CA209025-49-79_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	13.339	Phase III_RCC_CA209025	US/CANADA	39	F	WHITE	0144_Marios_PD1_Inhib2_HP-AE354856-10.raw
SA089624	CA209025-58-739	CA209025-58-739_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	16.953	Phase III_RCC_CA209025	WESTERN EUROPE	65	F	OTHER	0022_Marios_PD1_Inhib2_HP-EA395245-6.raw
SA089657	CA209025-58-74	CA209025-58-74_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	15.376	Phase III_RCC_CA209025	WESTERN EUROPE	85	M	OTHER	0654_Marios_PD1_Inhib2_HP-E9425623-5.raw
SA089682	CA209025-62-523	CA209025-62-523_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	6.374	Phase III_RCC_CA209025	WESTERN EUROPE	64	M	WHITE	0651_Marios_PD1_Inhib2_HP-E9241323-6.raw
SA089690	CA209025-65-306	CA209025-65-306_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	20.797	Phase III_RCC_CA209025	WESTERN EUROPE	71	M	WHITE	0951_Marios_PD1_Inhib2_HP-E9778372-6.raw
SA089681	CA209025-69-810	CA209025-69-810_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	17.084	Phase III_RCC_CA209025	REST OF WORLD	74	F	WHITE	0887_Marios_PD1_Inhib2_HP-EA715964-8.raw
SA089677	CA209025-70-617	CA209025-70-617_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	3.943	Phase III_RCC_CA209025	REST OF WORLD	78	F	WHITE	0477_Marios_PD1_Inhib2_HP-EA088456-6.raw
SA089673	CA209025-70-678	CA209025-70-678_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	19.647	Phase III_RCC_CA209025	REST OF WORLD	59	M	WHITE	0980_Marios_PD1_Inhib2_HP-E9784272-6.raw
SA089675	CA209025-70-845	CA209025-70-845_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	11.236	Phase III_RCC_CA209025	REST OF WORLD	60	M	WHITE	0873_Marios_PD1_Inhib2_HP-EA715508-8.raw
SA089676	CA209025-70-883	CA209025-70-883_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	25.528	Phase III_RCC_CA209025	REST OF WORLD	77	M	WHITE	0702_Marios_PD1_Inhib2_HP-EA715506-8.raw
SA089683	CA209025-72-211	CA209025-72-211_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	4.895	Phase III_RCC_CA209025	WESTERN EUROPE	84	M	WHITE	0673_Marios_PD1_Inhib2_HP-E9145496-6.raw
SA089691	CA209025-73-512	CA209025-73-512_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	11.565	Phase III_RCC_CA209025	WESTERN EUROPE	69	M	WHITE	0913_Marios_PD1_Inhib2_HP-E9106383-6.raw
SA089687	CA209025-73-645	CA209025-73-645_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	9.166	Phase III_RCC_CA209025	WESTERN EUROPE	67	M	WHITE	0657_Marios_PD1_Inhib2_HP-EA474551-6.raw
SA089674	CA209025-80-184	CA209025-80-184_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	19.581	Phase III_RCC_CA209025	WESTERN EUROPE	63	M	WHITE	0649_Marios_PD1_Inhib2_HP-E9433499-6.raw
SA089671	CA209025-80-265	CA209025-80-265_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	16.920	Phase III_RCC_CA209025	WESTERN EUROPE	58	M	WHITE	0579_Marios_PD1_Inhib2_HP-EA083058-6.raw
SA089656	CA209025-80-656	CA209025-80-656_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	8.279	Phase III_RCC_CA209025	WESTERN EUROPE	66	M	WHITE	0809_Marios_PD1_Inhib2_HP-EA456769-5.raw
SA089672	CA209025-80-824	CA209025-80-824_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	14.982	Phase III_RCC_CA209025	WESTERN EUROPE	69	M	WHITE	1001_Marios_PD1_Inhib2_HP-EA813062-6.raw
SA089654	CA209025-82-506	CA209025-82-506_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	20.205	Phase III_RCC_CA209025	WESTERN EUROPE	64	M	WHITE	0674_Marios_PD1_Inhib2_HP-E9703917-6.raw
SA089651	CA209025-84-894	CA209025-84-894_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	5.651	Phase III_RCC_CA209025	REST OF WORLD	49	M	WHITE	0821_Marios_PD1_Inhib2_HP-L1448910-11.raw
SA089667	CA209025-90-247	CA209025-90-247_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	8.871	Phase III_RCC_CA209025	WESTERN EUROPE	60	F	WHITE	0104_Marios_PD1_Inhib2_HP-E9792547-6.raw
SA089666	CA209025-93-460	CA209025-93-460_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	13.865	Phase III_RCC_CA209025	WESTERN EUROPE	66	F	WHITE	0690_Marios_PD1_Inhib2_HP-EA214041-6.raw
SA089662	CA209025-95-318	CA209025-95-318_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	20.764	Phase III_RCC_CA209025	REST OF WORLD	70	M	WHITE	0764_Marios_PD1_Inhib2_HP-S3792628-6.raw
SA089663	CA209025-95-721	CA209025-95-721_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	FALSE	5.684	Phase III_RCC_CA209025	REST OF WORLD	49	M	WHITE	0574_Marios_PD1_Inhib2_HP-S4110491-8.raw
SA089694	CA209025-126-149	CA209025-126-149_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	TRUE	21.388	Phase III_RCC_CA209025	WESTERN EUROPE	59	M	WHITE	0309_Marios_PD1_Inhib2_HP-E9124112-6.raw
SA089693	CA209025-138-480	CA209025-138-480_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	TRUE	28.255	Phase III_RCC_CA209025	US/CANADA	60	M	WHITE	0612_Marios_PD1_Inhib2_HP-AE428483-6.raw
SA089692	CA209025-138-619	CA209025-138-619_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	TRUE	16.723	Phase III_RCC_CA209025	US/CANADA	73	M	WHITE	0858_Marios_PD1_Inhib2_HP-AE428482-6.raw
SA089701	CA209025-139-989	CA209025-139-989_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	TRUE	26.086	Phase III_RCC_CA209025	US/CANADA	65	M	WHITE	0122_Marios_PD1_Inhib2_HP-AF438577-8.raw
SA089696	CA209025-158-183	CA209025-158-183_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	TRUE	19.023	Phase III_RCC_CA209025	REST OF WORLD	51	F	OTHER	0946_Marios_PD1_Inhib2_HP-S3653087-6.raw
SA089698	CA209025-160-786	CA209025-160-786_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	TRUE	8.904	Phase III_RCC_CA209025	REST OF WORLD	74	F	OTHER	0854_Marios_PD1_Inhib2_HP-S4103654-7.raw
SA089700	CA209025-164-901	CA209025-164-901_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	TRUE	25.823	Phase III_RCC_CA209025	REST OF WORLD	65	F	OTHER	0356_Marios_PD1_Inhib2_HP-S4093211-8.raw
SA089699	CA209025-166-957	CA209025-166-957_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	TRUE	13.963	Phase III_RCC_CA209025	REST OF WORLD	68	M	OTHER	1033_Marios_PD1_Inhib2_HP-S4152611-8.raw
SA089695	CA209025-23-20	CA209025-23-20_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	TRUE	43.335	Phase III_RCC_CA209025	US/CANADA	66	F	WHITE	0816_Marios_PD1_Inhib2_HP-AD490513-6.raw
SA089697	CA209025-23-72	CA209025-23-72_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	TRUE	13.175	Phase III_RCC_CA209025	US/CANADA	77	M	WHITE	0515_Marios_PD1_Inhib2_HP-AD461620-6.raw
SA089711	CA209025-27-906	CA209025-27-906_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	TRUE	17.150	Phase III_RCC_CA209025	US/CANADA	66	M	WHITE	1187_Marios_PD1_Inhib2_HP-AF009275-8.raw
SA089713	CA209025-39-150	CA209025-39-150_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	TRUE	14.324	Phase III_RCC_CA209025	WESTERN EUROPE	53	M	OTHER	1133_Marios_PD1_Inhib2_HP-E9210504-6.raw
SA089715	CA209025-44-785	CA209025-44-785_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	TRUE	26.316	Phase III_RCC_CA209025	US/CANADA	70	M	WHITE	0098_Marios_PD1_Inhib2_HP-AF016227-8.raw
SA089705	CA209025-48-284	CA209025-48-284_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	TRUE	15.836	Phase III_RCC_CA209025	WESTERN EUROPE	74	M	WHITE	0158_Marios_PD1_Inhib2_HP-EA344248-6.raw
SA089706	CA209025-48-500	CA209025-48-500_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	TRUE	5.552	Phase III_RCC_CA209025	WESTERN EUROPE	69	M	WHITE	0028_Marios_PD1_Inhib2_HP-EA344247-6.raw
SA089714	CA209025-63-790	CA209025-63-790_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	TRUE	8.706	Phase III_RCC_CA209025	WESTERN EUROPE	64	F	WHITE	0265_Marios_PD1_Inhib2_HP-E9241183-6.raw
SA089704	CA209025-79-73	CA209025-79-73_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	TRUE	45.175	Phase III_RCC_CA209025	REST OF WORLD	48	F	WHITE	0989_Marios_PD1_Inhib2_HP-L1293277-5.raw
SA089707	CA209025-82-139	CA209025-82-139_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	TRUE	4.370	Phase III_RCC_CA209025	WESTERN EUROPE	56	F	WHITE	0372_Marios_PD1_Inhib2_HP-E9190484-6.raw
SA089712	CA209025-82-355	CA209025-82-355_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	TRUE	4.205	Phase III_RCC_CA209025	WESTERN EUROPE	62	M	WHITE	0099_Marios_PD1_Inhib2_HP-E9190485-6.raw
SA089709	CA209025-89-129	CA209025-89-129_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	TRUE	4.304	Phase III_RCC_CA209025	WESTERN EUROPE	52	F	WHITE	0864_Marios_PD1_Inhib2_HP-E9103856-6.raw
SA089708	CA209025-90-30	CA209025-90-30_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	TRUE	9.593	Phase III_RCC_CA209025	WESTERN EUROPE	74	F	WHITE	0384_Marios_PD1_Inhib2_HP-E9103104-6.raw
SA089703	CA209025-9-754	CA209025-9-754_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	TRUE	34.037	Phase III_RCC_CA209025	US/CANADA	71	M	WHITE	1100_Marios_PD1_Inhib2_HP-AF002794-8.raw
SA089702	CA209025-97-569	CA209025-97-569_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	TRUE	29.766	Phase III_RCC_CA209025	REST OF WORLD	65	M	OTHER	0500_Marios_PD1_Inhib2_HP-S3722563-6.raw
SA089710	CA209025-98-673	CA209025-98-673_week 8	week 8	-	INTERMEDIATE	NIVOLUMAB	TRUE	11.499	Phase III_RCC_CA209025	REST OF WORLD	76	F	WHITE	0883_Marios_PD1_Inhib2_HP-S3862099-7.raw
SA089720	CA209025-102-86	CA209025-102-86_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	11.729	Phase III_RCC_CA209025	WESTERN EUROPE	56	M	WHITE	0494_Marios_PD1_Inhib2_HP-E9191097-6.raw
SA089745	CA209025-11-482	CA209025-11-482_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	4.501	Phase III_RCC_CA209025	US/CANADA	66	F	OTHER	0461_Marios_PD1_Inhib2_HP-AE487827-6.raw
SA089731	CA209025-119-192	CA209025-119-192_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	34.333	Phase III_RCC_CA209025	WESTERN EUROPE	66	F	WHITE	0686_Marios_PD1_Inhib2_HP-E9124259-6.raw
SA089719	CA209025-125-647	CA209025-125-647_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	35.253	Phase III_RCC_CA209025	REST OF WORLD	54	M	WHITE	0813_Marios_PD1_Inhib2_HP-L1426709-6.raw
SA089732	CA209025-12-65	CA209025-12-65_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	28.058	Phase III_RCC_CA209025	WESTERN EUROPE	60	M	WHITE	0705_Marios_PD1_Inhib2_HP-E9124691-6.raw
SA089736	CA209025-13-111	CA209025-13-111_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	25.002	Phase III_RCC_CA209025	US/CANADA	60	M	WHITE	0571_Marios_PD1_Inhib2_HP-AE059528-6.raw
SA089738	CA209025-143-515	CA209025-143-515_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	9.068	Phase III_RCC_CA209025	US/CANADA	60	M	WHITE	0616_Marios_PD1_Inhib2_HP-AF015780-8.raw
SA089744	CA209025-144-451	CA209025-144-451_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	22.439	Phase III_RCC_CA209025	US/CANADA	57	M	WHITE	0252_Marios_PD1_Inhib2_HP-AE506729-6.raw
SA089753	CA209025-144-596	CA209025-144-596_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	22.867	Phase III_RCC_CA209025	US/CANADA	53	M	WHITE	0641_Marios_PD1_Inhib2_HP-AE673812-6.raw
SA089751	CA209025-153-416	CA209025-153-416_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	5.092	Phase III_RCC_CA209025	US/CANADA	66	M	WHITE	0964_Marios_PD1_Inhib2_HP-AE613294-6.raw
SA089722	CA209025-165-83	CA209025-165-83_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	27.368	Phase III_RCC_CA209025	REST OF WORLD	72	M	OTHER	0035_Marios_PD1_Inhib2_HP-S3475421-6.raw
SA089721	CA209025-179-521	CA209025-179-521_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	6.439	Phase III_RCC_CA209025	WESTERN EUROPE	49	M	WHITE	1136_Marios_PD1_Inhib2_HP-EA277675-6.raw
SA089726	CA209025-17-981	CA209025-17-981_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	27.926	Phase III_RCC_CA209025	US/CANADA	57	M	WHITE	0630_Marios_PD1_Inhib2_HP-AF015805-8.raw
SA089748	CA209025-20-781	CA209025-20-781_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	36.961	Phase III_RCC_CA209025	US/CANADA	48	M	WHITE	0286_Marios_PD1_Inhib2_HP-AF002825-8.raw
SA089746	CA209025-21-1050	CA209025-21-1050_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	25.988	Phase III_RCC_CA209025	US/CANADA	65	M	WHITE	0452_Marios_PD1_Inhib2_HP-AF667456-8.raw
SA089750	CA209025-21-308	CA209025-21-308_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	18.300	Phase III_RCC_CA209025	US/CANADA	55	M	WHITE	0134_Marios_PD1_Inhib2_HP-AE206924-6.raw
SA089735	CA209025-23-9	CA209025-23-9_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	12.255	Phase III_RCC_CA209025	US/CANADA	69	M	WHITE	0449_Marios_PD1_Inhib2_HP-AD461621-6.raw
SA089743	CA209025-25-130	CA209025-25-130_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	13.602	Phase III_RCC_CA209025	US/CANADA	63	M	WHITE	0317_Marios_PD1_Inhib2_HP-AD610067-6.raw
SA089740	CA209025-25-987	CA209025-25-987_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	10.218	Phase III_RCC_CA209025	US/CANADA	85	M	WHITE	0195_Marios_PD1_Inhib2_HP-AF009262-8.raw
SA089723	CA209025-27-566	CA209025-27-566_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	9.593	Phase III_RCC_CA209025	US/CANADA	58	M	WHITE	0457_Marios_PD1_Inhib2_HP-AE302635-6.raw
SA089718	CA209025-2-76	CA209025-2-76_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	20.403	Phase III_RCC_CA209025	WESTERN EUROPE	48	F	WHITE	0136_Marios_PD1_Inhib2_HP-E9657534-6.raw
SA089739	CA209025-30-695	CA209025-30-695_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	9.528	Phase III_RCC_CA209025	US/CANADA	62	F	WHITE	0235_Marios_PD1_Inhib2_HP-AE817161-6.raw
SA089734	CA209025-33-7	CA209025-33-7_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	20.698	Phase III_RCC_CA209025	WESTERN EUROPE	30	F	WHITE	0542_Marios_PD1_Inhib2_HP-E9101803-6.raw
SA089737	CA209025-39-102	CA209025-39-102_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	11.663	Phase III_RCC_CA209025	WESTERN EUROPE	68	M	WHITE	1011_Marios_PD1_Inhib2_HP-E9210506-6.raw
SA089733	CA209025-42-316	CA209025-42-316_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	6.538	Phase III_RCC_CA209025	US/CANADA	52	M	WHITE	0210_Marios_PD1_Inhib2_HP-AE155091-6.raw
SA089729	CA209025-61-146	CA209025-61-146_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	13.437	Phase III_RCC_CA209025	WESTERN EUROPE	66	M	WHITE	0706_Marios_PD1_Inhib2_HP-E9240792-6.raw
SA089724	CA209025-62-225	CA209025-62-225_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	8.312	Phase III_RCC_CA209025	WESTERN EUROPE	42	M	WHITE	0394_Marios_PD1_Inhib2_HP-E9241321-6.raw
SA089725	CA209025-70-347	CA209025-70-347_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	42.382	Phase III_RCC_CA209025	REST OF WORLD	71	M	WHITE	0297_Marios_PD1_Inhib2_HP-EA088461-6.raw
SA089727	CA209025-71-709	CA209025-71-709_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	17.051	Phase III_RCC_CA209025	REST OF WORLD	68	M	WHITE	1184_Marios_PD1_Inhib2_HP-EA444380-6.raw
SA089728	CA209025-73-178	CA209025-73-178_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	15.343	Phase III_RCC_CA209025	WESTERN EUROPE	51	M	WHITE	0919_Marios_PD1_Inhib2_HP-E9106380-6.raw
SA089717	CA209025-82-302	CA209025-82-302_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	5.027	Phase III_RCC_CA209025	WESTERN EUROPE	63	M	WHITE	0787_Marios_PD1_Inhib2_HP-E9703915-6.raw
SA089749	CA209025-85-940	CA209025-85-940_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	9.331	Phase III_RCC_CA209025	REST OF WORLD	76	M	WHITE	1102_Marios_PD1_Inhib2_HP-L1453016-8.raw
SA089747	CA209025-85-992	CA209025-85-992_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	13.339	Phase III_RCC_CA209025	REST OF WORLD	58	M	WHITE	1016_Marios_PD1_Inhib2_HP-L1497984-11.raw
SA089716	CA209025-8-628	CA209025-8-628_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	44.386	Phase III_RCC_CA209025	WESTERN EUROPE	73	M	WHITE	0481_Marios_PD1_Inhib2_HP-E9125208-6.raw
SA089752	CA209025-89-34	CA209025-89-34_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	48.526	Phase III_RCC_CA209025	WESTERN EUROPE	60	M	WHITE	0431_Marios_PD1_Inhib2_HP-E9103858-6.raw
SA089742	CA209025-95-331	CA209025-95-331_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	46.686	Phase III_RCC_CA209025	REST OF WORLD	62	M	WHITE	0119_Marios_PD1_Inhib2_HP-S3792627-6.raw
SA089741	CA209025-95-681	CA209025-95-681_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	4.862	Phase III_RCC_CA209025	REST OF WORLD	66	M	WHITE	0523_Marios_PD1_Inhib2_HP-S4110494-8.raw
SA089730	CA209025-98-547	CA209025-98-547_week 8	week 8	-	POOR	NIVOLUMAB	FALSE	9.396	Phase III_RCC_CA209025	REST OF WORLD	48	F	WHITE	0693_Marios_PD1_Inhib2_HP-S4110018-8.raw
SA089763	CA209025-139-1025	CA209025-139-1025_week 8	week 8	-	POOR	NIVOLUMAB	TRUE	6.209	Phase III_RCC_CA209025	US/CANADA	72	F	WHITE	0852_Marios_PD1_Inhib2_HP-AF438576-8.raw
SA089757	CA209025-139-140	CA209025-139-140_week 8	week 8	-	POOR	NIVOLUMAB	TRUE	45.470	Phase III_RCC_CA209025	US/CANADA	70	M	WHITE	0256_Marios_PD1_Inhib2_HP-AD783023-6.raw
SA089754	CA209025-139-359	CA209025-139-359_week 8	week 8	-	POOR	NIVOLUMAB	TRUE	32.723	Phase III_RCC_CA209025	US/CANADA	61	M	WHITE	0948_Marios_PD1_Inhib2_HP-AE490137-6.raw
SA089755	CA209025-158-70	CA209025-158-70_week 8	week 8	-	POOR	NIVOLUMAB	TRUE	26.711	Phase III_RCC_CA209025	REST OF WORLD	39	F	OTHER	0002_Marios_PD1_Inhib2_HP-S3473963-6.raw
SA089762	CA209025-25-930	CA209025-25-930_week 8	week 8	-	POOR	NIVOLUMAB	TRUE	7.655	Phase III_RCC_CA209025	US/CANADA	56	M	WHITE	0044_Marios_PD1_Inhib2_HP-AF009261-8.raw
SA089759	CA209025-41-485	CA209025-41-485_week 8	week 8	-	POOR	NIVOLUMAB	TRUE	7.491	Phase III_RCC_CA209025	US/CANADA	71	M	WHITE	0345_Marios_PD1_Inhib2_HP-AE525983-24.raw
SA089761	CA209025-56-522	CA209025-56-522_week 8	week 8	-	POOR	NIVOLUMAB	TRUE	4.731	Phase III_RCC_CA209025	WESTERN EUROPE	40	M	WHITE	0830_Marios_PD1_Inhib2_HP-E9106996-6.raw
SA089760	CA209025-62-552	CA209025-62-552_week 8	week 8	-	POOR	NIVOLUMAB	TRUE	3.253	Phase III_RCC_CA209025	WESTERN EUROPE	50	M	WHITE	1220_Marios_PD1_Inhib2_HP-E9241319-6.raw
SA089758	CA209025-69-539	CA209025-69-539_week 8	week 8	-	POOR	NIVOLUMAB	TRUE	18.136	Phase III_RCC_CA209025	REST OF WORLD	54	F	WHITE	0281_Marios_PD1_Inhib2_HP-EA350205-6.raw
SA089756	CA209025-89-132	CA209025-89-132_week 8	week 8	-	POOR	NIVOLUMAB	TRUE	10.218	Phase III_RCC_CA209025	WESTERN EUROPE	64	M	WHITE	0221_Marios_PD1_Inhib2_HP-E9103859-6.raw